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Abstract
Mathematical models have been used to study the cell cycle for the last 50 years. Now
it is well established that cell replication is a controlled process with sequential and timely
activation and degradation of cyclins leading to swift transitions between the phases of the
cell cycle. The essential achievement in identifying the key components and in dissecting
the mechanisms of the cell cycle circuitry has been attributed to the simultaneous use of
model systems like yeast, frogs, sea urchin, starfish, and flies. Present understanding of the
cell cycle needs to be extended to investigate whether those findings also apply to mam-
malian in-vivo models like mice. Some mammalian cell cycle models exist focusing on
specific check points or transitions, but there is no integrated model yet where the cell cycle
is induced after injury in the mammalian cells.
Liver regeneration is one of the most synchronised cell proliferation phenomenon, where
95% of the cells simultaneously enter cell cycle after being induced by injury. Therefore
cell cycle in regenerating livers was chosen as the model system. Focusing on how injury
induced pro-inflammatory signals prime the cells in G1 phase and consequently both cy-
tokine and growth factor induced pathways lead to further cell cycle progression, the G1-S
phase transition was modeled. The model was further extended to mitotic events leading to
the all-or-none G2-M transition and mitotic exit. I focussed on the emerging role of Cdh1
in the mammalian cell cycle. Cdh1 is known to play a key role in maintaining quiescence
during G1. The role of Cdh1 in the G2 delay was further investigated. Cdh1 was suggested
to be at the core of the cell cycle machinery controlling cyclin dynamics.
This model is an attempt in understanding core machinery of the mammalian cell cycle.
Better understanding of the cell cycle control system in mammalian cells would enable
studying cell physiology in a larger context of response to the environmental changes and
heterogeneous cell proliferation at the tissue level. This leads to the major goal of cell cycle
modeling in understanding perturbations of the human cell cycle machinery which lead to
diseases like cancers.
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Zusammenfassung
Während der letzten 50 Jahre wurden mathematische Modelle zum Studium des Zell-
zyklus verwendet. Nach dem heutigen Verständnis ist die Zellreplikation ein kontrollierter
Prozess aus sequentieller und zeitlich koordinierter Aktivierung und Abbau von Zyklinen,
die einen schnellen Übergang zwischen den Zyklusphasen ermöglichen. Dabei ist der Er-
folg bei der Ermittlung der wichtigsten Komponenten und Aufgliederung der Schaltmecha-
nismen im Wesentlichen auf die gleichzeitige Anwendung von Modellsystemen wie Hefe,
Frosch, Seeigel, Seestern und Fliege zurückzuführen. Das heutige Verständnis des Zellzy-
klus muss erweitert werden, um zu überprüfen ob die Erkenntnisse auch auf in-vivo Mo-
delle von Säugetieren wie der Maus zutreffen. Es existieren solche Modelle, die sich auf
spezifische Kontrollpunkte oder Übergänge konzentrieren, allerdings noch kein integriertes
Modell, in dem der Zellzyklus durch eine Verletzung im Säugetier induziert wird.
Das Modellsystem der Leberregeneration bei Nagern wurde gewählt, da es sich durch
das am höchsten verbreitete Phänomen der Synchronisation der Zellproliferation auszeich-
net. Hierbei treten 95% der Zellen nach einer Verletzung gleichzeitig in den Zellzyklus ein.
Mit dem Fokus auf die Frage, wie die Zellen durch pro-inflammatorische Signale nach Ver-
letzungen ins Priming in der G1 Phase eintreten, gingen wir in einen durch Zytokine und
Wachstumsfaktoren induzierten Säugetier-Zellzyklus über. Dank der gut untersuchten G1-
S-Phase der Leberregeneration konnten wir die nachgelagerten, durch pro-inflammatorische
Zytokine und Wachstumsfaktoren induzierte Signalwege modellieren, die nach einer Ver-
letzung zum G1/S- Übergang in der Leber führen. Weiterhin wurden mitotische Ereignisse
modelliert, die zum Alles-oder-Nichts G2/M Übergang und dem mitotischen Ausgang füh-
ren. Wir konzentrieren uns auf die vielversprechende Funktion von Cdh1 in der Zellzyklus-
kontrolle, welches bekanntlich eine Schlüsselrolle in der Aufrechterhaltung der Ruhephase
während der G1 Phase spielt. Weiterhin haben wir dessen Rolle bei der Verzögerung der
G2 Phase untersucht. Wir vermuten eine zentrale Rolle von Cdh1 im Zellzyklus durch die
Kontrolle der Dynamik der Zykline.
Das Modell ist ein Versuch, die Kernmechanismen der Zellzykluskontrolle bei Säugetie-
ren zu verstehen. Besseres Verständnis der Mechanismen in der Säugetierzelle würde das
Studium der Zellphysiologie im größeren Zusammenhang der Antwort auf Umweltverände-
rungen und der heterogenen Zellproliferation auf Gewebeebene ermöglichen. Diese Schritte
führen zum großen Ziel der künftigen Zellzyklusmodellierung im Hinblick auf Störungen
der humanen Zellzyklusmaschinerie, welche zu Krankheiten wie Krebs führen.
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1 Liver regeneration
Synopsis
Liver regeneration after surgical resection is one of the most studied models of cell, organ,
and tissue regeneration. The complexity of the signaling pathways initiating and terminating
this process have provided paradigms for regenerative medicine. Many aspects of the signaling
mechanisms involved in hepatic regeneration are under active investigation. The purpose of
this chapter is to introduce regeneration phenomena observed in rodents giving insights into the
signals controlling the proliferation, function and structure of the liver during liver regeneration.
1.1 The liver
Figure 1.1:
Liver anatomy. Liver consists of two main lobes: left lobe and right lobe. Blood from heart and intestines is supplied
to liver through the portal vein and purified blood leaves through the hepatic vein. Upon injury the cell proliferation
first begins in the cells that surround the portal vein of the liver lobule and then proceed towards the hepatic artery.
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Figure 1.2:
Liver lobule. Lobule is the functional unit of liver. Hepatocytes are the main cell types in the lobules which arrange
themselves into hepatic plates. Sinusoids surround these hepatic plates and maintain the flow of blood between
branches of portal and hepatic veins supplying essential nutrients to the cells.
The liver is an important organ of the body that has a central role in metabolic homeostasis, as
it is responsible for the metabolism, synthesis, storage and redistribution of nutrients, carbohy-
drates, fats and vitamins. The liver produces large numbers of serum proteins including albumin,
acute-phase proteins, enzymes and cofactors. Importantly, it is the main detoxifying organ of
the body removing wastes and xenobiotics by metabolic conversion and biliary excretion. There
are two distinct sources that supply blood to the liver: 1) oxygenated blood flows in from the
hepatic artery; 2) nutrient-rich blood flows in from the hepatic portal vein (Fig. 1.1).
At the central area the common bile duct, portal vein, and hepatic artery enter the liver. Branches
of the hepatic artery and portal vein guide blood to the periportal regions of the lobules. From
there, it flows through microvessels, the sinusoids, along hepatocyte columns that are lined with
endothelial cells (generally known as sinusoidal cells), and drains into the central vein. The
liver consists of two main lobes. These lobes are organized in repetitive functional units called
liver lobules, which besides its main constituents, hepatocytes, consists of sinusoidal endothelial
cells, Kupffer, stellate, and bile duct cells. Upon injury the cell proliferation first begins in
the cells that surround the portal vein of the liver lobule and then proceed towards the central
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vein. The complex lobule architecture ensures a maximal exchange area between blood and
hepatocytes in healthy liver (Fig. 1.2). In liver disease, such as hepatocellular cancer, the contact
surface between hepatocytes and sinusoidal cells decreases and contributes to compromised liver
function (Hoehme et al., 2010) .
1.2 Liver regeneration
Figure 1.3:
Liver regeneration legend: Prometheus revisited. Liver is the main detoxifying organ of the body. Thus nature
provides it with a remarkable regeneration capacity against injury from ingested toxins. First depiction of liver
regeneration capacity can be traced back in the Greek myth. Prometheus was punished by Gods of Olympus for
stealing the secret of fire from them. A portion of his liver was eaten up by an eagle daily, which regenerated
overnight and provided eagle with eternal food and Prometheus with eternal pain (Taub, 2004).
Being the main detoxifying organ of the body, it is quite susceptible to get damaged by ingested
toxins. In order to maintain its architecture and function, nature provides it with a remarkable
capacity to regenerate after injury by counterbalancing the cell death with compensatory cell
division. Earliest recognition of its extraordinary regenerative capacity can be found in Greek
myth of Prometheus. Gods of Olympus punished prometheus for stealing the secret of fire from
them. A portion of his liver was eaten up by an eagle daily, which regenerated overnight, thus
providing eagle with eternal food and Prometheus with eternal pain (Fig. 1.3). Although adult
hepatocytes are long lived and normally do not undergo cell division, they maintain the ability
to proliferate in response to toxic injury and infection.
Remarkable capacity of liver to regenerate after injury and to adjust its size to match its host
has intrigued scientists since many years. The regenerative process is compensatory because the
3
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size of the resultant liver is determined by the demands of the organism, and, once the original
mass of the liver has been re-established, proliferation stops. Adding to its adaptive capacity, in
some cases, transplanting liver from a baboon to a human, caused liver to grow to the size of the
human liver and transplanting liver from a large dog to a small dog led to loss of liver mass until
it reached the size appropriate to the small dog (Michalopoulos and DeFrances, 1997). There are
various central questions regarding the process of liver regeneration. What triggers the process
of liver regeneration? How the size and function of liver is maintained during regeneration?
What turns off the phenomenon once the liver mass is reconstituted? Understanding the process
might assist in treatment of serious liver diseases and may also find implications for certain types
of gene therapies.
1.3 Experimental animal models of liver regeneration
Most studied experimental models of liver regeneration are those of rodents (mouse and rat).
Studies with hepatic resections in larger animals (dogs and primates) and humans have estab-
lished that the regenerative response is proportional to the amount of liver removed. Studies
on transplantation of liver from other bigger animals to humans (Francavilla et al., 1992; Starzl
et al., 1993) demonstrate that liver mass is precisely regulated and that signals from the body
can have negative as well as positive effects on liver mass until the correct size is reached. Type
of liver injury inflicted to the animal can be classified into two types: 1) Partial hepatectomy and
2) Cell necrosis .
Partial hepatectomy Partial hepatectomy is the surgical removal of a part of liver. Bucher
and Swaffield (1964) show that the extent of hepatocyte replication in the regenerating liver of
adult rats is proportional to the amount of tissue resected for resections involving 40-70% of
the liver. Removal of 30% of the liver lies below this threshold and does not elicit a clear wave
of DNA replication. Liver regeneration phenomena is most clearly shown by the 70% partial
hepatectomy model in rodents, which was pioneered by Higgins and Anderson in 1931 (Higgins
and Anderson, 1931) . It is a simple operation (partial hepatectomy, PH) in which two-thirds of
the liver of a rat is removed. Specific liver lobes are removed intact, without damage to the lobes
left behind. The residual lobes enlarge to make up for the mass of the removed lobes, though the
resected lobes never grow back. The whole process lasts 5 to 7 days.
Cell necrosis In this model hepatocytes are directly damaged and thereby induced to undergo
necrosis, similar growth-factor- and cytokine mediated pathways are activated as occurs after
partial hepatectomy (Dabeva and Shafritz, 1993). Proliferation of hepatocytes is also involved in
the liver regeneration that occurs after massive hepatocyte necrosis, or apoptosis that is induced
by hepatic toxins such as CCl4 or systemically introduced Fas ligand, but the cell-cycle response
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is not as synchronized (Fausto, 1999). As expected, there are also significant changes in liver
architecture during liver regeneration, both after partial hepatectomy and liver necrosis.
1.4 Patterns of DNA synthesis and gene expression during
regeneration
Figure 1.4:
Patterns of DNA synthesis and gene expression during rat liver regeration. (a) After partial hepatectomy, DNA
synthesis in hepatocytes (H; green) peaks around 24 hours, whereas DNA synthesis in the non-parenchymal cells
(NP; yellow) peaks around 36–48 hours. Re-accumulation of liver mass (red) is complete within a week. (b) The
induction pattern of gene expression for growth-regulated genes, such as -actin. (c) The induction pattern of gene
expression for cell-cycle-regulated genes, such as insulin-like-growth-factor-binding protein-1 (IGFBP1). (d) Some
genes, such as that encoding the isoform of CCAAT-enhancer-binding protein (C/EBP), are downregulated during
the period of maximal growth and are re-expressed after the growth phase has occurred (Taub, 2004). Note that in
mice DNA synthesis peaks 12–16 hours later compared to rat (Weglarz and Sandgren, 2000)
Cell division is rarely seen in hepatocytes in the normal adult liver, as these cells are in the G0
phase of the cell cycle (Michalopoulos and DeFrances, 1997; Webber et al., 1994). However,
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after partial hepatectomy approximately 95% of hepatic cells, which are normally quiescent,
rapidly re-enter the cell cycle. In the rat liver, the rate of DNA synthesis in hepatocytes begins
to increase after about 12 hours as they enter the S phase of the cell cycle and peaks around 24
hours (Fig. 1.4). However, the induction of DNA synthesis occurs later in the non-parenchymal
cells (at 48 hours for Kupffer and biliary epithelial cells, and at 96 hours for endothelial cells).
Subsequent levels of DNA synthesis in hepatocytes are lower, as complete restoration of liver
mass requires an average of 1.6 cycles of replication in all cells. By comparison, the peak in
DNA synthesis in mice occurs later (36–40 hours after partial hepatectomy) and varies between
strains. The onset of DNA synthesis is well-synchronized in hepatocytes, beginning in cells that
surround the portal vein of the liver lobule and proceeding towards the central vein. The inci-
dence of mitosis (M phase) is lower than is predicted on the basis of the number of hepatocytes
that undergo DNA synthesis, and the ploidy of hepatocytes and percentage of binucleate cells
increases with successive rounds of DNA synthesis, which ultimately limits further regenera-
tion. Most of the increase in liver mass has occurred by 3 days after partial hepatectomy and
mass restoration is complete in 5–7 days (Taub, 2004).
Changes in gene expression associated with regeneration are observed within minutes of hepatic
resection (Fig. 1.4). Growth regulated genes demonstrate elevated expression throughout the
entire growth phase and expression returns to normal after about three days. Cell cycle regulated
genes show a sharp peak of expression that coincides with the G1 phase of hepatocyte cell cycle,
including the first round of replication and a second smaller round of replication that occurs 48
hours after 2/3 PH. In this way a cell cycle regulated cascade of gene and protein expression
allows cells to progress through the G1 phase of cell cycle. Ultimately, changes in the levels of
cyclins and their regulatory kinases allow for transition through the late phases of G1 (D-type
cyclins) into S phase (Cyclin E) (Taub, 2004).
1.5 Autonomy vs circadian control of liver regeneration
The extent and timing of liver regeneration are known to vary according to circadian rhythms
(Barbason et al., 1995); a recent study has identified a mechanism by which these rhythms
control hepatocyte proliferation after PH. In these experiments, the peak of DNA replication
after PH in mice always occurred 36 hours after the operation, regardless of the time of the day
at which the procedure was performed. The entry of cells that had replicated their DNA (G2
cells) into mitosis, however, always occurred at the same time of day. This finding suggests that
a circadian clock controls the G2/M transition (Matsuo et al., 2003b).
On the other hand, the timing of DNA replication, which is not under the control of circadian
rhythms, appears to be an intrinsic property of hepatocytes. Rats and mice differ in the timing
of DNA replication after PH, which is 12 to 16 hours earlier in rats. Weglarz and Sandgren
(2000) transplanted rat hepatocytes into the livers of mice after PH and found that rat hepatocytes
replicated earlier than mouse hepatocytes in the resultant chimeric liver. These results indicate
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that the timing of hepatocyte DNA replication after PH is an autonomous process, primarily
guided by intrinsic signals .
1.6 Metabolic pathways and liver regeneration
Liver regeneration after PH is a perfectly calibrated response whose apparent sensor is the body’s
requirement for liver function. The increased metabolic demands imposed on the liver remnant
after PH are likely connected with activation of the machinery directly involved in DNA replica-
tion. mTOR (mammalian target of rapamycin) is part of a complex that senses nutrient or energy
status, and also integrates growth factor signals. In the regenerating liver, rapamycin – a phar-
maceutical agent that is known to block hepatic regeneration – inhibits the activation of Cyclin
D through the inhibition of mTOR, thereby preventing progression through G1 and entry into
the DNA-synthesis phase of the cell cycle (Taub, 2004). The mTOR complex may regulate liver
regeneration by modulating cell growth and proliferation in response to the energy demands of
the remaining liver, given that rapamycin, an inhibitor of mTOR, inhibits DNA replication after
PH.
Several of the liver-restricted immediate-early genes encode enzymes and proteins that are in-
volved in regulating the gluconeogenic response of the liver. Gluconeogenesis results in the net
production of glucose by the liver, which increases the serum glucose level and can also be used
to produce glycogen, glycoproteins and other sugars. The induction of gluconeogenic genes by
partial hepatectomy represents an adaptive response of the liver whereby the remaining third
of the liver compensates to produce sufficient glucose for the whole organism. Liver-specific
transcription factors have an important role in determining liver-specific functions, including
the level of glucose production, by regulating the expression of genes that encode liver-specific
enzymes (such as metabolic enzymes) and liver-specific secreted proteins (such as albumin).
The adaptive response of the liver during regeneration, which allows for the maintenance of
metabolic homeostasis, is accomplished by the interplay between different sets of transcription
factors. Specifically, this involves those transcription factors that are induced by the regenera-
tive response, and those that are normally expressed in the liver, to regulate the differentiated
functions of the hepatocyte (Taub, 2004).
Expression of many liver-specific genes – such as those which encode IGFBP1, glucose 6-
phosphatase and α-fibrinogen is regulated in the basal state by hepatic nuclear factor-1 (HNF1),
which is a liver-specific transcription factor. Transcriptional activity of HNF1 is upregulated
during liver regeneration, which is accomplished by binding of HNF1 to the growth-induced
transcription factors STAT3 and AP1. So, together, these two types of transcription factors –
growth-induced (STAT3 and AP1) and tissue-specific (HNF-1) – provide an adaptive response
to liver injury and amplify the expression of hepatic genes that are important for the homeo-
static response during organ repair (Taub, 2004). Such mechanisms enable the liver to maintain
metabolic function, despite the loss of two thirds of its functional mass.
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2 G1 and S phase of the cell cycle during liver
regeneration
Synopsis
During liver regeneration, normally quiescent hepatocytes enter cell cycle. A large number of
genes are involved in the cell cycle control during liver regeneration. The essential circuitry
required for the process comprises cytokine and growth factor induced pathways. The innate
immune system plays an important role in the initiation of liver regeneration after an induced
external damage. Injured sites release cytokines which prime the hepatocytes to readily respond
to growth factors and enter the cell cycle. This chapter summarizes the known molecular and
cellular mechanisms of liver regeneration which lead to initiation of the cell cycle machinery
and DNA synthesis.
2.1 Introduction
Figure 2.1:
Hepatocyte cell cycle. Hepatocyte cell cycle can be divided into two parts: priming and progression. Pro-
inflammatory cytokines like TNF, IL-6 prime the quiescent cell to G1 phase from where cells can return to quiescence.
At late G1, upon being induced by growth factors such as HB-EGF, HGF, cells commit themselves irreversibly to
further progression. Growth factor HB-EGF mainly lies at the interface of priming and progression (Fausto et al.,
1995).
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In a normal adult liver cells rarely divide and are considered to be in a quiescent state, i.e., in the
G0 phase of cell cycle. However, after 2/3 PH 95 % of the hepatic cells rapidly enter cell cycle
(Fig. 2.1). The eukaryotic cell cycle is traditionally divided into four phases: S-G1-M-G2. S is
the synthesis phase during which the DNA replicates and M is the mitosis phase during which
chromosomal separation occurs and cells finally divide. S and M phase are separated in time
by two gaps (G1 and G2 phases). During G1 and G2 phases cells prepare for the next phase,
synthesizing needed protein and increasing their mass. The transition of quiescent cells from
G0 phase to G1 phase, which is often called priming (Fausto, 2000), is reversible and from here
cells can return to quiescence upon growth factor withdrawal. Once it crosses G1 check point
cell is committed to DNA synthesis and completion of a cell division cycle (Fig. 2.1).
2.2 Cell cycle during liver regeneration
Liver regeneration is a complex process, involving activation of multiple pathways, including
those induced by cytokines (e.g. interleukin-6 (IL-6), tumor necrosis factor (TNF-α)), growth
factors (e.g. hepatocyte growth factor (HGF), epidermal growth factor (EGF), heparin binding
growth factor (HB-EGF), transforming growth factor (TGF-α)), thyroid hormones, insulin and
norepinephrine (Fig. 2.2). The entry of quiescent hepatocytes into the cell cycle can be divided
into two parts: Priming and progression (Fig. 2.1).
1. Priming: During Priming cells exit the G0 quiescent state (G0-G1 transition) and become
sensitive towards growth factors. Cells do not respond to growth factors before being
primed. Priming is triggered by TNF-α and IL-6 released from Kupffer cells. IL-6/TNF-
α elicit immediate early gene expression in hepatocytes (Fausto, 2000).
2. Progression: Growth factors trigger primed cells to enter DNA synthesis. Growth fac-
tors including HGF, HB-EGF help the cell to pass through G1 restriction point. Primed
cells with growth factors progress through G1 phase with appearance of Cyclin D in the
mid-G1 phase. Cyclin D is important for progression beyond a late G1 restriction point.
Appearance of Cyclin E in the late G1 phase and early S phase and its tightly regulated
expression makes it the most important marker for G1-S transition. Eventually, Cyclin D
and Cyclin E levels are brought down by a family of cyclin dependent kinase inhibitors
(CKIs) (Fausto, 2000).
Besides cytokines and growth factors there are many other signals from various cell types am-
plifying hepatocyte activity. Insulin and norepinephrine amplify the mitogenic response of EGF
and HGF. Norepinephrine rises rapidly in the plasma within 1 hour after PH (Cruise et al., 1987).
Norepinephrine induces secretion of EGF from the Brunner’s glands of the duodenum (Olsen
et al., 1985). Pancreatic islets supply insulin to the liver continually through portal vein. Insulin
infusion corrects liver atrophy by a process involving hepatocyte replication (Gupta et al., 1988).
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Figure 2.2:
Liver regeneration as interplay of several pathways. After liver injury, several signals are initiated simultaneously
in the liver. Gut-derived factors, such as LPS, are upregulated after liver injury or hepatectomy and reach the liver
through the portal blood supply. They activate hepatic non-parenchymal cells (including Kupffer cells and stel-
late cells) and increase the production of TNFα and IL-6. Other factors are released from the pancreas (insulin),
duodenum or salivary gland (EGF), adrenal gland (norepinepherine), thyroid gland (T3) and stellate cells (HGF).
Cooperative signals from these factors allow the hepatocytes to overcome cell-cycle checkpoint controls and move
from G0, through G1, to the S phase of the cell cycle. This leads to DNA synthesis and hepatocyte proliferation.
TGFβ signaling, which inhibits hepatocyte DNA synthesis, is blocked during the proliferative phase but is restored
at the end of the process of regeneration by helping to return hepatocytes to the quiescent state (Taub, 2004).
2.2.1 Priming phase
Pro-inflammatory cytokine pathway (PICs)
The PICs induced initiation of liver regeneration: Cytokines which are small secreted pro-
teins which mediate and regulate immunity, inflammation, and hematopoiesis. They are pro-
duced in response to an immune stimulus. Pro-inflammatory cytokine are a general term for
those immuno-regulatory cytokines that favor inflammation. Tumor necrosis factor (TNF) and
interleukin-6 (IL-6) are two major pro-inflammatory cytokines that are responsible for early re-
sponses. They are mainly produced by Kupffer cells. Pro-inflammatory network is initiated
through the binding of TNF to its receptor TNFR1, leading to activation of NF-κB in Kupffer
cells NF-κB activation results in upregulation of IL-6 transcription in Kupffer cells. IL-6 is re-
leased into the serum and activates the neighboring hepatocytes by binding to its receptor, IL-6R.
Activation of IL-6R which is a complex of gp80 and gp130 subunits leads to phosphorylation of
STAT3 (signal transducer and activator of transcription 3) monomers by JAKs (janus-associated
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kinases). STAT3 then homodimerizes and translocates to the nucleus, where it induces transcrip-
tion of a number of target genes. lL-6 is also able to signal via the Map kinase pathway (Fig.
2.3) (Taub, 2004).
Figure 2.3:
Cytokine pathways activated during liver regeneration. The figure illustrates interactions in cytokine pathways be-
tween Kupffer cells and hepatocytes in the regenerating liver (other non-parenchymal cells also may be involved).
TNF binds its receptor TNFR1 on Kupffer cells, leading to the activation of NF-κB. Components of immune system
such as C3a, C5a, and MyD88 also can activate NF-κB after PH. IL-6 and TNF are both NF-κB target genes; IL-6 is
subsequently released into the serum, and binds to its receptor on hepatocytes. Activation of gp130, which is one of
the subunits of the receptor complex , leads to phosphorylation of STAT3 monomers by JAKs. STAT3 then homod-
imerizes and translocates to the nucleus, where it induces transcription of a number of target genes. In parallel with
STAT3 phosphorylation, gp130 activation also leads to activation of ERK and MAPK signaling. All these signaling
events lead to transcription of several genes involved in various liver regeneration processes (adapted and extended
from (Fausto et al., 2006) and (Taub, 2004)).
Why PICs are important for initiation of liver regeneration Evidence for the importance
of pro-inflammatory cytokines during this phase of regeneration includes (1) increase in liver
mRNA and serum levels of TNF and IL-6 after PH (Akerman et al., 1992; Trautwein et al.,
1996; Iwai et al., 2001); (2) activation of the transcription factors NF-κ B and STAT3 (Fitzgerald
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and Kreutzer, 1995; Cressman et al., 1995); (3) inhibition of DNA replication by anti-TNF
antibodies[20]; (4) blockage of liver regeneration in IL-6 and TNF receptor type I (Tnfr1) KO
mice (Cressman et al., 1996; Yamada et al., 1997); and (5) correction of the defect in TNFR1
KO mice by IL-6 injection (Yamada et al., 1997).
Further evidence that cytokines are important for regeneration arises from the fact that certain
cytokines have the ability to prime resting hepatocytes for cell division without PH. Hepatocytes
in the normal liver are quiescent (G0 phase) and exhibit only a minimal response to potent in
vitro mitogens, such as transforming growth factor alpha (TGF), epidermal growth factor (EGF),
and hepatocyte growth factor (HGF). However, growth factor infusion into rats preceded by a
single TNF injection induces replication in up to 40% of hepatocytes in the normal liver (Webber
et al., 1998).
The precise role of IL-6 in liver regeneration has been particularly difficult to define. It has been
calculated that almost 40% of the immediate early genes expressed in the regenerating liver (Su
et al., 2002; White et al., 2005) may be IL-6 dependent, (Li et al., 2001) suggesting that the role
of IL-6 in this process is complex. The primary function of IL-6 in regeneration was originally
shown to be proliferative, as IL-6 KO mice had a striking deficit in DNA replication after PH
(Blindenbacher et al., 2003; Klein et al., 2005; Wallenius et al., 2001; Sakamoto et al., 1999;
Wuestefeld et al., 2003).
IL-6 production is needed only for a short period to induce hepatocyte growth, as uncontrolled
synthesis would lead to continuous acute phase response and catabolism detrimental to the health
of the host. The main production machinery of IL-6, Kupffer cells, are adapted to control their
own IL-6 production through PGE2 (Goss et al., 1992). PGE2 is induced by IL-6 activated by
Kuppfer cells(Fennekohl et al., 2000). When PGE2 is significantly elevated it starts inhibiting
IL-6 in a negative feedback loop fashion (Goss et al., 1992, 1993). PGE2 negatively regulates
the production of both TNF-α (Tanaka et al., 1996) and IL-6 (Callery et al., 1990; Goss et al.,
1992).
Triggering the PICs: Role of components of the innate immune system Because cytokine
activation participates in the initiation of liver regeneration, identifying the mechanisms that
trigger the activation of this network is important. A logical candidate for a master upstream
molecule is lipopolysaccharide (LPS), which is released from enteric bacteria into the portal
circulation (Cornell, 1985). Indeed, Cornell (1990) found that rats with restricted production
of LPS and mice that are naturally hypo-responsive to LPS (C3H/HeJ mice) have a delay in
regeneration after PH. The LPS resistance of C3H/HeJ mice (Poltorak et al., 1998) was later
found to be the consequence of a point mutation in the gene for Toll-like receptor 4 (TLR4),
a member of a class of receptors that bind various microbial products. LPS binding to TLR4
activates multiple intracellular signaling pathways, some of which are dependent on myeloid
differentiation factor 88 (MyD88), an adapter protein that mediates intracellular signals from
several TLRs (Akira et al., 2001). Myd88 KO mice failed to activate TNF and IL-6 (Seki et al.,
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2005; Campbell et al., 2006). STAT3 activation and expression of important STAT3 target genes,
such as Socs3 and acute phase response genes, were also blocked in Myd88 KO mice after PH.
Identifying the ligand and receptor that signal through MyD88 early after PH is an exciting
challenge, and perhaps in doing so the mechanisms that initiate the liver regeneration cytokine
cascade will be identified.
Other components of the innate immune system appear to be critical for normal regeneration
as well; mice deficient in the C3 and C5 components of complement display significant deficits
after PH (Strey et al., 2003). In these animals, diminished activation of the cytokine pathway
is manifested by lack of increases in TNF and IL-6 levels, and in impaired NF-B and STAT3
activity. Whether and how these two aspects of innate immunity, TLR-MyD88 signaling and the
complement cascade, converge to initiate cytokine signaling in liver regeneration is not clear.
2.2.2 Progression Phase
Cell cycle progression induced by growth factors The cytokine network acts at the priming
phase of liver regeneration, which corresponds to the passage of quiescent hepatocytes into the
cell cycle (G0 to G1). Cell cycle progression is then driven by growth factors, which override a
restriction point in late G1. Passage from G1 to S phase is associated with retinoblastoma (Rb)
phosphorylation, increased expression of the Rb family members and of Cyclin D, -E, and -A,
and formation of Cyclin D and Cyclin E complexes with their cyclin dependent kinase partners
Cdk4 and Cdk2 respectively (Menjo et al., 1998; Albrecht et al., 1993, 1998). Rb dependent
regulation of cyclins is covered in more details in section 3.2.
HGF and the EGF receptor (EGFR) ligand family are important growth factors that drive cell
cycle progression during liver regeneration (Matsumoto and Nakamura, 1992; Michalopoulos
and Khan, 2005). HGF is produced by mesenchymal cells and acts on hepatocytes in a paracrine
or endocrine fashion. Its effects are multiple and have been grouped into morphogenic, mito-
genic, and mitogenic categories. HGF is known to be the most potent mitogenic growth factor,
with meticulously maintained expression by activation and inhibition via urokinse-type plas-
minogen activator (uPA) and plaminogen activator inhibitor (PAI), respectively (Shimizu et al.,
2001). PAI is induced by mediators of acute phase response such as IL-6 and plays an important
role in early stages of liver regeneration. PAI suppresses the active form of HGF thus negatively
controlling its activity. HGF expression is stimulated by several factors, which are seen to be
elevated during immediate early phase including interleukines (IL-6, TNF-α) (Liu et al., 1994;
Ohira et al., 1996), C/EBP-β (Jiang and Zarnegar, 1997; Liu et al., 1994) and a range of growth
factors (EGF, TGFα) (Gohda et al., 1994; Matsumoto et al., 1992). Via its receptor Met, HGF
activates many signaling molecules (Ras/Erk/MAPK, PI3K/Akt) and immediate early genes (c-
jun, c-fos) (Borowiak et al., 2004). Few signal transduction molecules (for example, ERK, JNK,
MAPK), transcription factors (for example AP1,C/EBP-β ) and many other downstream targets
seem to be shared and synergistically activated by cytokines and growth factors (Taub, 2004).
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Studies of liver regeneration in mice with hepatocyte-specific deletion of c-met, the gene for
the HGF receptor, were conducted (Huh et al., 2004; Borowiak et al., 2004). Borowiak et al.
(2004) demonstrated that HGF/c-met signaling is essential for cell cycle entry after PH, and
that it is responsible for the activation of extracellular signal-regulated kinase 1/2 (ERK1/2). In
contrast, Huh et al. (2004) reported that hepatocyte c-met-deficient mice had massive mortality
after PH, and thus examined the role of this pathway in other liver injury models. They conclude
that HGF/c-met signaling is important in hepato-protection from apoptosis, and in facilitating
healing after CCl4 administration. The discrepancy in post-operative survival between the two
reports is most likely related to the different surgical techniques used by the two groups, as noted
by Borowiak et al. (2004). Until additional data become available, deciding whether HGF/c-met
signaling functions primarily in mitogenesis, or whether it maintains hepatocyte homeostasis
and thus facilitates cell replication, is not possible.
The family of ligands that bind the EGFR, in addition to EGF, includes TGF, heparin-binding
EGF-like growth factor (HB-EGF), and amphiregulin (AR). TGF is an autocrine growth factor,
both produced by and active on hepatocytes (Mead and Fausto, 1989). Although TGF has ef-
fects on cell motility and vascularization, its main effect is the stimulation of cell proliferation.
Transgenic mice that overexpress TGF display constitutive hepatocyte proliferation and even-
tually develop cancer (Webber et al., 1994). TGF expression increases after PH in wild-type
mice, but TGF KO mice have no defects in liver regeneration (Russell et al., 1996). The normal
regeneration seen in these animals is likely a consequence of compensation by other EGFR lig-
ands, although the roles of these growth factors after PH are not entirely redundant, as discussed
below.
HB-EGF is an important growth factor during hepatic regeneration. HB-EGF induction is sen-
sitive to the degree of damage (1/3 PH vs 2/3 PH) (Mitchell et al., 2005a) and other kind of
damages (Temizer et al., 1992; Kiso et al., 1995, 1996), while priming genes like IL-6, TNF-α ,
c-jun,c-fos,c-myc are similarly expressed in 1/3 PH and 2/3 PH. HB-EGF expression is induced
by Raf/MAPK pathway (Ellis et al., 2001; McCarthy et al., 1997, 1995), which is activated by
HGF via met signaling, as mentioned earlier.
HB-EGF is expressed earlier than HGF and TGF after PH and appears to have a unique role
in liver regeneration (Kiso et al., 1995, 2003). A 30% PH does not result in coordinated DNA
replication, despite activation of the cytokine cascade (Bucher and Swaffield, 1964; Mitchell
et al., 2005a). A single injection of HB-EGF 24 hours after 30% PH can override this blockage
between Priming and cell cycle progression, eliciting a wave of DNA replication. Interestingly,
this effect cannot be accomplished by similarly injecting HGF or TGF (Mitchell et al., 2005b).
In addition, HB-EGF KO mice have a delay in DNA replication after 70% PH, although this
deficiency is partially compensated by an earlier increase in TGF expression in these animals.
Both c-met and the EGFR are receptor tyrosine kinases, which recruit enzymes and scaffolding
proteins to phosphorylated intracellular domains of each receptor. Multiple intracellular sig-
naling pathways are thus activated, which regulate a multitude of transcription factors, initiate
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translation, and regulate metabolic pathways. One mitogenic signal transduction pathway that is
of particular interest, because it may integrate cytokine signals as well as growth factor signals,
is the Ras-Raf-MEK cascade, which results in the activation of ERK1/2. ERK1/2 activation
is correlated with hepatocyte DNA replication in vivo and hepatocyte proliferation in vitro (Ta-
larmin et al., 1999; Thoresen et al., 2003; Li et al., 2002; Coutant et al., 2002). Moreover, growth
factors such as HGF and TGF and cytokines such as TNF and IL-6 stimulate ERK1/2 activity
in primary hepatocytes and hepatocyte cell lines (Argast et al., 2004; Francavilla et al., 1986;
Scheving et al., 2002).
2.2.3 CKIs during liver regeneration
Assembly of cyclins with their activating partners, cyclin dependent kinases (cdks) ,and their en-
zymatic activity are regulated by a number of small proteins termed CKIs. To date, two different
families of CKIs have been described in mammalian cells that differ in structure, mechanism
of inhibition, and cdk target specificity. The Ink family of CKIs includes the tumor suppres-
sor protein p16Ink4a, as well as p15Ink4b, p18Ink4c, and p19Ink4d, that appear to specifically
target the G1 phase Cyclin D-Cdk4/Cdk6 complexes (Sherr and Roberts, 1995, 1999). The
structurally and functionally distinct Cip/Kip family comprises three proteins: p21 (also known
as Cip1, Waf1, Sdi1) (el Deiry et al., 1993; Harper et al., 1995; Noda et al., 1994; Xiong et al.,
1993), p27Kip1 (Polyak et al., 1994; Toyoshima and Hunter, 1994), and p57Kip2 (Lee et al.,
1995; Matsuoka et al., 1995). These proteins are able to bind and inhibit with different efficacy
the activity of most cyclin-cdk complexes including Cdk2, Cdk3, Cdk4, and Cdk6 (Harper et al.,
1995; Matsuoka et al., 1995).
A wide variety of environmental signals can regulate expression and activity of CKIs. Interest-
ingly, either growth arrest resulting from DNA damage, cell senescence, and terminal differenti-
ation or cell cycle entry and progression after stimulation with growth factors were accompanied
by p21 gene activation (Macleod et al., 1995; Noda et al., 1994; Nourse et al., 1994; Sherr, 1994)
through various transcription factors including p53 (el Deiry et al., 1993; Macleod et al., 1995).
Beyond its role as a CKIs, at low stoichiometric concentrations, p21 may act as an assembly
factor for active Cyclin D-Cdk4/6 complexes and could potentially function as an activator of
these kinases (Cheng et al., 1999; LaBaer et al., 1997; Sherr and Roberts, 1999). In contrast
to p21, expression of p27 protein generally declines in several cell types in response to mito-
genic stimulation (Agrawal et al., 1995; Nourse et al., 1994). Furthermore, inhibitory activity of
this protein increases by different anti-mitogenic signals, such as TGF- or by contact inhibition
(Polyak et al., 1994; Poon et al., 1995).
Several reports (Dotto, 2000; Glaise et al., 1998; Macleod et al., 1995; Matsuoka et al., 1995;
Sherr and Roberts, 1995) highlight the important difference that exists between cell types con-
cerning regulation of these CKIs, expression, and role during development and differentiation.
Particularly, these proteins are involved in coordinate regulation of cell proliferation and dif-
ferentiation and maintenance of terminally differentiated cells in quiescent state (Zhu and Sk-
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oultchi, 2001). Because of the high proliferative potential of mature hepatocytes at the adult
stage, a specific regulation of CKIs is intended. Several prior studies (Albrecht et al., 1997,
1998, 1999; Ehrenfried et al., 1997; Jaumot et al., 1999; Kato et al., 1998; McIntyre et al., 1999;
Pujol et al., 2000; Timchenko et al., 1997) have documented the pattern of CKIs expression in
proliferating hepatocytes including p21, p27, and p57. However, although some investigators
demonstrated that p21 decreased in regenerating rat liver (Timchenko et al., 1997), others re-
ported its upregulation during cell cycle progression of rat hepatocytes in vivo (Albrecht et al.,
1999; Jaumot et al., 1999; Kato et al., 1998). In addition, most reports described expression of
CKIs in vivo during regeneration of rat or mouse liver. A lack of immunohistochemical analysis
could not fully support the conclusion that observed patterns of CKIs expression in regenerating
liver are fully derived from hepatocytes. Only a very limited number of reports documented
patterns of p21 and p27 expression in hepatocytes during rat liver regeneration by immuno-
cytochemistry (Jaumot et al., 1999; Pujol et al., 2000). Although a few reports described some
aspects of CKIs expression in primary mouse and rat hepatocytes in pure culture (Albrecht et al.,
1999; McIntyre et al., 1999), the functional role of these proteins in proliferating cells and their
regulation by different signal transduction pathways have not yet been investigated .
2.2.4 Cyclins during liver regeneration
Cell cycle progression is regulated by sets of cyclin and cdk complexes. Cyclin D, -E, and -A are
cyclically synthesized during G1, G1-S, and S phases, respectively. Cyclin D, with its catalytic
partner Cdk4/6, leads to phosphorylation of Rb, releasing transcriptional factors such as E2F
that activate genes required for entry into S-phase. (Fausto, 2000; Sherr, 1993). Concomitant
binding of Cyclin E and A with their catalytic partner Cdk2 contributes to the initiation and
progression of S-phase (Kitamura et al., 1998).
Quiescent cells contain low levels of D-type cyclins. Upon mitogenic stimulation, the expression
of D-type cyclins increases and then Cyclin D-Cdk4 complexes can assemble and translocate to
the nucleus (Michalopoulos and DeFrances, 1997; Fausto, 2000). The activation of Cyclin D-
Cdk4 complexes at mid G1 is responsible for the phosphorylation of Rb and the other members
of the pocket family (p107 and p130). As a result of this phosphorylation transcription factors
of the E2F family are released and the expression of genes necessary for cell cycle progres-
sion is induced (Thompson et al., 1986; Alcorn et al., 1990; Morello et al., 1990; Feldenberg
et al., 1999; Cressman et al., 1995). Cyclin D-Cdk4 activity is negatively regulated by CKIs,
which consist of two major families. The Ink4 inhibitors (p15, p16, p18, and p19) specifically
inhibit Cdk4 and Cdk6 by preventing complex formation with the D-type cyclins (Sherr and
Roberts, 1995). The Cip/Kip family of proteins (p21, p27, and p57) bind and inhibit numerous
cyclin-cdk complexes. The interplay between Cyclin D-Cdk4 and other G1-regulatory proteins
is complex and incompletely understood . Cyclin D proteolysis requires phosphorylation by
GSK3beta at Thr-286; additional work recently established that p286-D1 is a substrate for the
SCF(Fbx4/alphaB-crystallin) E3 ligase (Barbash and Diehl, 2008).
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Figure 2.4:
Proteolytic ligase activity during G1 and early S phase. G1 stability is sustained by APCCdh1 dependent degradation
of G1 cyclins and SCFSkp2 dependent degradation of G1-S cyclins. The transition into S phase is mediated by a
change in activity of the SCFSkp2 complex upon inhibition of APCCdh1. Thus, proteolytic targets are altered in
a phase-dependent manner according to the selectivity of the active ubiquitin ligase at that time. Maintenance of
subsequent phases and their transitions also involves similar mechanisms of phase specific selectivity of ligases (Ang
and Harper, 2004).
Cyclin E-Cdk2 complexes formed at mid-late G1 also phosphorylate the pocket proteins. How-
ever, the major role of these complexes is accomplished in the G1-S transition, possibly by
phosphorylating key proteins involved in the firing of DNA replication (Lundberg and Wein-
berg, 1998; Krude et al., 1997). Cyclin A-Cdk2 complexes are necessary for S phase progression
although the putative substrates for these complexes are still unknown (Sherr, 1994).
2.3 Proteolytic degradation
Ubiquitin mediated proteolysis begins through an enzymatic cascade involving E1 ubiquitin
activating enzymes, E2 ubiquitin conjugating enzymes, and E3 biquitin ligase enzymes. These
enzymes ultimately serve to mediate the covalent attachment of Ub molecules by the E3 ligase
to a lysine residue in the target substrate, or on the growing multi-ubiquitin chain extending
from the "tagged" protein. This Ub chain serves as a signal for the 26S proteasome to unfold
and digest the target. Most of the target selectivity of this system is conferred by the E3 ligase
because of its direct interaction with the ubiquitination substrate. The two most prominent E3
ligases in cell cycle control are the anaphase-promoting complex (APC) and the SCF complexes
[reviewed in (Hershko and Ciechanover, 1998)].
APC The APC core consists of 12 subunits and is regulated by two activating subunits: Cdc20
(also known as Fizzy) and Cdh1 (also known as Hct1 or Fizzy-related) (reviewed in (Vodermaier
and Peters, 2004; Harper et al., 2002; Zachariae and Nasmyth, 1999)). These activating subunits
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each confer differential substrate selectivity to APC. Moreover, each associates with the APC
core under different circumstances: Cdc20 is more likely to associate with the APC core during
mitosis under conditions of high Cdk activity, and Cdh1 is more likely to activate the APC core
during mitotic exit and G1 phase under conditions of low Cdk activity. Substrate specificity of
APC and its stage specific activation is discussed in more details in Chapter 3. Here we limit
our discussion to Cdh1 associated APC and its role during G1 phase.
Cdh1 recognizes various proteins in late M and G1 phases, such as mitotic cyclins, Cdc20,
Cdh1, Aurora A, Aurora B, Plk1, Skp2 (reviewed in (Castro et al., 2005)). Cdh1 levels are
relatively constant throughout the cell cycle (Zachariae et al., 1998; Jaspersen et al., 1999).
Cdh1 activity is regulated by cell cycle dependent phosphorylation and dephosphorylation, being
unphosphorylated in late M and G1 phases, and then phosphorylated during S, G2 and early
M phases (Zachariae et al., 1998; Jaspersen et al., 1999). The phosphorylation of Cdh1 by
cyclin-cdk complexes inhibits APC activation by preventing Cdh1 from binding to the core
APC subunits, whereas dephosphorylation of Cdh1 due to degradation of Cyclin B at late M
phase and inactivation of Cdk1, induces APC activation by allowing Cdh1 to access the core
APC subunits (Kramer et al., 2000). After Cdc20 is completely degraded at the end of mitosis,
APCcdh1 remains as the active form of the APC during G1 and also during the first part of S-
phase (Jaspersen et al., 1999; Kramer et al., 2000).
SCF The SCF E3 ligase comprises three subunits at its core; Skp1, Cullin, and Rbx1. This core
interacts with modular F-box proteins, which all share an F-box sequence motif. F-box proteins
directly bind to the target substrate and bridge the interaction between the E3 ligase and target
substrate, and so the identity of the F box determines the target of SCF. There are various F-box
proteins, including subfamilies with WD40 domains (Fbws) and those with leucine-rich-repeats
(Fbls). F-box proteins frequently recognize their substrates through phosphorylation-dependent
mechanisms. In the case of Fbws, the WD40 motif recognizes a phosphodegron domain on
the substrate that forms after appropriate phosphorylation events [reviewed in (Deshaies, 1999;
Koepp et al., 1999)].
The F-box-protein Skp2 bound to SCF complexes is most well studied among over 70 F-box
proteins identified in human. SCF-Skp2 mainly ubiquitinates and degrades CKIs as well as G1-
S cyclin (Frescas and Pagano, 2008). Controlling Skp2 activity is clearly important for proper
cell cycle control. Skp2 can function as an oncogene in model systems and is overexpressed
in a number of tumor types (reviewed in (Pagano and Benmaamar, 2003)). Bashir et al. (2004)
and Wei et al. (2004) have indicated a Cdh1 dependent mechanism by which G1 cells maintain
low levels of SCFSkp2 , thereby putting a break on S-phase entry until the criteria for S-phase
entry have been met. Thus, G1 stability is maintained by APCCdh1 dependent degradation of
G1 cyclins and SCFSkp2 dependent degradation of G1-S cyclins. The transition into S phase is
mediated by a change in activity of the SCFSkp2 complex upon inhibition of APCCdh1.
Therefore, proteolytic targets are altered in a phase-dependent manner according to the selec-
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tivity of the active ligase at that time. Maintenance of subsequent phases of cell cycle and their
transitions also involves similar mechanisms of phase specific selectivity of ligases(Fig. 2.4).
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Synopsis
Mitotic activation in mammalian cells is promoted by multiple redundant controls at the tran-
scriptional, posttranslational and degradation level, but the relative contribution of these sepa-
rate pathways to the decision to enter mitosis is currently not well resolved. There is a lot of
emerging FoxM1 mediated transcriptional and Cdh1 mediated proteolytic control of Cyclin B
in mammalian cells which is developing a new level of understanding for the mammalian cell
cycle. This chapter summarizes the known molecular and cellular pathways observed in the con-
trol of mitotic cyclins and the mechanisms leading to activation, inactivation and degradation of
cyclins.
3.1 Introduction
Early in the cell cycle, the DNA is replicated and chromosomes duplicated in the S phase. The
second major phase of the cell cycle is the M phase, which typically consists of two events:
nuclear division (mitosis) and cell division (cytokinesis). The period between the end of one M
phase and the beginning of the next is called interphase.
Mitosis is a complex and beautiful process that distributes the duplicated chromosomes equally
into a pair of daughter nuclei. The pairs of sister-chromatids are attached in early mitosis to
the mitotic spindle, a bipolar array of protein polymers called microtubules. By the midpoint of
mitosis (metaphase), sister-chromatids in each pair are attached to microtubules coming from op-
posite poles of the spindle. At the next stage (anaphase), sister-chromatid cohesion is destroyed
resulting in sister-chromatid separation. The microtubules of the spindle pull the separated sis-
ters to opposite ends of the cell (sister-chromatid segregation) and the two sets of chromosome
are each packed into new daughter nuclei. Following mitosis cell itself divides by cytokinesis.
Mitosis is preceded by gap phase called G2 when cells prepare themselves for mitosis (Fig. 3.1).
Cell cycle events are regulated at three regulatory checkpoints. First is the G1-S checkpoint
which we have discussed earlier in chapter 2. There are two checkpoints during the G2/M
transition where the progression of cell cycle can be blocked. Failure to complete DNA repli-
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Figure 3.1:
Events of cell division cycle. The central events of cell reproduction are chromosome duplication, which takes place
in S phase, followed by chromosome segregation and nuclear division (cytokinesis), which are collectively called M
phase. G1 is the gap phase between S and M phases; G2 is the gap phase between S and M phases. At metaphase
sister chromatids are aligned on the mitotic spindle and during sister chromatids get separated and pulled to opposite
spindle poles (Morgan, 2007).
cation blocks the cell in G2 phase from entry into mitosis. Delay in spindle assembly blocks
the metaphase-to-anaphase transition, thereby preventing sister-chromatid segregation until the
spindle is ready. Cell cycle can thus be viewed as a linked series of tightly regulated molecular
switches, each of which triggers the initiation of cell cycle progression at a specific regulatory
checkpoint.
Cyclin oscillations regulating the cell cycle control system The whole process of cell divi-
sion is mainly orchestrated by cdks. As the cells progress through the cell cycle, abrupt changes
in the enzymatic activities of these kinases lead to changes in phosphorylation state and thus the
state of activation of proteins that govern the cell cycle processes. Concentrations of cdks are
constant throughout the cell cycle. Oscillations in their activity depend on the corresponding
oscillations in the levels of their respective cyclin subunits. Different cyclins are produced at
different cell cycle stages with additional controls imposed on them by various other cell cycle
regulators (Fig. 3.3), resulting in a series of cyclin-cdk complexes which govern distinct cell
cycle events (Fig. 3.2).
Cyclin D and Cyclin E form active complexes with cdks during G1-S transition which trigger
DNA synthesis as discussed in chapter 1. The rise of G1-S cyclins is accompanied by the appear-
ance of Cyclin A which also forms complexes with cdks. Cyclin A-Cdk2 is thought to initiate
chromosome condensation during prophase. Towards the end of S phase, Cyclin B expression
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Figure 3.2:
Overview of the cell cycle control system. Levels of three major cyclin types oscillate during the cell cycle (top),
providing the basis for oscillations in the cyclin-cdk complexes that drive cell cycle events (bottom). In general,
cdk levels are constant and in large excess over cyclin levels. Thus, cyclin-cdk complexes form in parallel with
cyclin levels. The enzymatic activities of cyclin-cdk complexes also tend to rise and fall in parallel with cyclin
levels, although in some cases cdk inhibitor proteins or phosphorylation introduce a delay between the formation
and activation of cyclin-cdk complexes. Formation of active G1-S cyclin-cdk complexes commits the cell to a new
division cycle at G1-S checkpoint. G1-S cyclin-cdks then activate the S cyclin-cdk complexes that initiate DNA
replication at the beginning of S phase. M-cdk cyclin activation occurs after the completion of S phase, resulting in
progression through the G2/M checkpoint and assembly of the mitotic spindle. Proteolytic ligases (APC and SCF)
impose another level of control on cell cycle oscillations. At the metaphase-to-anaphase transition APC activation
triggers sister-chromatid separation. APC activation also causes the destruction of S and M cyclins and thus the
inactivation of cdks, which promotes the completion of mitosis and cytokinesis. APC activity is maintained in G1
until G1-S cyclin-cdk activity rises again and commits the cell to the next cell cycle. G1-S cyclins are further degraded
by SCF (adapted from Morgan (2007)).
is switched on, leading to accumulation of Cyclin B-Cdk1 complexes during G2. Switch like
activation of Cyclin B-Cdk1 complexes trigger the G2-M transition (Fig. 3.4). Spindle assembly
and other early mitotic events lead to the alignment of duplicated sister chromatids on the mitotic
spindle in metaphase. In addition to that Cyclin B-Cdk1 eventually stimulates activation of APC,
which triggers the metaphase-to-anaphase transition by stimulating the destruction of proteins
that hold sister-chromatids together. The APC also causes destruction of S and M phase cyclins,
resulting in the inactivation of all major cdk activities in late mitosis. Increased production of
CKIs also occurs in late mitosis. The resulting inactivation of cdks allows dephosphorylation of
their mitotic targets, which is required for spindle disassembly and the completion of M phase.
Low levels of cdks are maintained until late in the following G1, when rising G1-S cyclins again
commit the cell to a new cycle (Morgan, 2007).
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Figure 3.3:
Regulators of cell cycle control system. Cyclins are periodically expressed during cell cycle. Cyclin-cdk complexes
are also formed in parallel with cyclins. Most crucial for the cell cycle transitions are the activity levels of cyclin-
cdks. Properties like switch-like activation and delay in activation are introduced by various cell cycle regulators.
CKIs prevent premature activation of Cyclin D, Cyclin E and Cyclin A by stoichiometrically inhibiting them. Cdc25
activates and Wee1 inactivates Cyclin B-Cdk1 in a positive feedback manner by phosphorylation-dephosphorylation
events enabling switch-like activation of Cyclin B-Cdk1 at G2/M transition. Proteolytic degradators APC and SCF
control the timely phase specific degradation of cyclins. APC with its activator subunit Cdc20 degrades Cyclin B at
mitosis. With its another activator subunit Cdh1, APC degrades Cyclin B and Cyclin A till G1. SCF degrades Cyclin
D and Cyclin E from Late G1 to S phase (adapted from Vermeulen et al. (2003)).
3.2 E2Fs regulating transcription of cyclins
E2F family of transcription factors are known to control the expression of various genes respon-
sible for entry into and progression through S phase (e.g. Cyclin D, Cyclin E, Cyclin A). The
applications of new technologies such as DNA microarray analysis, chromatin immunoprecipi-
tation (ChIP) techniques and bioinformatics has enlarged the view of the number and nature of
genes potentially regulated by E2F, including various G2 (e.g. Cyclin A) and M phase genes
(e.g. Cdc2, Cyclin B) (Ren et al., 2002; Zhu et al., 2004; Osterloh et al., 2007).
E2F proteins can be (1) activators of transcription (E2F1, E2F2 and E2F3a) or (2) repressors of
transcription (E2F3b, E2F4, E2F5 and E2F6) (Calzone et al., 2008a). For simplicity we only
talk about the activator E2Fs and lump all three of them into one entity named E2F. E2F activity
is tightly controlled by binding to retinoblastoma protein (Rb). Rb belongs to a family of pocket
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Figure 3.4:
Switch-like activation of mitotic players at G2/M transition. At G2/M transition the cell enters mitosis in an all-or-
none fashion which is enabled by switch-like activation of Cdk1 associated with Cyclin B. Increased Cdk1 activity
triggers the activation of APCCdc20, causing rapid Cyclin destruction and Cdk1 inactivation. Cdk1 inactivation, leads
to APCCdh1 activation, which further degrades Cyclin B till S phase (adapted from Morgan (2007)).
proteins which have the ability to bind proteins to their pockets. The protein binding function of
Rb is regulated by phosphorylation. Rb sequesters E2F and inhibits its transcriptional activity.
This hold of Rb on E2F depends on its phosphorylation level; higher the Rb phosphorylation
level more the E2F is released from its hold and is available for transcriptional activation of
further downstream genes.
Phosphorylation of Rb is regulated by various cdks. Complete phosphorylation and inactivation
of Rb via cyclins occurs in a sequential and cooperative manner (Knudsen and Wang, 1996;
Zarkowska and Mittnacht, 1997). At mid G1 Cyclin D-Cdk4/6 complexes initiate the phospho-
rylation of Rb. Cyclin D can only achieve partial phosphorylation of Rb. Complete phosphory-
lation of Rb and subsequent release of E2F in excess requires further phosphorylation of Cyclin
D hypophosphorylated Rb by Cyclin E. Cyclin E hyperphosphorylates Rb during G1-S phase
(Lundberg and Weinberg, 1998) (Fig. 3.5).
E2F together with B-myb is required for the activation of Cyclin B gene in G2. B-myb is an E2F
target gene expressed at G1-S, but is not fully active until phosphorylated by Cyclin A-Cdk2 in
S phase. This provides a possible explanation for delayed transcriptional activation of Cdc2 and
Cyclin B in G2 (Zhu et al., 2004; Osterloh et al., 2007). Thus E2F also provides a link between
G1-S and G2-M specific transcription and also provides a mechanism by which the temporal
distinction is achieved. However, for simplicity reasons we do not explicitly consider B-myb
mediated regulation of Cyclin B via Cyclin A.
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Figure 3.5:
Sequential activation of Rb-E2F. Phosphorylation of Rb is regulated by various cyclin-associated-kinases. Complete
phosphorylation and inactivation of Rb via cyclins occurs in a sequential and cooperative manner. At mid G1, Cyclin
D-Cdk4/6 complexes initiate the phosphorylation of Rb. Cyclin D can only achieve partial phosphorylation of Rb.
Complete phosphorylation of Rb and release of E2F in excess requires phosphorylation of Cyclin D hypophosphory-
lated Rb by Cyclin E. Cyclin E hyperphosphorylates Rb during G1-S phase.
3.3 Cyclin dependent kinase inhibitors (CKIs)
Cyclin dependent kinase inhibitors (CKIs) provide additional regulation to the timely cell cycle
dependent expression of cyclins. CKIs are grouped into two categories: Ink4 and Cip/Kip. Ink4
proteins inhibit Cyclin D associated kinase activity. Cip/Kip family consists of three members:
p21, p27 and p57. These proteins share a homologous inhibitory domain, which is both neces-
sary and sufficient for binding and inhibition of Cdk4- and Cdk2 containing complexes. These
proteins act as stoichiometric inhibitors of Cdk2 and Cdk1; and they preferentially act on Cdk2
complexes (Vidal and Koff, 2000). p21 binds to all four cyclin-cdk complexes with a preference
for those containing Cdk2 and inhibits their activation by generally blocking their catalytic sites.
However, the mechanism behind CKIs dependent negative regulation of Cyclin B levels is still
not clear (Gillis et al., 2009; Tyner, 2009).
p21 is predominantly transcriptionally regulated via IL-6 dependent STAT3, Myc and E2F (Gar-
tel and Tyner, 1999; Coller et al., 2000), but recently its post-transcriptional control is reported to
be equally important for its stability and degradation(Jascur et al., 2005; Sheaff et al., 2000). p27
mRNA levels remains majorly constant. Regulation of p27 protein is more complex involving
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more posttranslational control (Pagano et al., 1995; Malek et al., 2001; Vervoorts and Luscher,
2008). p21 is also a transcriptional cofactor regulating the activity of E2F, STAT3, Myc and in
turn, the transcription events regulated by them (Coqueret, 2003).
SCFSkp2 and APCCdc20 promote the proteolysis of p21 bound to Cyclin E and -A in complex
with Cdk2 or Cyclin A and Cyclin B in complex with Cdk1 (Wang et al., 2005; Amador et al.,
2007).
All these observations suggest a complex two way role of CKIs in connecting S phase to mitosis
via E2F, STAT3, Myc mediated transcriptional network and via proteolysis mediated by SCF
and APC. Both ways directly or indirectly regulate activation of various cyclins.
3.4 Cyclins
Cyclin A Cyclin A has a function in both S phase and mitosis (Pagano et al., 1992) and it is
associated with both Cdk1 and Cdk2 (Garnier et al., 2009). Cyclin A is known to be mainly
an S-G2 phase cyclin starting to accumulate during S phase and is destroyed before metaphase.
Transcription of Cyclin A is mediated by E2F transcription factor(Schulze et al., 1995).
Xenopus (Minshull et al., 1990), mice (Sweeney et al., 1996), and humans (Yang et al., 1997)
contain two A type cyclins – Cyclin A1 and Cyclin A2. Cycin A is only expressed in meosis
and very early embryos, whereas Cyclin A2 starts to accumulate during S phase and diminishes
at early mitosis (Pines and Hunter, 1990). We limit our discussion to Cyclin A2 which is more
S phase specific and we refer to it as Cyclin A for simplicity.
Cyclin A levels are low during G1, but Cyclin A increases at the onset of S phase, when it
contributes to the stimulation of DNA synthesis (Resnitzky et al., 1995) both by initiating DNA
replication and by restricting the initiation only once per cell cycle (Coverley et al., 2000; Pe-
tersen et al., 1999; Ishimi et al., 2000). The amount of Cyclin A remains high at S phase and
in early mitosis. At early mitosis it associates with Cdk1 and stimulates entry into M phase
(Draetta et al., 1989). Cyclin A in association with Cdk2 and Cdk1 also drives the initiation
of chromosome condensation and possibly nuclear envelope breakdown (den Elzen and Pines,
2001; Furuno et al., 1999; Gong et al., 2007) . Hyperphosphorylated forms of Rb-E2F induce
Cyclin A synthesis (Lundberg and Weinberg, 1998).
Timely disappearance of Cyclin A at the end of G2 phase is controlled by APC dependent por-
teolysis of Cyclin A (den Elzen and Pines, 2001). It is regulated by the D-box dependent recog-
nition by APC proteosome like Cyclin B. Both APCCdh1 and APCCdc20 can promote ubiquitina-
tion of Cyclin A (Geley et al., 2001; Sudakin et al., 1995). Despite the similarity in degradation
mechanisms of the two mitotic cyclins, there are clear differences in the destruction behavior of
Cyclin A and Cyclin B considering its spindle-checkpoint independent destruction (Geley et al.,
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2001).
APCCdh1 degrades Cyclin A during G1 phase thus preventing its premature activation during G1
phase(Listovsky et al., 2000; Kramer et al., 2000; Listovsky et al., 2004; Rape and Kirschner,
2004). Premature activation of Cyclin A during late G1 phase is also controlled by its stoichio-
metric inhibition by p27 which forms an inhibitory complex with Cyclin A. p21 is also required
to inhibit the M-phase-promoting activity of Cyclin A (Furuno et al., 1999).
Cyclin B Mitotic entry is catalyzed by the kinase activity of Cdk1 in complex with Cyclin B.
Cyclin B-Cdk1 levels are periodically regulated by transcription and degradation cycles. Cy-
clin B levels first rise during G2, which allows the accumulation of Cyclin B-Cdk1 complexes.
Phosphorylation-dephophorylation dependent activation of this Cyclin B-Cdk1 complex drives
the cell cycle entry into mitosis; leading to enhanced chromosome condensation and nuclear en-
velope breakdown. Once all the chromosomes are attached to the mitotic spindle in bi-oriented
fashion, progressive loss of Cyclin B-Cdk1 activity occurs. Cyclin B-Cdk1 inactivation and
Cyclin B degradation is controlled by APC,leading to chromosome segregation and completion
of cell division (Pines, 2006). Thus, there are three critical steps in the activation of Cyclin
B-Cdk1 complex: 1) Transcriptional levels of Cyclin B available to form a complex with Cdk1
(Solomon et al., 1990). 2) Phosphorylation level of Cdk1 which is regulated by the opposing
activities of Wee1 and Cdc25 (O’Farrell, 2001). 3) Degradation of Cyclin via APC proteasomal
subunit (Fig. 3.6).
Transcription of Cyclin B starts in S phase and peaks in late G2. Several transcription factors
including E2F, NF-Y, FoxM1, and B-Myb have been shown to activate transcription of Cyclin
B promotor (Lindqvist et al., 2005). All these transcription factors are activated by cdk activity,
ensuring that transcription of Cyclin B is efficient only when Cyclin A-Cdk2 activity builds up
during S and G2 phase (Chae et al., 2004; Osterloh et al., 2007; Laoukili et al., 2008). When
the levels of Cyclin B reach a threshold concentration Cyclin B-Cdk1 starts being activated
(Solomon et al., 1990).
Thus, precise temporal regulation of Cyclin B-Cdk1 activity is ensured by the coordinated action
of various positive and negative regulators of Cdk1 activity which form various feedback loops
around Cyclin B-Cdk1.
3.5 Proteolytic degradation
Degradation of Cyclin B is regulated by APC, a multisubunit E3 ligase that can only poly-
ubiquitinylate many mitotic targets regulators to target them for destruction by the proteasome.
Polyubiquitinylation of Cyclin B starts in metaphase, when the spindle assembly checkpoint
is silenced (Acquaviva and Pines, 2006; van Leuken et al., 2008). APC continues to promote
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degradation of Cyclin B until early S phase (Lukas et al., 1999; Hsu et al., 2002).
Ubiquitin-mediated protein degradation plays a key role in the regulation of cell cycle. At-
tachment of a polyubiquitin chain to a protein targets that protein for degradation by the 26S
proteasome (Coux et al., 1996; Baumeister et al., 1998). Ubiquitin becomes covalently attached
to a substrate by interaction with a cascade of ubiquitin protein ligase enzymes (E1, E2 and E3)
in a three step process. The last in the series, E3, transfers the ubiquitin to the substrate protein
(Hershko and Ciechanover, 1998).
Two ubiquitin protein ligases play a role in the cell cycle: the SCF (Skp1/Cullin/F-box) com-
plex and the APC (anaphase-promoting complex) (Peters, 1998; Zachariae and Nasmyth, 1999).
Both are multi-subunit complexes that recognize the substrate protein and bring them face-to-
face with the proteosome. Both complexes are known as the proteolytic machinery of the cell
cycle degrading the cell cycle proteins. Recent studies have established their role much beyond
degradation of cyclins. APC-type ligases regulate entry into and exit from mitosis, whereas
SCFSkp2 controls entry into S phase. APCCdc20 degrades the G2-M substrates while APCCdh1
degrades the late mitotic and G1 substrates. By targeting the SCF-component Skp2 for destruc-
tion, APCCdh1 not only regulates exit from mitosis, but also controls the duration of G1 (Kurland
and Tansey, 2004) (Fig. 3.7).
SCF The SCF complex consists of three invariable components: Rbx1 (Ring-finger protein),
Cul1 (scaffold protein), and Skp1 (adaptor protein), as well as one variable component called F
box protein that binds to Skp1 and is responsible for substrate recognition. Three F box proteins
: Skp2 (S-phase kinase-associated protein, Fbw7 (F-box and WD-40 domain protein 7 (Fbw7)
and β -TRCP (β -transducine repeat-containing protein), are thought to be involved in cell cycle
control (Nakayama and Nakayama, 2006) (Fig. 3.8).
SCF although originally thought to function mainly at the G1-S transition, is active from late
G1 to early M phase (Nakayama and Nakayama, 2006). In conjunction with the F box protein
Skp2 , the SCF complex targets CKIS ((Carrano et al., 1999), (Bornstein et al., 2003), (Kamura
et al., 2003)) for degradation; which are the breaks that antagonize the cell cycle progression
by inhibiting various cyclins. Skp2 is also reported to degrade many accelerators of cell cycle
progression like Cyclin D (Yu et al., 1998; Lin et al., 2006), and Cyclin E (Nakayama et al.,
2000) (Fig. 3.9). Cyclin E is targeted for proteasomal degradation also by another F box protein
subunit of SCF, Fbw7 (Koepp et al., 2001; Strohmaier et al., 2001) (Fig. 3.8) (Fbw7 subunit
of SCF not depicted in the figure for simplicity). Thus, SCF helps in removing S phase blocks
by degrading cell cycle breaks imposed by CKIs and allows DNA replication by degrading
accelerators of cell cycle progression.
APC The APC ubiquitination complex is structurally similar to the SCF complex, and consists
of invariable core components : APC11 (Rbx1-related RING-finger protein), APC2 (CUL1-
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related scaffold protein) and at least 11 other components without a defined role, as well as
variable components known as activator. There are two such variables in mitotically cycling
cells: cell division cycle 20 (Cdc20) and Cdh1 (Fig. 3.8). They confer substrate specificity
in the same way that F box proteins do in the SCF complex (Harper et al., 2002; Castro et al.,
2005). The APC is active from mid-mitosis (anaphase) to the end of G1 phase (Nakayama and
Nakayama, 2006). Cdc20 and Cdh1 recognize proteins that have a destruction box (D box) or a
KEN box (Pfleger and Kirschner, 2000; Burton and Solomon, 2001). The windows of activity of
APCCdc20 and APCcdh1 are clearly different: the former is active from mid-mitosis (anaphase) to
late mitosis, whereas the later is activated at late mitosis, remains active through G1 phase and
is extinguished at the G1-S boundary (Harper et al., 2002; Castro et al., 2005) (Fig. 3.10).
APCCdc20 contributes to the proteolysis of securin, and thereby triggers chromosomal separation
at anaphase. After replication, sister chromatids are accompanied until anaphase by the multi-
protein complex cohesin. Separase cleaves cohesin, but its activity is suppressed by securin.
The degradation of securin by APCCdc20 activates separase, resulting in the cleavage of cohesin
and separation of sister chromatids (Uhlmann et al., 1999, 2000; Yanagida, 2000) (Fig. 3.10).
Although Cdc20 is expressed in G2 phase before the entry to M phase, the activity of APCCdc20
is suppressed until spindle attachment at kinetochores is completed in mitosis. This surveillance
system, known as the spindle checkpoint, precludes precocious segregation of chromosomes,
which would result in abnormal chromosome number (aneuploidy), a prevalent form of genetic
instability in human cancers. The main mediators of this system are mitotic arrest deficient
(Mad) and budding uninhibited by benzimidazole (Bub) proteins which bind to, and inhibit, the
function of Cdc20 (Bharadwaj and Yu, 2004). Once all kinetochores are attached to spindles at
the metaphase-anaphase transition the MCC is dissociated from CDC20, resulting in the acti-
vation of APCCdc20 and chromosome segregation (Harper et al., 2002; Castro et al., 2005) (Fig.
3.10).
APCCdh1 on the other hand, recognizes broad range of proteins from late M and G1 phases, such
as mitotic cyclins, Cdc20, Cdh1, Aurora A, Aurora B, Plk1, Skp2 (reviewed in (Castro et al.,
2005)). Unlike Cdc20, Cdh1 levels are relatively constant throughout the cell cycle (Zachariae
et al., 1998; Jaspersen et al., 1999). Cdh1 activity is regulated by cell cycle dependent phos-
phorylation and dephosphorylation, being unphosphorylated in late M and G1 phases, and then
phosphorylated during S, G2 and early M phases (Zachariae et al., 1998; Jaspersen et al., 1999).
The phosphorylation of Cdh1 by cyclin-cdk complexes inhibits APC activation by preventing
Cdh1 from binding to the core APC subunits, whereas dephosphorylation of Cdh1 due to degra-
dation of M phase cyclin, Cyclin B and inactivation of Cdk1, induces APC activation by allow-
ing Cdh1 to access the core APC subunits (Kramer et al., 2000). After Cdc20 is completely
degraded at the end of mitosis, APCcdh1 remains as the active form of the APC during G1 and
also during the first part of S phase (Jaspersen et al., 1999; Kramer et al., 2000) (Fig. 3.10).
APCcdh1, degrades Cyclin A and -B till G1 (Kramer et al., 2000; Listovsky et al., 2004; Rape
and Kirschner, 2004). Rise in Cyclin A levels during late G1 and S phosphorylates Cdh1 and
prevents its activatory assembly with APC (Lukas et al., 1999)
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Bashir et al. (2004) and Wei et al. (2004) independently demonstrate that APCCdh1 target the
subunits of SCF, viz, Skp2 and Cks1 for ubiquitination and destruction during G. SCF being
degradator of CKIs is thus consequently prevented APCCdh1 from mediating premature degra-
dation of CKIs in G1. This in turn prevents premature S phase. These studies reveal a circuit
that can stabilize the G1 state through the down-regulation of S-phase promoting factors by an
indirect proteolytic mechanism dependent on APCCdh1.
3.6 Additional feedback controls
Sheer association of Cyclin B with Cdk1 is not sufficient for its full activation, as the Cdk1
subunit undergoes posttranslational modifications via various phosphorylation and dephospho-
rylation events that affect its kinase activity. During interphase CyclinB-Cdk1 complexes are
kept inactive by phosphorylation of Cdk1 at specific sites by Wee1 kinases. At G2/M transition
Wee1 is inactivated while the dual specificity phosphatase, Cdc25, is activated. Cdc25 dephos-
phorylates Cdk1, allowing its activation and entry into mitosis.
Just as Cyclin B-Cdk1 activation is highly regulated, both Wee1 and Cdc25 are tightly controlled
through the cell cycle. Cdc25 and Wee1 are similarly regulated, though their activities oscillate
in opposition to one another, consistent with their role of inhibiting or activating mitotic entry.
Both are directly controlled by mitotic kinases like Cyclin B-Cdk1. Wee1 keeps Cyclin B-Cdk1
inactive by phosphorylation, while Cdc25 removes this inhibitory phosphorylation.
Cdc25 proteins are dual specificity phosphatases that uniquely function to dephosphorylate spe-
cific tyrosine/threonine residues on cdks. Three isoforms of Cdc25 are known in mammalian
cells: Cdc25A, -B, -C which cooperate to activate Cyclin B-Cdk1 complexes during the G2M
transition (Lindqvist et al., 2005; Boutros et al., 2006). All three isoforms of Cdc25 are re-
sponsible for dephosphorylating Cdks on Thr14 and/or Tyr15 residues. This dephosphorylation
triggers the final activation of Cylin B-Cdk1 during G2/M transition. Complete activation of Cy-
clin B-Cdk1 requires phosphorylation by Cdc25C at the onset of mitosis (Boutros et al., 2006).
The levels of Cdc25 proteins expressed at each stage of the cell cycle depends on the balance
between protein synthesis and degradation. While Cdc25C protein levels remain fairly constant
throughout normal cell division (Girard et al., 1992), those of Cdc25 A and -B vary in a cell cy-
cle dependent manner (Boutros et al., 2006). Cdc25A is expressed from mid to late G1 (Boutros
et al., 2006) and is degraded by ubiquitin-mediated proteolysis at the end of mitosis (Donzelli
et al., 2002). Cdc25B accumulates from S phase and peaks in mitosis (Gabrielli et al., 1996;
Lindqvist et al., 2004) and is degraded by ubiquitin mediated proteolysis following phosphory-
lation by Cyclin A-Cdk1 (Baldin et al., 1997).
Three isoforms of Cdc25 are lumped together into a single entity for simplicity and named
as Cdc25 in future discussions, unless stated otherwise. Cdc25 activity and phosphorylation
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levels are kept low during interphase in the presence of incompletely replicated DNA (Izumi
et al., 1992; Kumagai and Dunphy, 1992). Cyclin A and Cyclin B mediated phosphorylation
of Cdc25 renders it active (Izumi and Maller, 1993). Thus mitotic cyclins activate Cdc25 by
phosphorylation which further activates CyclinB-Cdk1 in a positive feedback loop manner.
Wee1 constitutes another positive feedback to Cyclin B-Cdk1 in the form of a double negative
regulation. Cyclin B-Cdk1 activity can also be positively regulated by negative regulation of its
inactivators Wee1 and Myt1 by phosphorylation on two inhibitory residues - T14 and Y15. Wee1
is a tyrosine kinase that phosphorylates Y15 (Parker and Piwnica-Worms, 1992), and Myt1 is
a dual-specificity kinase that can phosphorylate both sites (Mueller et al., 1995). During G2/M
transition Wee1 and Myt1 kinases are phosphorylated and inactive when Cyclin B-Cdk1 activity
rises. After mitotic exit, Wee1 and Myt1 kinases become activated and can lock Cdk1 in the
inactive state, thus serving to inhibit Cdk1 during G1 (Potapova et al., 2009). Wee1 is positively
regulated during interphase by autophosphorylation (Murakami et al., 1999).
These two Wee1 and Cdc25 mediated phosphorylation and dephosphorylation mechanisms serve
as positive feedback that induces a robust autoamplification of Cdk1 activity (O’Farrell, 2001),
and they are responsible for the switch like activation of Cdk1(Pomerening et al., 2005).
Spatial regulation of cyclin B concentration in the nucleus and cytoplasm also adds up another
level of complexity in its regulation. For simplicity spatial control of Cyclin B is not considered
for the modeling.
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Figure 3.6:
Cyclin B regulation. Cyclin A and Cyclin B activity build up during S and G2 phase due to increased transcription
of mitotic genes such as E2F, NF-Y, FoxM1, and B-Myb. At G2-M, mutually antagonistic inactivation of Wee1 by
Cyclin B-Cdk1 and activation of Cdc25 by Cyclin B-Cdk1 impose a double positive feedback on Cyclin B activity.
Thus, leading to abrupt full activation of Cyclin B-Cdk1 resulting in a switch-like G2/M transition. Degradation of
Cyclin B is carried out by APC Ubiquitin-ligases, when the spindle assembly checkpoint is silenced. At metaphase
Cyclin B-Cdk1 activates its degradator APCCdc20, while during late mitosis degradation of Cyclin B leads to the
activation of APCCdh1 which continues degradation of cyclins till late G1 phase. At G1 phase APCCdh1 also degrades
SCF which is a degradator of G1-S phase cyclins, thus connecting mitosis to G1 phase. Therefore, precise temporal
regulation of Cyclin B-Cdk1 activity is ensured by the coordinate action of various positive and negative regulators
of Cdk1 activity and degradators of cyclins which form feedback loops around Cyclin B-Cdk1.
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Figure 3.7:
Cell cycle driven by waves of Ub ligase-dependent protein degradation. By destroying specific substrates, APC-type
ligases regulate entry into and exit from mitosis, whereas SCFSkp2 controls entry into S phase. APCCdc20 degrades
the G2-M substrates while APCCdh1 degrades the late mitotic and G1 substrates. By targeting the SCF-component
Skp2 for destruction, APCCdh1 not only regulates exit from mitosis, but also controls the duration of G1 (Kurland
and Tansey, 2004). Because of the central role of Cdh1 in controlling mitotic and G1 substrates, loss of Cdh1 has
implications in exit from quiescence, G2 delay and mitotic aberrations.
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Figure 3.8:
APC and SCF structure. The SCF complexes consist of three invariable components: Ring-finger protein (Rbx1 in
SCF, APC11 in APC), scaffold protein (Cul1 in SCF, APC2 in APC), and adaptor protein (Skp1 in SCF and, not
yet well characterized in APC), as well as one variable component called F box protein that binds to adaptor protein
and is responsible for substrate recognition. SCF related F box proteins such as Skp2 and Fbw7 recognize G1-S
substrates mainly. Among APC related F box proteins, Cdc20 recognizes mitotic substrates, whereas Cdh1 is less
specific and can also recognize a broad range of substrates including Cyclin A, Cyclin B and Skp2 (adapted from
Nakayama and Nakayama (2006)).
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Figure 3.9:
Regulation and function of SCF. The SCF is active from late G1 to early M phase (Nakayama and Nakayama, 2006).
In conjunction with Skp2 , the SCF targets CKIs for degradation. CKIs are inhibitors of G1-S phase cyclins (Cyclin
D, Cyclin E and Cyclin A). Thus, SCF contributes in removal of S phase blocks by degrading cyclin inhibitors, CKIs,
and allows DNA replication by degrading G1 and S phase cyclins (adapted from Nakayama and Nakayama (2006)).
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Figure 3.10:
Regulation and function of APC. (a) APCCdc20 is kept inactive at G2 by spindle checkpoint proteins Bub and Mad. (b)
At metaphase, Cyclin B-Cdk1 phosphorylates and activates APCCdc20 which then degrades securin freeing separase
to assist in cleaving sister chromatids, thus leading to chromosomal segregation. (c) Further, APCCdc20 degrades
Cyclin B, leading to mitotic exit. Degradation of Cyclin B also results in dephosphorylation of Cdh1, which then
attaches to APC to form active APCCdh1 complex. APCCdh1 then continues the job of degrading mitotic and G1
cyclins (adapted from Nakayama and Nakayama (2006)).
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4.1 Introduction
Study of the cell cycle began with the discovery of cell division. In 1960s first mathematical
models of cell cycle came into existence that tried to explain some key aspects of cell cycle
regulation from phenomenological observations (Koch and Schaechter, 1962; Shields, 1977;
Smith and Martin, 1973). These early efforts regarded the machinery that controlled the cell
division cycle as a black box, and attempted to produce a mathematical description of the rules
it obeyed. The landscape changed dramatically in the 1980s, as work on yeasts and the rapid
cell divisions of fertilized eggs produced a molecular description of the cell cycle oscillator as a
fluctuation in the activity of Cdks that is driven by a combination of phosphorylation reactions
and the periodic destruction of the cyclins that activate Cdks (Norel and Agur, 1991; Goldbeter,
1991; Thron, 1991; Tyson, 1991) when some data on the underlying molecular regulatory net-
work came to light (Nurse, 1990). Experimentally, this oscillation can depend on a single Cdk
– Cdk1, also known as Cdc2 or, in budding yeast, as Cdc28 – and a single cyclin, cyclin B.
These discoveries quickly inspired a new type of mathematical analysis, one which attempted
to represent the molecular details of the cell cycle oscillator and the pathways that it interacted
with as differential equations.
In recent years, with the birth of systems biology (Kitano, 2002), new experimental techniques
have led to an extension of these models, and there now appears to be a bright future for models
of cell cycle regulation. Several excellent reviews are available on computational modeling
techniques (Gilbert et al., 2006; Karlebach and Shamir, 2008), on cell cycle regulation (Morgan,
2007; Nurse, 2000; Tyers, 2004)and on cell cycle modeling (Csikasz-Nagy et al., 2008b; Fuss
et al., 2005; Ingolia and Murray, 2004; Sible and Tyson, 2007; Tyson and Novak, 2008).
4.2 Cell cycle differences between different model organisms
After it took a century to confirm that cell replication is a controlled process, the last three
decades were spent to cast the current cell cycle regulation model. The essential achievement in
identifying the key components and in dissecting the mechanisms of the cell cycle circuitry has
been attributed to the simultaneous use of model systems like yeast, frogs, sea urchin, starfish,
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and flies. Now is the time to investigate whether those findings also apply to mammalian in vivo
models like mice and eventually can be used for effective disease therapy in humans.
The intrinsic biological advantages of model organisms have facilitated the understanding of
the cell cycle. For instance, the mitotic cell cycle of frog oocytes and early embryos proceed
without the G1 and G2 phases because maternally inherited materials govern the progression of
cell division. Therefore frog is an ideal model for dissecting DNA replication and mitosis.
Similarly, Drosophila only expresses a single D-type as well as E-type cyclin that could ease the
analysis of the G1 and S phases. However, the potential drawback of this simplicity is that the
model might not reflect the cell cycle regulation that occurs in humans and may therefore hinder
the interpretation and translation for clinical purposes.
In contrast, yeasts have a typical G1-S-G2-M cell cycle pattern and a short cell cycle of around 2
h. In addition, yeasts have multiple cyclins allocated to a single cyclin dependent kinase (Cdk1)
resembling the requirement of mammals. These characteristics of yeasts made them potent
candidates for mutagenesis and genetic studies of the cell cycle regulation (Hartwell et al., 1970;
Nurse et al., 1976). One caveat of the yeast model is that it is based on only one cyclin-dependent
kinase, Cdk1, interacting with multiple oscillating cyclins (Cln1/2/3 and Clb1/2/3/4/5/6) during
different phases of the cell cycle. In addition, Cdk1/cyclin B (Cdc2/Cdc13) complexes alone
are sufficient to drive cells to complete the S phase and mitosis (Fisher and Nurse, 1996). This
situation does not apply to the mammalian cell cycle where multiple Cdks and cyclins interact
to promote cell cycle progression and development as described below. Therefore, the genetic
redundancy of the activating cyclins, the inhibiting as well as the promoting factors in yeast
may not exactly reflect the situation in mammals. Despite the intrinsic disadvantages of these
aforementioned models, they do provide broad references for cell cycle studies in the mouse,
and by analogy in humans.
4.3 Cell cycle models
As mentioned above the story goes back about 50 years, when Prescott found that cells need to
reach a critical size to divide [95]. This and other phenomenological observations drove the first
wave of mathematical models that tried to understand how cell progresses through its different
phases to finally divide into two daughter nuclei. Once the molecular interactions that control
the cell cycle were discovered many groups started to work on mathematical models to figure
out the key concepts of these interactions.
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Yeast cell cycle models
The most studied organism in the modeling platform is budding yeast Saccharomyces cerevisiae.
A detailed model of cell cycle regulation in Saccharomyces cerevisiae is developed by Novák
and Tyson group. They proposed that a different hysteretic switch controlled the entry into
S phase (Chen et al., 2000) which was first tested experimentally by Fred Cross’s group in a
seminal paper focusing solely on verifying a mathematical model of cell cycle regulation (Cross
et al., 2002). Later they created a model that can simulate the behavior of more than 120 mutants
(Chen et al., 2004). This model also predicted the existence and regulation of a phosphatase that
later was identified (Queralt et al., 2006). Other groups have also presented their own models of
the budding yeast cell cycle, focusing on various aspects of the regulatory system (Braunewell
and Bornholdt, 2007; Barberis et al., 2007; Sriram et al., 2007; Stelling and Gilles, 2004).
The other favorite test organism of cell cycle research is the fission yeast Schizosaccharomyces
pombe, for which there exist models describing its DNA replication (Lygeros et al., 2008; Novak
and Tyson, 1997), cell division (Csikasz-Nagy et al., 2007) and the behavior of some interesting
mutants (Sveiczer et al., 2000; Steuer, 2004).
Embryonic cell cycle models
Embryonic cell cycles have been modeled not only in frogs but also in the fly, Drosophila
melanogaster (Calzone et al., 2007), and in the sea urchin (Ciliberto and Tyson, 2000).
The group of Béla Novák and John J. Tyson investigated the regulation of mitotic entry in eggs of
the frog Xenopus laevis and found that a model with two positive feedback loops could provide
a reliable switch for entry into mitosis (Novak and Tyson, 1993). Their model predicted that
the Cdk control system can be bistable: under certain conditions, Cdk may be either active or
inactive depending on the recent history of the cell. This bistability and hysteresis was verified
experimentally 10 years later in a seminal paper by Pomerening et al. (Pomerening et al., 2003;
Sha et al., 2003).
Mammalian cell cycle models
The most challenging task is to model cell cycle regulation in mammalian cells, where multiple
control mechanisms exist that hold cells back from proliferation. The physiological differences
among different types of mammalian cells make this task especially difficult. Cancer cell lines
are often (possibly always) perturbed in their cell cycle regulation (Hanahan and Weinberg,
2000), thus most existing models describe ’generic’ proliferating mammalian cells at various
levels of detail. A few of these models use some data on mouse fibroblasts; still, no model of the
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cell cycle network of a specific mammalian cell type has yet been constructed. Several models
exist that do not focus on any specific cell type but rather investigate some important aspects of
the regulatory modules of the general Cdk control network. These approaches are biologically
suitable, since it has been shown that the key cell cycle controllers and their interactions are
universal among eukaryotes (Nurse, 1990). Also, naturally synchronized cells in the whole
animal systems, such as hepatocytes in regenerating livers of mice, are being used to analyse the
cell cycle of naturally synchronized cells in the whole animal (Chauhan et al., 2008)
Prokaryotic cell cycle models
Recent modeling studies on cell cycle regulation of the prokaryote Caulobacter crescentus show
that, even though the key controller genes are completely unrelated to their eukaryotic coun-
terparts, the network wiring resembles the eukaryotic system (Brazhnik and Tyson, 2006; Li
et al., 2008). This conservation of network structure underlines certain key features of cell cycle
regulation.
4.4 Modeling methodologies
Positive and negative feedback loops have to be wired together for proper cell cycle regulation.
The positive feedbacks are important for robust transitions between cell cycle phases and they
assure that checkpoints can stop progression through the cell cycle, while the negative feedbacks
are necessary to reset the system to the beginning and drive the periodic repetition of the process
(Novak et al., 2007). The significance of positive feedback in robustness of cell cycle transitions
has recently been shown in different organisms (Holt et al., 2008; Pomerening et al., 2005;
Skotheim et al., 2008; Legewie et al., 2006, 2005).
Most of the above mentioned models based on molecular networks use systems of ordinary dif-
ferential equations (ODEs) to describe the dynamics of the system. This allows the use of some
mathematical analysis tools that can track the steady states and dynamical transitions of cell
cycle control system (Battogtokh and Tyson, 2004; Borisuk and Tyson, 1998; Swat et al., 2004;
Csikasz-Nagy et al., 2006). As the complexity of the known cell cycle regulatory network in-
creased in the last few years, logical dynamic modeling (Thieffry, 2007) and especially Boolean
algebra became another fashionable modeling formalism . This might be partially influenced by
the success of Li et al. (Li et al., 2004), who showed in a logical model of the budding yeast cell
cycle that trajectories from 86 % of all possible initial states lead the system into one state rep-
resenting G1-phase of the cell cycle. Most of these trajectories funneled into a path which steps
through the different phases of the cell cycle, showing that the cell cycle is robustly designed.
Although some of these logical models were already using stochastic updating, recently some
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much more detailed formalisms have started to consider the effects of molecular noise in the cell
cycle regulatory network (Gillespie, 2007). These stochastic models can investigate how indi-
vidual cells might differ from the average behavior of the population (the output of deterministic
ODE models). Stochastic fluctuations could be relevant for certain mutant cell populations that
show partial viability (Mura and Csikasz-Nagy, 2008). Furthermore, recent advances in ex-
perimental observations on single cells allow us to measure the distribution of behaviors in a
population of cells, for example, the measurements of the noisiness of the G1/S transition in
budding yeast cells provided by Cross’s group (Bean et al., 2006; Di Talia et al., 2007).
4.5 Advances and challenges in cell cycle modeling
Need for comprehensive databases
Comprehensive databases force modelers to face new challenges. They have to handle somehow
this huge amount of data, develop platforms to build large models, and find the suitable methods
to analyze them. Conventional, hand-written systems of ODEs have been studied by numerical
simulations, sensitivity analysis and bifurcation theory, in order to understand the model’s be-
havior. As our knowledge base is growing, we have reached a point where we need new tools
to build large models (Kitano et al., 2005), to code them in a platform-free language (Hucka
et al., 2003) and to store them for community use (Le Novere et al., 2006; Olivier and Snoep,
2004). For example, cell cycle models now have their own database with links to experimental
data (Alfieri et al., 2007).
Parameter optimization
Several modeling platforms have been used in cell cycle research (Dematté et al., 2008; Er-
mentrout, 2002; Schmidt and Jirstrand, 2006; Vass et al., 2004). These usually guide the user
from model building to some type of analysis. JigCell has been developed precisely for cell
cycle model simulations and data fitting (Vass et al., 2004). It can run multiple parameter sets
to simulate various mutants and it includes a comparator that can test how well the simulations
fit physiological details of mutants. Although it is difficult to define a suitable objective func-
tion for data that is not time dependent, JigCell provides tools for such estimations (Panning
et al., 2008). Indeed parameter optimization is one of the major challenges for modeling. High-
throughput measurements rarely give reliable kinetic rates; most often they should be estimated
from concentration profiles by a parameter optimization algorithm (Hoops et al., 2006; Lecca
et al., 2009; Saez-Rodriguez et al., 2008; Zi and Klipp, 2006; Zwolak et al., 2005).
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Missing interactions in the biological network
Search for missing rate values is just one part of the job that computational tools can do for us.
All models we create are some abstractions of the real biological system, thus we know that
we are missing some part of the whole network. Experimental data can also be used to infer
yet unknown molecular interactions, propose existence of regulating proteins, etc. Some useful
tools can handle such network data (Cline et al., 2007) and also some methods are developed
that can help the search for missing interactions and to infer network topology (Aldridge et al.,
2006; Andrecut et al., 2008; Fujita et al., 2007; Nelander et al., 2008). Since high throughput
data is available for cell cycle of various organisms now, we can start to think about how to fuse
these data to measurements on single gene perturbations to achieve a detailed understanding of
the system. The computational identification of cell cycle related transcription factors (Cheng
and Li, 2008; Wu and Li, 2008) is a promising initial result on these lines.
Spatial distribution of regulatory molecules
Another layer of complexity in cell cycle models is the matter of spatial distribution of regulatory
molecules. Many crucial events happen in the nucleus and many molecules are moved in/out of
the nucleus during the cycle. Still only a few cell cycle models consider compartmentalization
of the cell (Chen et al., 2004; Yang et al., 2006). Even in compartmental models, diffusion and
protein gradients are not considered, even though they might have important roles in regulation
(Kholodenko, 2006). Simulation packages are available to deal with spatial distributions of
proteins (Slepchenko et al., 2003), but experimental data on protein localization during the cell
cycle is too spotty to give meaningful constraints for such models.
Time intensive simulations
A serious problem of spatial models with many interacting components could be the extensive
computational time needed for simulations. Stochastic simulations face similar problems, in
large models with many interacting components the calculations could slow down dramatically.
In both cases, we need reliable methods for speeding up the simulations. In the case of stochastic
simulations, there is a promising idea, based on the total quasi-steadystate assumption of enzyme
kinetics (Borghans et al., 1996), for handling the coupled enzymatic reactions that are implied by
the positive and negative feedback loops of the cell cycle network (Barik et al., 2008; Ciliberto
et al., 2007). This and other methods (Gillespie, 2007) that decouple different time-scales can
help us to handle stochastic noise in larger models in the future.
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Qualitative models on dynamical properties of cell cycle
Other advances in the field of model analysis will extend the reach of bifurcation analysis, for
tracking qualitative changes in the dynamics of a system on ODEs (Csikasz-Nagy et al., 2006),
and sensitivity analysis, for identifying parameter combinations that crucially determine spe-
cific aspects of a simulation (Turanyi, 1990). Recently biological modeling has been enriched
by some new concepts that help to decompose cell cycle models into sub-networks (Conradi
et al., 2007), find the exact timing of cell cycle transitions (Lovrics et al., 2006) and check the ir-
reversibility of these transitions (Ballarini et al., 2009). The last example uses a model-checking
approach developed by computer scientists, and it is based on the automated verification of prop-
erties of the modeled systems that are encoded using some temporal logic formulae to verify if
a system can reach a given state. This approach has opened some new and interesting research
lines in biological modeling (Calzone et al., 2006; Heath et al., 2008; Mardare et al., 2004;
Monteiro et al., 2008).
Combinatorial complexity
Some other interesting concepts have invaded biological modeling from computer science. Rule
based modeling (Hlavacek et al., 2006; Regev and Shapiro, 2002) and especially various pro-
cess algebras (Ciocchetta and Hillston, 2008; Priami and Quaglia, 2004b,a) were proposed to
circumvent the problem of combinatorial complexity caused by modeling the nested network
of multisite modification processes and multi-component complex formations, which are both
relevant issues for cell cycle models (Kim et al., 2005; de Lichtenberg et al., 2005). The Beta
Workbench modeling environment was developed to handle this type of problem with a biolog-
ically friendly computational language based on process algebra (Dematté et al., 2008; Dematte
et al., 2008). This tool has been thoroughly tested and extended to handle large-scale models of
cell cycle regulation.
4.6 Perspective
The core cell cycle module is regulated by several incoming signals and it drives several down-
stream events. The duty of this central controller is to process the information it receives and
decide how to handle DNA replication and nuclear division. Current models use some parame-
ters as incoming signals and can tell how this input determines the timing of cell cycle events.
Some models already investigate how the circadian clock interacts with the cell cycle machin-
ery (Zamborszky et al., 2007; Altinok et al., 2007; Bernard and Herzel, 2006) and how the cell
cycle is regulated in response to checkpoint signals (Ciliberto et al., 2003; Alarcon et al., 2004;
Iwamoto et al., 2008; Obeyesekere et al., 2004). These models are very detailed either on the
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cell cycle machinery or on the signaling network, but comprehensive models that incorporate
both control systems in detail do not exist yet.
Several models are available for pathways that signal to the cell cycle machinery the presence of
nutrients, pheromones, stress inducing agents, etc. (Fuss et al., 2006; Klipp et al., 2005; Kofahl
and Klipp, 2004; Schaber et al., 2006; Schoeberl et al., 2002; Wang et al., 2006). These could
be merged with appropriate cell cycle models to reveal if our current knowledge of the signaling
pathway, cell cycle network interactions is indeed complete.
Similarly, many other biological pathways have been proposed to interact with the cell cycle,
such as polarized growth (Hayles and Nurse, 2001), the NF-κB pathway (Barre and Perkins,
2007), p53 regulation (Kastan and Bartek, 2004). While computational models also exist for
these processes (Altschuler et al., 2008; Csikasz-Nagy et al., 2008a; Ihekwaba et al., 2007; Ben-
tele et al., 2004), they have yet to be connected to the cell cycle models and to each other.
Another perspective is to step up from the single cell level and simulate how cell-to-cell interac-
tions alter cell proliferation at the tissue level. This requires multi-scale parallel handling of the
cell cycle controls within individual cells while simulating their interactions through signaling at
the same time. For this problem we need, first of all, reliable cell cycle models for animal cells,
desirably specific models of specific cell types, and in addition we need experimental measure-
ments on the signaling between cells. Such detailed models are far in the future, but we already
can learn from some models that take steps in this direction (Anderson et al., 2009; Chauhan
et al., 2008; Ribba et al., 2006).
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in liver regeneration
Synopsis
The liver regenerates and maintains its function and size after injury by counterbalancing cell
death with compensatory cell division. During liver regeneration, injured sites release cytokines,
which primes normally quiescent hepatocytes to enter the G1 phase of cell cycle. Growth fac-
tors stimulate the primed cells to overcome G1 checkpoint and enter cell cycle progression.
Using a mesoscale approach, we have implemented the first mathematical model that describes
cytokine-induced dedifferentiation of hepatocytes and the subsequent initiation of DNA synthe-
sis (G0-G1-S phase of the cell cycle). The model accurately reproduces experimentally mea-
sured kinetics of various signaling intermediates and DNA synthesis in hepatocytes for varying
degrees of liver damage, in both wild type and knockout backgrounds. Liver regeneration is
known to be a robust process, as liver mass reconstitution still occurs in various knockout mice
(albeit with different kinetics). We analyze the robustness of the model using methods of con-
trol analysis. Moreover, we discuss the system’s bandpass filtering properties and delays, which
arise from feedbacks and nested feed-forward loops.
5.1 Introduction
Mathematical modeling of cellular processes has been pioneered by Reinhardt Heinrich (Hein-
rich and Schuster, 1996). In order to quantify the transient dynamics during liver regeneration,
we apply tools of control analysis developed by Heinrich et al. (2002) for signaling cascades.
Being the main detoxifying organ of the body, the liver is susceptible to damage by ingested
toxins. In order to maintain its architecture and function, nature provides the liver with a re-
markable capacity to regenerate after injury by counterbalancing cell death with compensatory
cell division. Such cell division is mainly carried out by the major hepatic cell type, i.e., hep-
atocytes, and is complete within one week in mice. Experimentally, liver regeneration is often
initiated by surgical removal of a part of the liver, this procedure is also referred to as partial
hepatectomy (PH). Surgical resection[] of two thirds of the liver (2/3 PH) serves as a popular
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model for synchronous cell division in vivo, and has been extensively studied experimentally.
In a normal adult liver, cells rarely divide and are considered to be in a quiescent state, i.e., in the
G0 phase of the cell cycle. However, after PH, hepatocytes rapidly enter the cell division cycle,
which consists of four phases: G1-S-G2-M. During S phase, DNA replicates, and the M phase
is characterized by chromosomal separation and cell division. S and M phases are separated by
two gap phases, G1 and G2, during which cells prepare for the next phase. In the context of liver
regeneration, the transition from G0 to G1 is often called priming, while the subsequent passage
into S phase (G1-S transition) is usually termed progression (Fausto, 2000).
The entry of quiescent hepatocytes into the cell cycle is regulated by multiple pathways, in-
cluding those induced by cytokines (e.g., IL-6 and TNF-α) and growth factors (e.g., HGF and
HB-EGF). Priming is mainly governed by tumor necrosis factor (TNF-α) and interleukin-6 (IL-
6), which induce a variety of immediate early genes (IEG) including c-jun, c-fos, and c-myc.
These early priming events are necessary but not sufficient for the initiation of DNA synthe-
sis. Progression into S phase further requires cellular stimulation by growth factors, which are
transcriptionally induced in the late priming phase (Fausto, 2000; Taub, 2004).
Cytokines and growth factors coordinately induce the expression of cyclins, which are the
master regulators of the G1-S transition. Cyclin D, whose expression is directly regulated by
growth-factor and cytokine-induced intracellular signaling pathways, appears in the mid-G1
phase (Taub, 2004). Cyclin D/cdk4 complexes phosphorylate a variety of cellular substrates
leading to the expression of target genes necessary for progression into S phase. One of these
target genes, cyclin E, which appears in the late G1 phase and early S phase, is the main initiator
of DNA replication. The activities of cyclin D and cyclin E are inhibited by a family of cyclin
associated inhibitors (e.g., p21 and p27) and fine-tuned by regulated proteolysis (Malumbres and
Barbacid, 2005).
There are several models of the G1-S transition in cultured cell lines (Kohn, 1998; Aguda and
Tang, 1999; Qu et al., 2003b; Novak and Tyson, 2004; Swat et al., 2004; Haberichter et al., 2007).
Here we present a model of the initiation of synchronous cell division during liver regeneration
in vivo. Liver regeneration is orchestrated by a complex interplay between various intra- and
extracellular signaling pathways, which makes it difficult to include all molecular species. Thus,
we implement a mesoscale model to explain the G0-G1-S phase transition after PH in the mouse.
Mesoscale model refers to a higher level of description where we lump together some species and
reactions. The model is constructed to reproduce experimentally measured kinetics of various
signaling intermediates and DNA synthesis in hepatocytes for varying degrees of liver damage
in both wild type and knockout backgrounds. We further analyze the robustness and the filtering
properties of the model and find that the model exhibits a bandpass filter arising from feedbacks
and nested feed-forward loops.
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5.2 The model
Figure 5.1:
Graphical scheme for G0-G1-S transition during liver regeneration. G0-G1-S transition is driven by two pathways:
(1) Cytokine induced priming. Damage induces PIC (IL-6, TNF-α). PIC further induces synthesis of IEG (c-
jun, C/EBP-β ) and PAI-1, and activates inhibitors like PGE2 and CKI (p21, p27), simultaneously. IEG induces
transcription of growth factors HGF and HB-EGF , and also its inhibitor PAI-1. (2) Growth factor induced pathway:
Damage, IEG and HGF produce the growth factor HB-EGF . HB-EGF further induces cyclin E which is also
stimulated via cyclin D1, marking G1-S transition. Ultimately CKI and other degradating signals like deg lead to
degradation of cyclin E. Species inside rectangles represent single entities while species inside ellipses comprise a
group of species with similar kinetics.
Based on the existing literature and the time series data available on PH experiments in mice,
we construct a mesoscale model focussing on the initiation of DNA synthesis (Fig. 5.1). Arrows
in the figure typically represent complete signal transduction pathways from extracellular stim-
ulation to gene induction. We justify this drastic simplification with the assumption that tran-
scription occurs at a much slower rate than post-transcriptional signal transduction, so that the
dynamical behavior of the system can solely be described in terms of changes at transcriptional
level. We choose Hill equations to represent known features of signal transduction cascades such
as saturation and ultrasensitivity. We neglect ultrasensitivity (by setting the Hill coefficient to 1)
and/or saturation (by assuming a high half saturation point) if these features are not necessary
to describe experimentally measured time courses during liver regeneration. We assume that
protein degradation always follows linear kinetics.
The model input is liver damage induced by 2/3 PH. Regarding the output, most experimentalists
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analyzed the time course of DNA synthesis after PH as a readout for liver regeneration. The
time course of DNA synthesis agrees well with that of cyclin E activity during liver regeneration
(Wüstefeld et al., 2000). Moreover, cyclin E activity is highly sensitive to the degree of liver
damage (as is DNA synthesis), while no such sensitivity is observed for cyclin D (Mitchell et al.,
2005a). Thus, we use cyclin E activity (i.e. the amount of free cyclin E) as the output variable
in our model. The model consists of 12 rate equations and 40 parameters (Refer to appendix
in Chauhan et al. (2008). Details regarding the choice of kinetic parameters using experimental
data are provided as supplementary material in Chauhan et al. (2008). In the following we
summarize the basic state variables described by our model.
Damage The default input stimulus in our model is the liver damage caused by 2/3 PH in a
mouse. Two types of PH-induced damage are thought to be mainly involved in the induction
of downstream signaling and hepatocyte cell division: (i) Cell necrosis at injured sites triggers
inflammatory responses, e.g., the release of pro-inflammatory cytokines (Leu et al., 2003). (ii)
Liver mass depletion also seems to be involved in the induction of hepatocyte cell division
(Lambotte et al., 1997). Markers of liver cell necrosis such as serum aspartate aminotransferase
and alanine aminotransferase remain significantly elevated until 40 hours after 2/3 PH (Leu
et al., 2003). Liver mass increases steadily after 2/3 PH, with mass restoration being essentially
complete after 96 hours (Blindenbacher et al., 2003; Taub, 2004). Based on these observations,
we simulate a 2/3 PH experiment by assuming that the input in our model, termed Damage,
decays exponentially with a half-life of 20 hours.
PIC (Pro-Inflammatory Cytokines) and PGE2
(Prostaglandin E2) Experimental studies reveal that tissue damage due to PH triggers the
release of lipopolysaccharides (LPS) into the blood stream. LPS is known to induce the release
of TNF-α from Kupffer cells. TNF-α in turn activates the intracellular transcription factor NF-
κB in Kupffer cells, and thereby induces transcription of IL-6 (Taub, 2004). In our model, we
have lumped up IL-6 and TNF-α in one variable, the pro-inflammatory cytokines (PIC) (Fig.
5.1). PICs are assumed to be directly induced by Damage.
IL-6 release during liver regeneration after PH was shown to be transient (Liao et al., 2004). This
seems to be due to the fact that IL-6 induces PGE2 expression in Kupffer cells which regulates
the production of TNF-α and IL-6 in a negative feedback loop (Goss et al., 1993). Thus we
assume in our model that PIC is inhibited via PGE2.
IEG (Immediate Early Genes) The earliest genes expressed in hepatocytes after PH, referred
to as immediate early genes, are regulated by Kupffer-cell-derived PICs and appear within 1-2
hours. Among these immediate early genes there are several transcription factors including c-
jun, c-fos, STAT3 and C/EBP-β (Taub, 2004). We lump these early transcription factors into a
combined species referred to as IEG owing to its similar, transient kinetics of expression and
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phenotypically similar knockouts (Cressman et al., 1996; Greenbaum et al., 1998; Behrens et al.,
2002).
PAI-1 (Plasminogen Activator Inhibitor) PAI-1 functions as a negative regulator of liver re-
generation by inhibiting the proteolytic maturation of HGF (Michalopoulos and DeFrances,
1997; Taub, 2004). PAI-1 is induced early after PH and was shown to be regulated by TNF-
α and IL-6 (Healy and Gelehrter, 1994; Shimizu et al., 2001). Therefore we model PAI to be
induced by PIC.
CKI (Cyclin dependent kinase inhibitors) In the model, CKI represents the cip/kip family
of cyclin dependent kinase inhibitors (CKI) which include p21 and p27. They bind to a wide
range of cyclin/CDK complexes and stoichiometrically inhibit cyclin activity (Malumbres and
Barbacid, 2005). Since the expression of p21 is mediated by IL-6 via STAT3 (Wüstefeld et al.,
2000), we model CKI to be directly induced by PIC.
HGF (Hepatocyte Growth Factor) Early priming events are necessary but not sufficient for the
initiation of DNA synthesis (Fausto, 2000). Progression into S phase further requires cellular
stimulation with the growth factors such as HGF and HB-EGF. HGF, a potent stimulator of DNA
synthesis in hepatocytes (Michalopoulos and DeFrances, 1997), is induced by several factors
including pro-inflammatory cytokines (IL-6, TNF-α) via immediate early transcription factors
such as C/EBP-β (Liu et al., 1994), all of which are elevated during immediate early phase.
HGF in turn activates a variety of signaling molecules (Ras, Erk, Akt) and IEGs (c-jun, c-fos)
(Borowiak et al., 2004). Many of these signal transduction molecules and transcription factors
seem to be synergistically activated by cytokines and growth factors (Taub, 2004). Based on
these data, we assume that HGF is induced by IEG. HGF is modeled to further amplify IEG
induced gene expression, and thereby positively feeds back on its own expression. Additionally,
we assume in the model that HGF synthesis is blocked by PAI-1, as the proteolytic maturation
of HGF was experimentally shown to be inhibited by PAI-1 (Shimizu et al., 2001).
HB-EGF (Heparin Binding Endothelial Growth Factor) HB-EGF is an important EGF family
growth factor whose expression correlates well with cyclin E activity and DNA synthesis during
hepatic regeneration (Mitchell et al., 2005a). HB-EGF expression is induced by the Raf/MAPK
pathway (McCarthy et al., 1995), and is therefore expected to be activated by HGF. However, in
contrast to HGF and priming genes, HB-EGF expression is known to be sensitive to the amount
of liver excised during PH (Mitchell et al., 2005a). These data suggest that HB-EGF expression
is regulated by early upstream damage sensing pathways as well as by HGF. In order to model
HB-EGF’s ability to act as a sensor for the degree of damage, we assume in the model that
HB-EGF synthesis requires simultaneous inputs from both Damage and HGF .
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Cyclin D and Cyclin E Cyclins and their regulatory kinases (cdks) regulate the progression of
the cell cycle from G1 phase (D cyclins, cdk4,6) into S phase (cyclin E/cdk2). Cyclin D and
cyclin E complexes are important for G1-S transition because they phosphorylate Rb and E2F
factors, which in turn, lead to expression of genes necessary for cell cycle progression. Cyclin D
is induced by growth factors via Ras/Raf/Erk signaling (Aguda, 2001). Thus, we model cyclin
D to be coordinately regulated by HGF and IEG. Cyclin E expression is known to be positively
regulated by cyclin D, and can be induced directly by growth factors as well (Aguda, 2001). In
particular, it was shown that cyclin E activity correlates well with that of HB-EGF expression
during liver regeneration (Mitchell et al., 2005a). Owing to these data, we assume in the model
that cyclin E synthesis is induced by cyclin D and HB-EGF in an additive manner. As discussed
before, our mesoscale approach implies that we lump together many individual steps. Owing
to the complexity of Rb/E2F regulation during G1-S transition (Swat et al., 2004), we do not
model the dynamics of Rb and E2F explicitly, but incorporate them implicitly within the cyclin
D and cyclin E activation pathways.
CKIs such as p21 are known to be stoichiometric inhibitors of cyclin E (Malumbres and Bar-
bacid, 2005). Hence, we have modeled CKI-inhibition of cyclin E by a reversible association
of both proteins into an inactive complex. Cyclin D/CDK complexes are also known to bind to
CKIs, and thus complex formation between CKIs and cyclin D are considered in the model as
well.
Degradator (deg) The expression levels of cyclin D and E are tightly regulated by ubiquitin-
dependent proteolysis. Cyclin E degradation was reported to depend at least in part on cyclin E
activity, and cyclin E degradation seems to occur in a negative feedback loop fashion (Welcker
et al., 2003). Cyclin D was also shown to be efficiently degraded during S phase (Guo et al.,
2005), but the underlying regulatory mechanisms remain obscure. For simplicity, we assume in
our model that cyclin D degradation is also governed by the S phase master regulator, namely,
cyclin E. Thus cyclin E induces the expression of deg in the model, and these in turn enhance
the degradation of both cyclin E and cyclin D in a negative feedback loop.
5.3 Results
Having established the topology of the network for G0-G1-S phase transitions of cell cycle dur-
ing liver regeneration, we adjust the kinetic parameters (see Appendix and supplementary data
from Chauhan et al. (2008) for details of simulations) such that the model represents the dynamic
patterns of the hepatic responses to varying external stimuli (2/3 vs 1/3 PH) and perturbations
such as knockouts.
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5.3.1 Kinetics and extent of DNA synthesis
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Figure 5.2: Simulations of dynamic variables in 2/3 PH (solid curve) and 1/3 PH mouse (dashed curve).
Numerical simulations of the model are carried out to resemble the damage caused by 2/3 PH.
Most experimental studies showed that priming factors like IL-6, IEG, PAI-1 rise early after PH
and are back to basal levels within 10-15 hours (Greenbaum et al., 1998; Li et al., 2002; Behrens
et al., 2002; Fausto, 2000). The corresponding model species (PIC, IEG and PAI) reflect such
transient behavior reasonably well (PIC is shown as an example in Fig. 5.2a).
p21 mRNA has been experimentally observed to start rising slowly at 1-2 hours and to remain
elevated for 48 hours (Behrens et al., 2002). CKI, representing p21 in the model, reproduce
these temporal dynamics (Fig. 5.2b).
Among growth factors, active HGF levels have been shown in experiments to be below de-
tectable levels for several hours after PH. Then there is a strong increase in the levels of HGF
and subsequently a gradual decrease takes over (Pediaditakis et al., 2001; Shimizu et al., 2001).
HB-EGF on the other hand, is known to be expressed before HGF with a peak at 24 hours fol-
lowed by a fast decline (Fausto et al., 2006). HGF and HB-EGF in the model reproduce these
temporal dynamics correctly (Fig. 5.2c, 5.2d).
The major regulators cyclin D and cyclin E are observed experimentally to have a 12-16 hours
delayed peak appearing between 36-48 hours followed by a decline to near zero levels (Liao
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et al., 2004). Our numerical simulations mimic these observations (Fig. 5.2e, 5.2f).
Various 1/3 vs. 2/3 PH experiments have shown that the magnitude of DNA synthesis is sensitive
to the amount of liver excised while the timing of DNA synthesis remains essentially unchanged
(Lambotte et al., 1997; Mitchell et al., 2005a). We carry out numerical simulations of 1/3 PH
and 2/3 PH by varying the magnitude of Damage, I0, in the model, and use cyclin E activity
(i.e., the amount of free cyclin E) as a measure of DNA synthesis (see model derivation). In
accordance with the experimental studies, the simulated amplitude of cyclin E activity is quite
different for 1/3 PH and 2/3 PH while the timing stays fairly constant (Fig. 5.2f).
Mitchell et al. (2005a) compared effects of 1/3 PH vs. 2/3 PH on protein expression during
priming and progression phases of liver regeneration. HB-EGF expression was found to be
sensitive towards the amount of damage exerted on the liver, with greatly reduced levels at 1/3
PH unlike PIC, HGF and cyclin D. The model reproduces this decrease in HB-EGF , while it
shows insensitive behavior towards the amount of damage in the case of PIC, HGF and cyclin
D (Fig. 5.2a, 5.2c, 5.2e), which is in accordance with experimental data.
Thus the model reflects the experimentally established fact that expression of priming factors
such as PICs and IEGs alone is not sufficient for cyclin E activation and DNA synthesis. The
sensitivity of both HB-EGF expression and cyclin E activity to the degree of damage supports
that HB-EGF is crucial for progression through G1-S transition and links priming with progres-
sion (Mitchell et al., 2005a).
5.3.2 Simulations of knockouts
Knockouts of important positive and negative regulators were modeled by setting their synthesis
to zero, or, in the case of lumped factors, by decreasing their synthesis (Fig. 5.3) (see Appendix
and supplementary data). The resulting time courses of cyclin E activity are compared to exper-
imental measurements of DNA synthesis.
Cressman et al. (1996) measured the kinetics of DNA synthesis for IL-6 knockout mice. Owing
to the redundancy of species (IL-6 and TNF-α) in PIC, we modeled PIC(−/−) by decreasing the
synthesis rate of PIC. In accordance with the experimental studies (Cressman et al., 1996), the
simulated IL-6(−/−) system exhibits reduced peak cyclin E activity when compared to wild type,
but no change in the timing of peak cyclin E activity. Wüstefeld et al. (2000) engineered trans-
genic mice which overexpress soluble IL-6 receptor/gp80 to analyze the effect of hyperstimula-
tion with IL-6. They observed a delayed onset and peak of DNA synthesis and a reduced peak.
To simulate overexpression, we increase the synthesis rate of PIC. PIC(oe) shows a markedly
decreased DNA synthesis with the peak shifted by 19 hours (Fig. 5.3a).
Recall that IEG is a lumped variable describing various transcription factors. STAT3 knockout
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Figure 5.3:
Simulations of knockouts. (a) solid line: wild type IL-6, dashed line: IL-6(-/-), dotted line: IL-6 hyperstimulation;
(b) solid line: wild type IEG, dashed line: IEG(+/-), τ , S and ϑ : signal time, signal amplitude and signal duration as
defined by Heinrich et al. (2002); (c) solid line: wild type HGF, dashed line: α HGF antibody; (d) solid line: wild
type HB-EGF, dashed line: HB-EGF(-/-); (e) solid line: wild type PAI-1, dashed line: PAI-1(-/-); (f) solid line: wild
type CKI, dashed line: CKI(-/-)
.
(Li et al., 2002), c-jun deletion (Behrens et al., 2002) and targeted disruption of the C/EBP-β
gene (Greenbaum et al., 1998) can be simulated by decreasing the synthesis rate of IEG. In
all these experimental knockouts, the amplitude of DNA synthesis was markedly reduced while
peak timing stayed fairly unchanged. The amplitude of cyclin E synthesis in IEG(+/−) is greatly
reduced to about one-third with no marked change in peak timing, as observed in the experiments
(Fig. 5.3b).
HGF signalling was blocked experimentally by knocking out the HGF receptor met (Borowiak
et al., 2004) or by an α-HGF antibody (Burr et al., 1998). In both cases, a drastic reduction
in cyclin E synthesis was observed. We model HGF depletion (α-HGF(+/−)) by decreasing
the synthesis rate of HGF and find a dramatically reduced cyclin E synthesis as shown in the
experiments (Fig. 5.3c).
Mitchell et al. (2005a) performed 2/3 PH in HB-EGF knockout mice and observed a delayed and
significantly reduced DNA synthesis. Due to redundant EGF family members such as TGF-α ,
HB-EGF synthesis could not be reduced to zero. HB-EGF knockout is mimicked by lowering
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the synthesis rate of HB-EGF . The simulated cyclin E activity in the model is significantly
reduced which correlates well with the experiments (Fig. 5.3d).
Experimental studies reveal that negative regulators delay DNA synthesis during liver regen-
eration, but have relatively minor effects on the amplitude (Shimizu et al., 2001; Jaime et al.,
2002; Luedde et al., 2003; Hayashi et al., 2003). Simulations of PAI-1(−/−) and CKI(−/−) show
a forward shift in timing of cyclin E synthesis with no marked difference in the amplitudes of
wildtype and knockout mice, as observed experimentally (Fig. 5.3e, 5.3f).
Taken together, we can conclude that knockouts of the negative regulators of G1-S transition
during liver regeneration seem to modulate the timing of DNA synthesis much more than the
amplitude of synthesis. On the contrary, positive regulators seem to affect the amplitude, but
have much less effect on the timing of synthesis. This indicates that positive signaling mainly
determines the extent of DNA synthesis, whereas negative signaling (via p21 and PAI-1) sets
the timing of DNA synthesis. In the following section[], we systematically study how amplitude
and timing are controlled.
5.3.3 Sensitivity analysis of the model and robustness of liver regeneration
Liver regeneration is known to be a very robust process, as liver mass is still capable of recon-
stituting even in the absence of important species. Therefore we expect that the total cyclin E
activity, as a measure of total DNA synthesis, to be a robust property of the model. We ana-
lyze the control of integrated response, signal amplitude and signal time with respect to changes
in biochemical parameters. More specifically, we perturb the synthesis rates of each individ-
ual species over a 100-fold range and analyzed the sensitivity of cyclin E in terms of its signal
amplitude (S) and signal time (τ), as defined by Heinrich et al. (2002) (see Fig. 5.3b).
With 100-fold perturbations, changes in cyclin E amplitude and integrated response were below
10-fold in all but one cases. Since the rate of synthesis of deg is immediately downstream to
cyclin E, the time course of cyclin E activity is most sensitive to its perturbations (Fig. 5.4a).
Perturbations in the synthesis rates of PGE2 (Fig. 5.4b), PAI (Fig. 5.4c), and IEG (Fig. 5.4d) led
to less than 10-fold changes in cyclin E integrated response and amplitude. HB-EGF-dependent
rate of synthesis of cyclin E (Fig. 5.4e), Damage dependent rate of synthesis of HB-EGF (Fig.
5.4f), rate of synthesis of HGF and rate of synthesis of CKI (Fig. 5.4g) show less than 7-fold
changes over a 100-fold range of perturbations. In the other cases the amplitude and integrated
response change less than 2-fold despite 100-fold parameter changes as summarized in Fig.
5.4h.
In terms of signal time (τ) the system seems to be even more insensitive to parameter changes.
With 100-fold change of synthesis rates, signal times is changed by less that 2-fold in all cases.
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Figure 5.4:
Fold change in integrated response, signal amplitude (S) and signal time (τ) of cyclin E with fold change in param-
eters. (a) Rate of cyclin E mediated Degradator synthesis; (b) rate of PGE2 synthesis; (c) rate of PAI-1 synthesis;
(d) rate of IEG synthesis; (e) rate of HB-EGF-mediated cyclin E synthesis; (f) rate of HB-EGF synthesis; (g) rate
of CKI synthesis; (h) remaining 9 synthesis rates.
In summary, the model simulations confirm the robustness of liver regeneration. Only in a
few cases, 100-fold changes of 16 synthesis parameters lead to drastic changes of the signal
amplitude and the integrated response.
5.3.4 Filtering properties of the model
Sensitivity analysis of the model gave insights into the modulation of timing and amplitude at
each stage of the model leading to a balanced and robust DNA synthesis. We further study
the filtering properties of the model output of cyclin E by changing the Damage input. We
vary the magnitude of Damage (I0) in such a way that the total amount of Damage (area under
curve for Damage) remains constant while adjusting the decay time. High magnitude I0 means
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Figure 5.5: Input/output relationship of the model with changes in magnitude of Damage (I0)
a large but short lived Damage, and a low magnitude I0 refers to a weak and prolonged Damage.
Interestingly, too sharp and too prolonged Damages were filtered out, and thus the output (area
under curve for cyclin E) showed the attributes of a bandpass f ilter (Fig. 5.5).
The model architecture contains various feed-forward loops. This means that the common input
regulator (Damage) regulates the output (cyclin E) via independent (multistep) branches. This
is a generalization of classical feed-forward loops discussed by Dekel et al. (2005). We found
that the nested feed-forward loops in the PIC mediated pathway including the incoherent feed-
forward loop from PIC to HGF via PAI and the incoherent feed-forward loop from PIC to cyclin
E via CKI is responsible for filtering out sharp short-lived inputs. On the other hand, weak and
long-lived inputs are filtered out due to ultrasensitivity involved in HB-EGF production and
HB-EGF mediated cyclin E induction (see equations and supplementary data).
Compared to the amplitude, the timing of cyclin E synthesis is much less sensitive to changing
of Damage (Fig. 5.5). This confirms the experimental observation that the timing of hepatocyte
DNA synthesis after PH is robust. When PH treated rat hepatocytes are transplanted into PH
treated mouse liver, rat hepatocytes in mouse liver display rat kinetics despite the new surround-
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ing. Thus the model can also simulate cell autonomous behavior of timing of hepatocyte entry
into DNA synthesis (Weglarz and Sandgren, 2000).
5.4 Discussion
In this chapter, we presented a mesoscale model of liver regeneration where we lumped similarly
acting species into single variables, but did not consider individual mRNA and protein concentra-
tions. This approach allows us to accurately describe the complex dynamics of liver regeneration
(see Figs. 2 and 3) even though only few quantitative experimental informations were available.
The model can be used to make experimentally testable predictions. In particular, the model can
be used to predict how the dynamics of DNA synthesis during liver regeneration is altered in
transgenic mice which overexpress key mediators of liver regeneration. In particular, it turns out
that positive signaling governs the extent of DNA synthesis and inhibitors control the timing.
Liver regeneration is a remarkably robust process, as mass reconstitution accurately occurs in
most cases, even if the key players of liver regeneration are knocked out. Liver mass reconstitu-
tion mainly occurs by compensatory cell division. Therefore we expected integrated response of
Cyclin E activity to be a robust property of the model, as it reflects the total amount of DNA syn-
thesized during liver regeneration. Our simulations shown in Fig. 4 revealed that the integrated
response of Cyclin E is indeed relatively insensitive to parameter changes and explaining the
observed robustness of liver mass reconstitution. We also found that the amplitude and the tim-
ing of DNA synthesis are relatively unaffected by parameter changes. This is also in accordance
with experimental studies, as hepatocytes initiate DNA synthesis during liver regeneration in a
highly synchronous manner, even though individual cells are likely to significantly differ from
each other.
Our analysis of the model’s filtering properties revealed that the model acts as a bandpass filter,
that is, it suppresses short, high amplitude signals and long, low amplitude signals (Fig. 5). Such
bandpass filtering appears to be physiologically relevant in the context of liver regeneration,
because very strong liver damage suppresses the DNA synthetic response rather than increasing
it (Bucher and Swaffield, 1964). More detailed analyzes suggested that incoherent feed-forward
loops, i.e., simultaneous activation and inhibition in parallel, are responsible for filtering out
short, high amplitude pulses. More specifically, it seems that inhibitory molecules such as p21
and PAI-1 are already expressed in response to short inputs, while activators of cell division
require longer stimulation. These findings might also be of broader interest, as incoherent loops
are involved in a variety of physiological processes. For example, cell death signals such as
TNF-alpha trigger prosurvival signals such as NF-κB in addition to prodeath signals (Stehlik
et al., 1998). The short-pulse filtering properties of incoherent feed-forward loops discussed in
this paper might help cells to ignore erroneous short inputs, but to execute cell fate decisions in
response to sustained stimulations.
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In this work, we used a top-down approach to model liver regeneration. This framework will
allow us to model currently lumped species in more detail in the future. For example, the im-
mediate early genes (IEG) could be modeled as a network of transcription factors, which will
allow direct comparison of the model with microarray data of liver regeneration. Additional
extensions such as a complete description of the whole cell division cycle, as well as of spatial
and stochastic effects, will enable us to determine why some hepatocytes enter a second round
of cell division, while others do not.
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6 The integrated mammalian cell cycle model
of regenerating liver
Synopsis
The whole process of cell division in mammalian cells is mainly orchestrated by cell cycle de-
pendent oscillations in the levels of cyclins. Different cyclins are produced at different cell cycle
stages with additional controls imposed on them by various regulating mechanisms which gov-
ern distinct cell cycle events. G1-S cyclins which trigger DNA synthesis are discussed in chapter
2 and 2. The rise of G1-S cyclins is accompanied by the appearance of Cyclin A. Later mitotic
events are controlled by Cyclin B . Mitotic transition is promoted by abrupt accumulation of
active Cyclin B controlled by multiple redundant feedback loops at the transcriptional posttrans-
lational and degradation levels. However, the relative contribution of these separate feedback
loops to the decision to enter mitosis is currently under the scanner. Mitotic transcription factors
like FoxM1 are being implicated more and more in the maintenance of G2 phase. Also, Cdh1 de-
pendent proteolytic degradation of mitotic cyclins, which is more known for controlling the G1
phase, is being implicated in the control of G2 phase and G2-M transition. Exit from mitosis is
controlled by Cyclin B degradation and mitotic exit is rendered irreversible due to systems-level
feedbacks imposed by Wee1 and Cdc25 at early G1 phase. This chapter presents an integra-
tive model of mammalian cell cycle focusing on Cdh1 at the core of cell cycle machinery and
importance of FoxM1 and Wee1 in the mitotic machinery.
6.1 Introduction
In the presence of pro-inflammatory cytokines (PICs), hepatocytes quit a quiescent state, denoted
G0, and enter priming. Primed cells in the early G1 phase are then driven by growth factor (GFs)
to pass the restriction point, which is a point of no return beyond which they are irreversibly
engaged in the cell cycle and do not require the presence of growth factors to complete mitosis
(Taub, 2004). Progression in the cell cycle is controlled by the sequential activation of a family
of cdks, which allow an ordered succession of the cell cycle phases G1, S, G2, and M (Morgan,
2007). The cdk proteins are active only when forming a complex with their corresponding cyclin.
The Cyclin D-Cdk4/6, Cyclin E-Cdk2, Cyclin A-Cdk2, and Cyclin B-Cdk1 complexes promote,
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respectively, progression in G1, the transition to S from G1, progression in S and G2, and finally
the G2-M transition, allowing entry into mitosis (Morgan, 2007). Cdk regulation is achieved
through a variety of mechanisms that include association with cyclins and protein inhibitors,
phosphorylation/dephosphorylation, and cyclin synthesis or degradation (Morgan, 2007).
A number of theoretical models for the cell cycle have been proposed which are discussed in
more detail in chapter r˜efChapter4. Initially, these models pertained to the early cell cycles in
amphibian embryos (Tyson, 1991; Goldbeter, 1991; Novak and Tyson, 1993; Sha et al., 2003;
Pomerening et al., 2003) which consist of only two phases, interphase and mitosis (Murray and
Kirschner, 1989). Chen et al. (2004) later proposed a detailed computational model for the yeast
cell cycle, which accounts for the behavior of a large number of mutants. Theoretical models
were subsequently proposed for portions of the mammalian cell cycle, particularly the G1-S
transition and the restriction point (Aguda and Tang, 1999; Qu et al., 2003a,b; Swat et al., 2004;
Novak and Tyson, 2004). A generic model for the eukaryotic cell cycle has also been presented
Csikasz-Nagy et al. (2006).
We still lack a detailed, integrative model coupling the different cyclin-cdk complexes that con-
trol the successive phases of the mammalian cell cycle, which would be capable of describing
their sequential activation. Models of this sort were proposed for the yeast cell cycle in which a
key role is played by cell growth; in those models mitosis is controlled by cell mass (Chen et al.,
2004). In mammalian cells, cell mass is not a determining factor for the control of cell cycle.
Also, modeling cell cycle regulation in mammalian cells is most daunting task, since it involves
multiple control mechanisms that hold cells back from proliferation. Different types of mam-
malian cells are physiologically different from one another which makes the task of modeling
mammalian cells even more difficult. Adding to this complexity, in vitro systems of artificially
dividing cells are obtained under non-comparable experimental conditions, and different arti-
ficial cell cycle synchronization procedures. Liver regeneration being a highly synchronized
proliferating system, provides the possibility to analyze the cell cycle of naturally synchronized
cells in the whole animal.
The availability of comparatively well studied G1-S phase experimental models of liver regen-
eration in rodents allowed us to model a cytokine and growth factor mediated G1-S transition in
regenerating hepatocytes in the previous chapter (Chauhan et al., 2008). In chapter r˜efChapter3,
we have discussed present state of the art of understanding and knowledge of mitotic events
focussing on mammalian cells. Based on the present mechanistic understanding of mitotic sys-
tems, first integrative mammalian cell cycle model of regenerating liver is implemented in this
chapter.
Materials and methods
Lack of data and experiments on mitotic cells during liver regeneration and also lack of complete
understanding of various mechanisms controlling mitosis limits the availability of specific mam-
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malian cell type data. Therefore, heuristic and ad-hoc approaches were implemented to model
mitotic events. Building on previous work that showed the occurrence of cyclin oscillations in
models for the cell cycle in embryos (Tyson, 1991; Goldbeter, 1991; Novak and Tyson, 1993;
Sha et al., 2003; Pomerening et al., 2003) and yeast (Chen et al., 2004), and in less detailed or
partial models for the mammalian cell cycle (Aguda and Tang, 1999; Qu et al., 2003a,b; Swat
et al., 2004; Novak and Tyson, 2004), I present an integrated model of mammalian cell cycle
focusing on the cell cycle progression response during liver regeneration. To this end, the con-
trol by cell mass was disregarded, which appears less stringent in mammalian cells than in yeast
(Conlon and Raff, 2003).
The model is based on the sequential activation of cyclin-dependent kinases. Using the existing
knowledge of various cyclin control mechanisms and their temporal organization during liver
regeneration, the network controlling the cyclin-dependent kinase activity at various stages of
the cell cycle was designed(Fig. 6.1). Using basic principles of biochemical kinetics the model
scheme was translated into a set of non-linear ordinary differential equations. Protein degra-
dation was always assumed to follow a linear kinetics. The kinetic parameters (see Appendix
1 for details of equations and parameters ) were adjusted so that the model represents the ex-
perimentally observed temporal dynamics of each protein species responsible for entry and exit
from mitosis. Some of their knock-outs were also simulated. All protein concentrations in the
model are expressed in arbitrary units (a.u.) since for most of the regulatory proteins the actual
concentrations are not known.
To limit the number of variables in the model, we only considered explicitly the proteins but not
the corresponding mRNAs. Thus, induction of gene expression by pro inflammatory cytokines
and growth factors and by E2F, were incorporated directly as functions modulating the synthesis
of cyclins. Focusing on proteins also allowed us to readily incorporate post-translational regu-
lation through phosphorylation-dephosphorylation or through the formation of complexes with
p21/p27. For similar reasons of simplicity I did not distinguish between the nuclear and cy-
tosolic compartments of the cell. The model describes the dynamics of the cyclin-cdk network
within one cell.
For numerical simulations of the model Matlab was used and for bistability analysis the com-
puter program XPPAUT with the "stiff" integrator was used.
6.2 The model mechanisms and temporal organization
6.2.1 Mitosis
The regenerating liver has proven to be an excellent in vivo model system to study the mech-
anisms of growth control within a natural tissue environment. Liver regeneration after both
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Figure 6.1:
Damage induced model of the cell cycle during liver regeneration based on sequential cyclin activation and degra-
dation. PH induced Damage pushes the quiescent cells to priming via cytokine signaling. Primed cells then activate
growth factor induced signaling cascades. Cytokine- and growth factor induced pathways act in concert to provide
mitogenic signals for Cyclin D activation in early G1 phase. Cyclin D initiates a chain of sequential phosphory-
lation of Rb-E2F which leads to sequential transcription of further G1-S (Cyclin E), S (Cyclin A) and M (Cyclin
B) phase cyclins. Also, stoichiometric inhibitors of cyclins, CKIs, are activated by cytokines already at early G1.
G1-S proteolytic degradation machinery, SCF, is set on by Cyclin E. Entry to mitosis is controlled by abrupt Cyclin
B-Cdk1 activation at G2-M by Cdc25 and Wee1 mediated positive feedbacks. Cdc25 and Wee1 mediated positive
feedbacks also regulate rapid exit from mitosis by swiftly inactivating Cyclin B-Cdk1 at M/G1 in coordination with
positive feedback from M/G1 degradator APCCdh1 and a negative feedback exerted by mitotic degradator APCCdc20.
All cyclin-cdk complexes are depicted as respective activating cyclin partner for simplicity. E2F in the scheme
represents all three forms of E2F, viz, unphosphorylated, hypophosphorylated and hyperphosphorylated.
PH and CCl4 treatment exhibits well-synchronized DNA synthesis and mitosis (Deguchi et al.,
2002).Temporal proliferation pattern of the cell in regenerating rodent liver consists of two
waves of mitosis (GRISHAM, 1962; Fabrikant, 1968). During the first round, hepatocytes syn-
chronously undergo DNA replication (peak at 36 hour), and mitosis (peak at 45 hour), which
lasts more than 72 hours (Faktor, 1971). Its is then followed by a second round of divisions of
lower synchrony. The mitotic peak occurs 4-12 hours after the peak of DNA synthesis at 36
hours (Matsuo et al., 2003a).
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6.2.2 E2Fs regulating sequential activation of cyclins
E2F activity is tightly controlled by binding to the retinoblastoma protein (Rb). Rb sequesters
E2F and inhibits its transcriptional activity. This hold of Rb on E2F depends on its phosphory-
lation level. Higher the Rb phosphorylation level more the E2F is released from its hold and is
available for transcriptional activation of further downstream genes. Phosphorylation of Rb is
regulated sequentially by various cyclin-associated-kinases as discussed in section 3.2. At mid
G1 Cyclin D-Cdk4/6 complexes initiate the phosphorylation of Rb. Complete phosphorylation
of Rb and E2F release requires further phosphorylation by Cyclin E. Cyclin E hyperphospho-
rylates Rb during G1-S phase releasing more E2F, which then leads to Cyclin A and Cyclin B
transcription(Lundberg and Weinberg, 1998). Also, transcription factors like FoxM1 and B-Myb
are known as activators of transcription of mitotic cyclins. FoxM1 is more specifically studied
during liver regeneration.
In the model, E2F, FoxM1 and B-Myb are lumped in to a single species called E2F. E2F ex-
ists in three forms: unphosphorylated, hypophosphorylated and hyperphosphorylated. Cyclin
D initiates Rb phosphorylation and E2F release yielding hypophosphorylated Rb-E2Fp. Rb-
E2Fp initiates Cyclin E transcription which further phosphorylates Rb-E2Fp giving rise to more
E2F and hyperphosphorylated Rb-E2Fpp. E2F released by hyperphosphorylated Rb-E2Fpp is
then able to start the initiation of Cyclin A and Cyclin B transcription (Calzone et al., 2008b)
(Fig. 3.5). Detailed equations of Rb-E2F phosphorylation dynamics can be seen in Appendix 3.
Cyclin D and Cyclin E mediated phosphorylation/dephosphorylation reactions of Rb and asso-
ciation/dissociation of its 3 phosphorylated forms with E2F are fast enough so that the three
phosphorylated forms of Rb and their complexes with E2F are always in equilibrium and hy-
perphosphorylated form of Rb-E2F can be described as an algebraic equation with the pool of
E2F dependent on the temporal evolution of Cyclin D and Cyclin E (Appendix 3). E2F mecha-
nism is closely related to the one considered by Swat et al. (Swat et al., 2004) with some slight
modifications.
6.2.3 CKIs at the interphase of S phase and mitosis
CKIs are grouped into two categories: Ink4 and Cip/Kip. Ink4 proteins inhibit Cyclin D as-
sociated kinase activity. Cip/Kip family consists of three members: p21, p27 and p57. These
proteins act as stoichiometric inhibitors of Cdk2 and Cdk1 (Vidal and Koff, 2000). We lump all
forms of CKIs together and refer to them as CKIs unless stated otherwise.
CKIs work as breaks providing additional regulation to the timely cell cycle dependent expres-
sion of cyclins. CKIs are predominantly transcriptionally regulated via IL-6 dependent STAT3,
Myc and E2F signaling (Gartel and Tyner, 1999; Coller et al., 2000). CKIs genes are also re-
ported to be transcriptional cofactors regulating the activity of E2F, STAT3, Myc and, in turn,
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the transcription events regulated by them (Coqueret, 2003). Thus, in our model we assume
PICs which constitutes IL-6, as an inducer of CKIs activation.
From the available data on various CKIs proteins we conclude that CKIs are markedly induced
after PH, beginning during G1 phase and peaking during the post-replicative phase (48 h). At
120 h after PH, CKIs are again barely detectable (Albrecht et al., 1998). CKIs are degraded by
proteolytic degradators. More detailed regulation of CKIs during mitosis is described in section
3.3.
In the model, CKIs exert a two-way control on cyclins. First, CKIs stoichiometrically inhibit Cy-
clin D, Cyclin E and Cyclin A by forming complexes with their cdk partners. Second, degrada-
tors SCF (G1-S controlled) and APCCdh1 (S and mitotic cyclin controlled) drive degradation of
CKIs imposing another level of feedback control on cyclins.
6.2.4 Cyclins
The whole process of cell division is mainly orchestrated by cyclin dependent kinases. As
the cells progress through the cell cycle, abrupt changes in the enzymatic activities of these
kinases lead to changes in phosphorylation state and thus the state of activation of proteins that
govern the cell cycle processes. Concentrations of these kinases are constant throughout the
cell cycle. Oscillations in their activity depend on the corresponding oscillations in the levels of
their respective cyclin subunits. Different cyclins are produced at different cell cycle stages with
additional controls imposed on them by various other cell cycle regulators (Fig. 3.3), resulting in
a series of cyclin-cdk complexes which govern distinct cell cycle events. Cyclin D and Cyclin E
are G1-S cyclins which trigger DNA synthesis as discussed in chapter 2 and 5. The rise of G1-S
cyclins is accompanied by the appearance of Cyclin A. Later mitotic transitions are controlled
by Cyclin B (Fig. 3.2).
Cyclin A Cyclin A has a function in both S phase and mitosis (Pagano et al., 1992) and it
is associated with both Cdk1 and Cdk2 (Garnier et al., 2009). Transcription of Cyclin A is
mediated by hyperphosphorylated Rb-E2F (Lundberg and Weinberg, 1998). Cyclin A levels
are low during G1 and increase at the onset of S phase, when it contributes to the stimulation
of DNA synthesis (Resnitzky et al., 1995). Degradation of Cyclin A at the end of G2 leads to
Cdh1 dephosphorylation enabling association of Cdh1 with APC. Active APCCdh1 in turn, leads
to timely degradation of Cyclin A (den Elzen and Pines, 2001). Regulation of Cyclin A during
mitosis is discussed in section 3.4 in more detail.
Thus in the model, mutually antagonistic control of E2F induced Cyclin A and APCCdh1 consti-
tutes a positive feedback on Cyclin A degradation and APCCdh1 activation at the end of G2.
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Cyclin B Transcription of Cyclin B is mediated by various transcription factors like E2F, NF-
Y, FoxM1, and B-Myb. Cyclin B protein forms a complex with Cdk1. Expression of Cyclin
B protein in hepatocytes starts in mid S phase. Cdk1 binds to Cyclin B during G2 phase, but
the complex is maintained inactive due to inhibitory phosphorylation at Threonin14 (T14) and
Tyrosine 15 (Y15) residues by Wee1. This inactive pool of Cyclin B/cdk keeps building during
G2 until its inhibitory phosphorylation on T14 is removed abruptly by Cdc25 at G2-M transition.
Active Cyclin B in turn activates Cdc25 by phosphorylating it. Active Cyclin B also inactivates
Wee1 by phosphorylating it and thus removing the Wee1 imposed Cyclin B inhibition. This
abrupt activation and inactivation of its activator Cdc25 and deactivator Wee1, respectively, gives
rise to a sudden flood of active Cyclin B which drives mitosis. In the late G2 phase, a very
transient induction of Cyclin B-Cdk1 activity is also observed in hepatocytes (Loyer et al., 1994).
Thus Cdc25 and Wee1 constitute two feedback loops which get simultaneously activated during
G2-M transition. The feedback loops create bistability, such that Cdk1 activation switches from
off to on and does not exist in an intermediate state of activation.
At metaphase, sufficiently high levels of active Cyclin B enables phosphorylation of its degrada-
tor Cdc20. Phosphorylated Cdc20 activates APC by forming an active complex APCCdc20, which
in turn degrades Cyclin B via proteolysis. This Cyclin B-APCCdc20 system constitutes a negative
feedback system controlling the mitotic exit.
When the Cyclin B-Cdk1 complex becomes inactive due to Wee1 mediated phosphorylation and
APCCdc20 mediated degradation of Cyclin B, Cdh1 cannot any more be kept in its inactive phos-
phorylated form. Dephosphorylation of Cdh1 leads to its assembly with APC and the activation
of the degradation machinery of APCCdh1. Moreover, Cdk1 inactivation at mitotic exit leads to
Wee1 activation and Cdc25 inactivation due to their dephosphorylation. Thus the mitotic exit
system constitutes three positive feedbacks from APCCdh1 , Wee1 and Cdc25 which lead to an
irreversible exit from mitosis.
More detail of how Cyclin B activation leads to mitotic entry and its degradation results in exit
from mitosis can be found in section 3.4.
6.2.5 Cdc25 and Wee1
Cdc25 A, -B and -C are expressed at different times during the cell cycle. All three coordinate
together to dephosphorylate Cdk1 and enable active Cyclin B-Cdk1 complex formation at G2-
M transition. In mice hepatocytes Cdc25 B mRNA levels peaks between 40 to 44 hours and a
substantial increase in nuclear staining of Cdc25 B protein at 40 hours. Cdc25 A protein shows
sustained expression throughout the period of hepatocyte proliferation. For simplicity we lump
all forms of Cdc25 into one which is activated during mitosis. Also, the activation of Cdc25 is
controlled via phosphorylation by Cyclin B-Cdk1 ((Hoffmann et al., 1993; Izumi et al., 1992;
Kumagai and Dunphy, 1992)).
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Wee1 mRNA levels in mice hepatocytes are high at the start of cell cycle and during mitotic exit
at 72 hour. Wee1 protein levels and its activity in mice hepatocytes are seen to be significantly
visible through out the cell cycle with a peak at 72 hour (Murata et al., 2007). Cdc25 and Wee1
mediated control of Cyclin B is explained in detail earlier in this section and in section 3.6. In
our model, Cyclin B-Cdk1 is held inactive till G2 phase by Wee1 mediated phosphorylation at
two of its inhibitory residues T14 and Y15. Only when T14 phosporylation on Cdk1 is removed
by Cdc25 that Cyclin B-Cdk1 becomes fully active. Partial phosphorylations and dephosphory-
lations by Wee1 and Cdc25 are assumed to be fast enough so that we only have two forms of
Cyclin B, fully active and inactive. Phosphorylation of Wee1 by active Cyclin B-Cdk1 renders
it inactive during mitosis.
6.2.6 APC and SCF: the degradation oscillators controlling the cell cycle
APC As discussed in section 3.5, APC is the proteasomal machinery degrading proteins after
being consecutively activated by two of its subunits Cdc20 or Cdh1, both having a separate
window of activity. Cdc20 is activated by Cyclin B-Cdk1 dependent phosphorylation during
mitosis. Active Cdc20 binds to APC, which then degrades Cyclin B. Cdh1 is inactivated by
Cyclin B-Cdk1 dependent phosphorylation. Thus Cdh1 becomes active at the end of mitosis,
when Cyclin B is degraded and assembles with APC to further degrade mitotic cyclins, Cdc20,
CKIs and SCF. Cdh1 also acts as G1 regulator destroying mitotic cyclins and CKIs during G1
and maintaining duration of G1 by destruction of SCF (Bashir et al., 2004; Wei et al., 2004).
Thus Cdh1 can be considered a master regulator of the cell cycle connecting mitosis to G1-S by
degrading G1-S inhibitors like SCF and CKI. It controls Cyclin A and -B at two levels: first in
a direct double feedback loop manner and second by inhibiting their inhibitors CKIs and Cdc20
respectively. Cdh1 also controls G1 cyclins, Cyclin D and - E, also by two mechanisms: Firstly
by degrading their degradator SCF and secondly by degrading their stoichiometric inhibitor
CKIs (Fig. 6.2).
SCF As described in section 2.3 and 3.5, SCF can degrade CKIs and G1 cyclins. SCF is
down-regulated in late M and G1 and induced by Cyclin E only when cells near S phase and its
degradator Cdh1 is degraded (Bashir et al., 2004). Thus, Cdh1 connects the SCF driven G1-S
proteolytic machinery with APC dependent mitotic and G1 proteolysis. Therefore, in the core
of cell cycle lies Cdh1 driven degradation which results in an interwoven proteolytic oscillator
controlling the cell cycle transitions.
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Figure 6.2:
Cdh1 at the core of cell cycle controlling cyclin dynamics. (a) The APC is activated by Cdh1 from the end of mitosis
through G1 (APCCdh1). APCCdh1 controls G1 to either allow differentiation or to prepare for a new round of cell
division. In G2, APCCdh1 can be activated in response to DNA damage to block mitotic entry and to initiate DNA
repair. In mitosis APC activated by Cdc20 (APCCdc20) mediates chromosomal separation and initiates mitotic exit.
At the end of mitosis APCCdh1 inactivates APCCdc20 and modulates anaphase-spindle dynamics and cytokinesis.
Inactivation of Cdh1 can contribute to tumorigenesis by deregulation of these cell-cycle transitions (adapted from
(Wasch et al., 2010)). (b) APCCdh1 controls G1-S cyclins by degrading their degradator SCF and stoichiometric
inhibitor CKIs. At the S phase, APCCdh1 exerts a two-layered control on Cyclin A, one by mutually antagonist
degradation of Cyclin A and secondly by degrading its stoichiometric inhibitor CKIs. At the mitotic exit, it degrades
APCCdc20, a mitotic degradator of Cyclin B. Further, APCCdh1 degrades Cyclin B in a mutually antagonist manner.
This intricate control exerted by APCCdh1 plays a crucial role in G2 delay imposed due to untimely degradation of
G2-M cyclins.
6.3 Results
6.3.1 Simulations of mitosis model
All the model species will be represented in italics in the coming discussions. Cyclin D and
Cyclin E from the G1-S model (Chauhan et al., 2008) serve as input for the E2F mediated
transcription of Cyclin A and Cyclin B in the mitosis model. Step-wise activation of E2F via
Cyclin D and Cyclin E leads to sequential activation of cyclins in a cell cycle phase specific
manner (Fig. 3.2), also controlled by other regulators (Fig. 3.3). Cyclin D appears at late
G1, Cyclin E at G1-S transition, Cyclin A in S phase and Cyclin B in late S phase and mitosis
(Fig. 6.3).
Active forms of mitotic players Cyclin B, Wee1, Cdc25 and Cdc20 complexed with APC exhibit
the observed delayed transient induction at mitotic entry (Fig. 3.4). This delayed and transient
induction is enabled due to positive feedback from Cyclin B inhibitor and activator Wee1 and
Cdc25 respectively.
Active Cdh1 forms a complex with APC from late mitosis to G1 phase keeping mitotic and
G1 cyclins degraded. SCF becomes active during G1-S phase leading to degradation of G1-S
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Figure 6.3:
Sequential activation and degradation of cyclins. Cyclin D appears at the late G1, Cyclin E at the G1-S transition,
Cyclin A in the S phase and Cyclin B in the late S phase and mitosis. At the G2-M interface of mitosis, transient
activation of Cyclin B, Cdc25 and inactivation of Wee1, leads to abrupt mitotic entry. On the other hand, at the M/G1
interphase of mitosis, Cdc25 and Wee1 are respectively rapidly inactivated and activated, leading to swift exit from
mitosis. APCCdc20 is also transiently activated once enough Cyclin B has accumulated at mitosis. APCCdh1 is active
from late mitosis to G1 phase keeping mitotic and G1 cyclins degraded during late mitosis and G1. SCF becomes
active during G1-S phase leading to degradation of G1-S cyclins. All concentrations are normalized by the maximum
concentrations.
cyclins (Fig. 6.3).
Cells in regenerating rodent liver exhibit two waves of mitosis (GRISHAM, 1962; Fabrikant,
1968). During the first round hepatocytes synchronously undergo DNA replication and mitosis.
It is then followed by a second round of divisions of lower synchrony. The model is also able
to simulate a secondary mitotic peak as observed in experiments (Fig. 6.4) when Wee1, Cdc25
imposed feedback is increased and APCCdc20 dependent negative feedback is delayed (Appendix
5).
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Figure 6.4:
Secondary peak of mitosis as observed in regenerating hepatocytes. Increased positive feedback strength at mitosis
and delayed negative feedback at mitotic exit leads to a secondary peak of mitosis. However, Cyclin E levels and so
DNA synthesis is unaffected.
Robustness analysis
Liver regeneration is known to be a very robust process, as liver mass reconstitutes itself even
in the absence of important cell cycle players. Therefore we expect that the Cyclin E activity,
as a measure of total DNA synthesis, to be a robust property of the model. We analyze the peak
amplitude and timing of the peak with respect to changes in biochemical parameters over a 100-
fold range. Change in Cyclin E amplitude and timing are less than two fold in case of most of
the parameters (Fig. 6.5), except the parameters immediately downstream of the input Damage,
such as, degradation of PAI and PICs, PGE2, IEG. Also, Cycin B is sensitive to changes in these
parameters ( 6.6). This sensitivity is because of the bandpass filtering properties of the model
which enables filtering out of very sharp and prolonged damages. Sharp short lived damage
input is filtered out due to two incoherent feed-forward loops from PAI and CKI. On the other
hand, weak and long-lived inputs are filtered out due to ultra-sensitivity involved in HB-EGF
production. Sensitivity to the amount of injury is also well documented in several experiments.
Liver regeneration response is proportional to the amount of PH performed. PH of less than 30
% or more than 90 % leads to no liver regeneration response (Lambotte et al., 1997).
Cyclin B shows an all-or-none kind of behavior towards the parameters variations (Fig. 6.6).
This all-or-none switch during mitosis is well known and well studied in various experiments
and also computational models (O’Farrell, 2001; Csikasz-Nagy et al., 2006), which is due to the
bistability observed at the G2-M transition (Fig. 6.17). Once the threshold value of a parameter
is reached amplitude and timing of Cyclin B activity is stabilized against any further change in
69
6 The integrated mammalian cell cycle model of regenerating liver
0 50 100
0
0.5
1
DNA synthesis
Time [h]
Cy
cli
n 
E 
[a
.u
.]
0 50 100
0
2
Mitosis
Time [h]
Cy
cli
n 
B 
[a
.u
.]
0.77 7.7 77
0
1
2
Am
pli
tu
de
0.77 7.7 77
0
1.5
3
Am
pli
tu
de
0.77 7.7 77
0
50
CKIs degradation parameter
Ti
m
ing
0.77 7.7 77
0
50
Ti
m
ing
CKIs degradation parameter
a
b
c
Figure 6.5:
Robustness of the model to parameter variations. Parameter variations at a 100 fold range, transmit only less than
two fold change in Cyclin E, the indicator of DNA synthesis, and Cyclin B, the indicator of mitosis. (a) Thick green
lines represent time courses of respective cyclins at the default degradation rate of CKIs. Red lines and blue lines
indicate time courses with up to 10 fold increase and up to 10 fold decrease respectively, in the parameter values
respectively . (b) Peak amplitude of the respective cyclins with respect to fold change in parameter. (c) Timing of the
peak amplitude of the respective cyclins with respect to fold change in parameter.
parameter values except for those of Wee1 production (Fig. 6.8).
Timing of entry of cells into mitosis is known to differ with the time of the day. Wee1 plays an
essential role in this circadian control of cell cycle which is illustrated further in our circadian
mutant simulations in section 6.3.2 . Simulations of our robustness analysis are consistent with
the observation that expression of Wee1 follows a circadian cycle, and the timing of entry of G2
cells into mitosis varies inversely with levels of Wee1 after PH (Fig. 6.8).
A fascinating counterpart to these observations is that the timing of Cyclin E activity and thus
DNA replication is insensitive to all the players active during mitosis. This is consistent with the
observation that DNA replication is not under the control of circadian rhythms and appears to be
an intrinsic property of hepatocytes. Rats and mice differ in the timing of DNA replication after
PH, which is 12 to 16 hours earlier in rats. Weglarz and Sandgren transplanted rat hepatocytes
into the livers of mice after PH and found that rat hepatocytes replicated earlier than mouse hep-
atocytes in the resultant chimeric liver (Weglarz and Sandgren, 2000). These results support the
fact that the timing of hepatocyte DNA replication after PH is an autonomous process, primarily
guided by intrinsic signals.
Parameters linked to Cdh1 and CKIs mostly induce a prolongation or shortening of Cyclin E
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Figure 6.6:
Sensitivity of DNA synthesis and mitosis towards variations in the input. Cyclin E and Cyclin B are sensitive to
variations in the parameters which are directly downstream of the input such as degradation parameters for PICs.
Amplitude and timing of the peak exhibit bandpass filter type input/output relationship.
degradation. Prolonged degradation corresponds to a delay in emergence of Cyclin B (Fig. 6.9).
This reflects the delayed mitosis and G2 delay observed in the experiments when DNA synthesis
is not completed in time (Park et al., 2007). CKI mediated inhibition via Erk signaling is impli-
cated in many of the G2 and mitosis delay studies (Dangi et al., 2006). Cdh1 mediated delay has
also been recently reported (Holt et al., 2010). Section 6.3.2 further probes into the the possible
role of Cdh1 during G2 delay.
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Figure 6.7:
All-or-none behaviour of Cyclin B towards parameter variations. Fold change in the parameters, e.g. positive feed-
back strength parameter, above a threshold value, switches on Cyclin B activity abruptly to high levels. Thus Cyclin
B activation and hence G2-M transition does not jump start as long as the feedback strength exceeds a certain critical
value.
6.3.2 Simulations of knockouts
Circadian Clock-Wee1 pathway controlling mitosis
Cell division in many mammalian tissues is associated with specific times of the day. However,
how the circadian clock controls the timing of cell division is a hot topic of research due to its
direct implications in tumor research and chemotherapy. To explore the relationship between
cell division and circadian rhythms, Matsuo et al. (Matsuo et al., 2003b) used a mouse model
with partial hepatectomy (PH). PH was performed on mice at ZT8 or ZT0 (ZT0 represents lights
on and ZT12, lights off) to compare the kinetics of subsequent cell cycles. The kinetics of S-
phase hepatocytes for both ZTs were comparable. In contrast, subsequent mitotic waves at ZT8
or ZT0 differed between 4 to 8 hours(Fig. 6.10). Analysis of the expression profiles of 68 cell
cycle-related genes showed only three genes – cyclin B1, Cdc2 (homologue of Cdk1), and Wee1
having remarkably different expression profiles between ZT8 and ZT0 and all three are mitosis
regulated (Fig. 6.11). These results suggested that the time of surgery has a marked effect on
the timing of mitosis controlling the progression of cell cycling itself.
Wee1 transcription is directly regulated by circadian clock components: activated by Clock-
Bmal1 heterodimers and suppressed by Per/Cry proteins. Lack of clock regulated cryptochromes
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Figure 6.8:
Mitosis is under circadian control of Wee1 while DNA synthesis is autonomous. Fold change in degradation of Wee1,
which is controlled in a circadian manner, has a strong linear correlation to the timing of Cyclin B activity while has
no affect on Cyclin E activity. Thus, circadian shifts in Wee1 might control entry of the cells to mitosis, while DNA
synthesis is unaffected by external stimuli.
(Crys) causes circadian disruption and impairment of hepatocyte proliferation. Also, Wee1 gene
is reported to have E-box elements which are targeted by Clock-Bmal1 heterodimers. In mutated
E-box region of Wee1 gene circadian transcription is reduced. In Cry-deficient mice, Wee1
mRNA levels are reported high at both ZTs. However, in Clock mutant (Clock/Clock) mice,
Wee1 expression was low at both ZTs. These findings suggest a direct regulation of circadian
clock by Wee1 (Matsuo et al., 2003b).
The peak of Wee1 activity in ZT8 occurs 4 to 8 hours before the corresponding mitotic peak
in ZT0. In Cry-deficient mice as well Wee1 activity peaks 4 hours before mitotic peak in ZT0.
Also, Cyclin B activity occurs 4 hours before in both Cry-deficient and ZT8 mice due to early
and increased levels of Wee1. Thus, we use Wee1 as a marker of circadian shift at ZT8 in our
model. We reduce degradation of Wee1 to mimic early increased peak of Wee1 in response to
PH at ZT8. The model is able to simulate the early peak in Wee1 and mitosis observed in ZT8
mice (Fig. 6.12). Therefore, our model is able to simulate circadian control of cell cycle during
liver regeneration.
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Figure 6.9:
Parameter changes causing G2 delay. Variations in parameters linked to Cdh1 and CKIs result in prolonged Cyclin
E degradation. This prolongation is directly proportional to the delay in the timing of Cyclin B activity and hence
mitosis. Thus, Cdh1 and CKI might have a role to play in untimely degradation of cyclins leading to G2 delay.
Impaired regeneration of fatty liver and mitotic delay
Fatty liver (hepatic steatosis) is the most common hepatic disorder which can be caused by
various etiologies such as obesity, diabetes mellitus and alcohol consumption. Impaired liver
regeneration in fatty livers is a cause of concern in living donor liver transplantations. Various
previous studies have reported some possible causes of impaired liver regeneration in fatty liver
after PH including disruption in cytokine signaling and mitotic factors. Murata et al. (2007)
studied the mitotic response after PH in fatty liver mice. Mitosis was drastically delayed in
fatty liver mice suggesting mitosis to be main cause of proliferation defects in fatty liver mice.
The protein levels of Cyclin B between livers in the lean and fatty mice did not substantially
differ. Interestingly, Cdc2 which is one of the markers of G2 stage and is the activating partner
of Cyclin B, was less phosphorylated in the fatty liver than in the lean group even though Cdc2
protein levels in both groups was almost the same. mRNA and protein levels of Wee1 which
phosphorylates Cdc2 at G2 were observed to be reduced and delayed in fatty liver. Thus delayed
and reduced expression of Wee1 causes Cdc2 phosphorylation at an inappropriate time leading
to delayed appearance of active Cyclin B-Cdc2 complex. In the model we mimicked reduced
Wee1 by increasing degradation parameter of Wee1 (see Appendix 5) and the model is able to
reproduce delayed and reduced expression of Wee1 and active Cyclin B (Fig. 6.13). Delayed
Cyclin B-Cdc2 leads to delayed mitosis and consequently impaired liver regeneration. We sim-
ulate the decreased Wee1 observed in fatty liver by increasing Wee1 degradation rate. Thus,
our model successfully simulates reduced Wee1 as a cause of delayed Cyclin B activity causing
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Figure 6.10:
Effects of time of PH on subsequent liver regeneration. Zeitgeber time (ZT) which is a 12 hour constant light- 12 hour
constant dark cycle, was used to control the day-night light time. White and black bars above the graphs represent
times when lights were on or off, respectively. (A) Kinetics of DNA synthesis (BrdU-incorporation) in hepatocytes
does not differ much between PH performed at ZT8 and PH performed at ZT0. (B) Kinetics of mitotic hepatocytes
after PH at ZT8 is 4-8 hours earlier than PH at ZT0. (C) Kinetics of Cdc2 kinase activity after PH at ZT8 is 4-8 hours
earlier than PH at ZT0 (Matsuo et al., 2003b).
Figure 6.11:
Temporal expression profiles of circadian clock regulated cell cycle genes. 3 cell cycle regulated genes, Cyclin B1,
Cdc2, and Wee1, showed remarkably different expression profiles between PH at ZT8 and PH at ZT0 (Matsuo et al.,
2003b).
impaired liver regeneration in fatty liver mice.
Interestingly, fatty liver disorder is also subjected to circadian regulation. Circadian mutants are
more susceptible to fatty liver disorder (Turek et al., 2005; Kudo et al., 2009). Wee1 is one of
the mediators of reduced mitosis observed in impaired regeneration of fatty liver mice. Wee1 is
also the gatekeeper of circadian regulation of cell cycle as already discussed above. Fatty liver
disorder being regulated by circadian rhythms, and Wee1 being important for both circadian
regulation and fatty liver disorder, suggests Wee1 to be a very important knockout model to
study fatty liver disorders.
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Figure 6.12:
Cyclin B and Wee1 activity in response to PH performed at ZT0 and ZT8. WT in the figure represents the PH
performed at ZT0 and ZT represents PH performed at ZT8, when Wee1 and Cyclin B activity peak earlier as observed
in Fig. 6.11. Note that the normalized amplitudes are plotted here since the focus is on delay.
FoxM1 in proliferation and G2 arrest
FoxM1 is a cell cycle regulated gene with peak expression during G2-M (White et al., 2005).
FoxM1 is a typical proliferation associated transcription factor which is in particular re-expressed
in liver regenerative proliferation following injury. Liver regeneration studies with genetically
altered mice that either prematurely express FoxM1 in hepatocytes (Ye et al., 1999) or contain a
hepatocyte-specific deletion of the FoxM1 targeted allele (Wang et al., 2002) demonstrate that
FoxM1 is required for hepatocyte proliferation through the control of the levels of cell cycle
regulatory proteins. It is found to be over expressed in majority of human tumors. FoxM1
knock-out models in mice indicate that it contributes to both tumor initiation and progression.
FoxM1 is also implicated in transcriptional control of many genes involved during G2-M tran-
sition including Cyclin A, Cyclin B. FoxM1 is active during DNA damage induced G2 arrest.
Alvarez-Fernandez et al. (2010) for the first time show that FoxM1 and some residual cdk activ-
ity is required for the checkpoint recovery after DNA damage; challenging the traditional view
that cdk activity should be completely inhibited during DNA damage to allow for repair. It is
not hard to imagine that some aspect cdk controlled cell cycle machinery remains poised for ac-
tion during DNA damage induced checkpoint. However, with that residual activity of cdk how
the cell makes sure that it does not roll into mitosis before that damage is fixed? Interestingly,
Alvarez-Fernandez et al. (2010) also show that siRNA mediated depletion of Cyclin A but not
Cyclin B strongly inhibits FoxM1 transcription. So one answer to this question would be that
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Figure 6.13:
Delayed mitosis in fatty liver disorder due to Wee1 mediated delayed Cyclin B induction. WT is the wild type mice
in the figure and FL is fatty liver mice. Both Wee1 and Cyclin B activity is delayed as observed in the experiments
(Murata et al., 2007)
.
Cyclin A bound cdk has a residual activity while Cyclin B bound cdk that is essential for mitotic
entry, is more completely blocked. In the model, parameters for Cyclin A and Cyclin B depen-
dent transcription were respectively reduced in order to mimic Cyclin A and Cyclin B siRNA
(see Appendix 5). The E2F species in the model which lumps FoxM1 is able to exhibit that
control of FoxM1 activity is dependent on Cyclin A whereas Cyclin B is dispensable. However,
over-simplification of FoxM1 regulation in our model by lumping it with E2F, limits us to further
dissect into possible systems level controls.
The new role of FoxM1 in G2-M checkpoint recovery and its intricate control by mitotic cyclins
during DNA damage recover makes it an interesting candidate gene for studying G2 arrest.
HGF treatment at S phase causes G2 delay
Growth factors are well known to promote the transition from G1 to S phase in cell cycle pro-
gression. Treatment of cells with HGF at S phase induces G2 delay. Mitosis entry is 1-2 hours
later with delay starting at G2 (Park et al., 2007). It is well known that the protein levels of Cy-
clin A and Cyclin B decrease during M phase progression resulting in the decrease of respective
kinase activities (Clute and Pines, 1999). G2 delay leads to delay in the degradation of Cyclin A
and Cycin B proteins. HGF injection at S phase was mimicked in the model (see Appendix 5)
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Figure 6.14:
FoxM1 (E2F in the model) activity at S-G2 is Cyclin A dependent. FoxM1 is a typical proliferation associated gene
controlling G2-M cyclins during liver regeneration following injury. It is implicated in DNA damage-induced G2
arrest. It is mainly regulated by Cyclin A during S phase, since Cyclin A RNAi significantly reduces its expression
while Cyclin B RNAi has no effect (Alvarez-Fernandez et al., 2010). Our model reproduces these Cyclin A and
Cyclin B RNAi mutants.
and the model was able to reproduce delayed degradation of Cyclin A and Cyclin B (Fig. 6.15).
Erk signaling is known to mediate this G2 delay via CKIs (Han et al., 2005; Dangi et al., 2006;
Park et al., 2007). However, our simulations suggest a contributed role of CKIs, APCCdh1 and
FoxM1 (E2F in the model) dependent delay in Cyclin A and Cyclin B degradation (Fig. 6.15).
FoxM1 plays a role in recovery from DNA damage induced G2 arrest as already discussed in the
previous FoxM1 mutant (Alvarez-Fernandez et al., 2010). Also, the deletion of subunit APC2,
leads to metaphase arrest and stabilization of APC substrates such a Cyclin A and Cycin B which
may be caused by the lack of APCCdh1 (Wirth et al., 2004; Teodoro et al., 2004). Also, spatial
regulation of APCCdh1 mediated Cyclin B degradation has been newly reported to play a role
in maintaining G2 arrest (Holt et al., 2010). All these observations suggest a much complex
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Cdh1 dependent mechanism controlling degradation of Cyclin A and Cyclin B controlling the
G2 arrest in response to growth factor induction at S phase.
As cyclins are major biological targets of APCCdh1-promoted ubiquitination and degradation,
and at the same time cyclin-cdk phosphorylation blocks APCCdh1 activation, creating a positive
feedback between cyclins and APCCdh1 . Such circuitry could result in hysteresis with stabil-
ity of both the G1 low-cyclin/high-Cdh1 state and the S/G2-M high-cyclin/low-Cdh1 state. In
our model, APCCdh1 exerts multiple layers of feedbacks on G2-M cyclins. It would be very
interesting to study the positive feedbacks exerted by APCCdh1 on Cyclin A and Cyclin B dur-
ing G2 delay. Also, in the wake of upcoming experimental evidences of FoxM1 and APCCdh1
related G2 delay, it would be very interesting to dissect a reduced G2-M model at systems level
to understand FoxM1 control of G2 transcription and its interplay with APCCdh1 to control G2
delay.
6.3.3 Irreversibility of mitotic exit
Cyclin proteolysis, is known to be responsible for the mitotic exit and the systems-level feedback
that affects synthesis and degradation rates, make M-G1 transition irreversible. It has been re-
ported that forced cyclin destruction in mitotic budding yeast cells efficiently drives mitotic exit
events. However, these remain reversible after termination of cyclin proteolysis, with recovery
of the mitotic state and cyclin levels. Mitotic exit becomes irreversible only after longer periods
of cyclin degradation, owing to activation of a double-negative feedback loop involving the cdk
inhibitor Sic1 (CKIs in mammals) (Kapuy et al., 2009). Quantitative modeling suggests that
feedback is required to maintain low cdk activity and to prevent cyclin re-synthesis. Recently,
Potapova et al. (Potapova et al., 2009) have reported such an irreversible behaviour of exit from
mitosis in Xenopus and Hela cells and argued a Wee1/Cdc25 mediated feedback mechanism
responsible for irreversibility of mitotic exit after longer periods of cyclin degradation. Thus
Wee1 and Cdc25 mediated positive feedbacks at M-G1 transition were dissected. In this regard,
a reduced version of our G2-M-G1 model was introduced, conserving all the feedback properties
on Cyclin B during G2-M-G1 (Appendix 6).
With this reduced model, we are able to demonstrate bistability observed in the Cyclin B produc-
tion during G2-M transition (Fig. 6.17). Total Cyclin B levels are dependent on its production
and degradation terms. Its activity is enhanced by positive feedbacks from Cdc25 and Wee1
and its degradation is carried out by APCCdh1 in a positive feedback manner and by APCCdc20
in a negative feedback manner (Fig 6.16). Cyclin B nullcline, the S-shaped curve in the plot, is
plotted against its production rate, which is the X-axis. Two thick lines represent its two stable
steady states and the dashed line represents the unsteady state. At lower stimulus strength Cyclin
B system always goes back to lower steady state, represented by down arrows. Once the stimulus
is increased beyond a threshold value (4.5 on X axis), system switches to upper steady state in an
all-or-none fashion, represented by up arrows. Once stimulated to higher level, the system stays
at the higher steady state even if the stimulus is decreased below the threshold value required to
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Figure 6.15:
Growth factor induction at S phase delays mitosis. At S phase HGF is induced (a) which leads to delay in the
degradation of Cyclin A (e) and Cyclin B (f). CKI (b), E2F (FoxM1) (c) and APCCdh1 (d) contribute together in
causing this delayed degradation of G2-M cyclins. Growth factor induction at S phase might lead to increased
FoxM1 (E2F) resulting in increased Cyclin A activity. Since two antagonists Cyclin A and APCCdh1 can not coexist,
APCCdh1 is delayed which leads to delay in Cyclin A and Cyclin B degradation. Also, delayed APCCdh1 might affect
CKIs dependent G2 delay.
flip it on.
In order to study irreversibility at mitotic exit, we are studying the dynamics of Cyclin B with re-
spect to its Wee1 mediated positive feedback, which gets activated at G1, and APCCdh1 mediated
positive feedback which degrades Cyclin B during late mitosis and G1. It is out of the scope to
be part of this thesis, but it would be interesting extension of this thesis to study the role of the
feedbacks at M-G1 transition causing irreversibility.
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Figure 6.16:
Systems level feedbacks acting on Cyclin B regulation during M-G1. Mitotic exit system constitutes three positive
feedbacks from APCCdh1, Wee1 and Cdc25 which lead to an irreversible exit from mitosis.
6.4 Discussion
First damage induced, cytokine and growth factor mediated model of mammalian cell cycle
progression is presented in this chapter, focussing on cell cycle events in regenerating livers of
rodents. The model couples different cyclin-cdk complexes that control the successive phases of
the mammalian cell cycle, which would be capable of describing their sequential activation. The
model presents re-entry of normally quiescent liver cells in to cell cycle after being induced by
injury. The model illustrates many interesting properties of the mammalian cell cycle, mainly
emphasizing on the emerging role of Cdh1 in mammalian cell cycle and of Wee1 during mitotic
exit. The role of Cdh1 and FoxM1 in G2 delay is investigated. The model also reinforces
the role of Wee1 as a gatekeeper of circadian regulated cell cycle and also illustrates reported
deregulation of Wee1 in circadian regulated diseases like fatty liver.
In the wake of upcoming evidences on the role of Cdh1 and FoxM1 during DNA damage in-
duced checkpoint recovery, it would be interesting to study various feedbacks in the model
imposed by Cdh1 on G2-M cyclins during the control of G2 arrest. Also the model proposes
that Wee1/Cdc25 mediated positive feedbacks on Cyclin B at G1 render mitotic exit irreversible.
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Figure 6.17:
Cyclin B synthesis at G2-M is bistable. Total Cyclin B is dependent on its production (Prod) and degradation via
APCCdh1 and APCCdc20. Cyclin B activity is enhanced by positive feedbacks from Cdc25 and Wee1 (Fig 6.16). Total
Cyclin B nullcline is plotted against its production rate. Two thick lines represent two stable steady states of Cyclin
B and the dashed line represents the unsteady state. At lower stimulus strength Cyclin B system always goes back to
lower steady state, represented by down arrows. Once the stimulus is increased beyond a threshold value (4.5 on X
axis), system switches to upper steady state in an all-or-none fashion, represented by up arrows. Once stimulated to
higher level, the system stays at the higher steady state even if the stimulus is decreased below the threshold value
which was required to flip it on.
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First damage induced model of mammalian cell cycle is presented. The model focuses on the
cell cycle during liver regeneration in rodents and illustrates many properties of mammalian cell
cycle, including the newly emerging scope and understanding of the ubiquitination machinery
in the mammalian cell cycle control system.
Role of Cdh1 in G2 delay
Cdh1 lies at the core of cell cycle control system in our model, connecting mitosis to G1 and
having a role to play in G2 arrest. Cdh1 has long been known to be a subunit of the APC
dependent ubiquitination machinery active during late mitosis and G1. Five years ago, discovery
of the role of Cdh1 in degrading G1/S degradator SCF (Bashir et al., 2004; Wei et al., 2004)
and stabilizing p27 in Hela cells opened the window for deciphering the involvement of Cdh1
in maintaining the G1 phase and thus quiescence in mammalian cells. Preserving these Cdh1
dependent properties of G1 control, I went on to further clarify the role of Cdh1 in G2 phase
delay.
Traditional understanding of G2 delay involves CKIs. Lately, Cdh1 has also been reported to
cause G2 arrest by affecting degradation of Cyclin A and Cyclin B. More specifically, Cdh1 was
recently reported to be nuclear guardian of G2 arrest in mice oocytes by controlling degradation
of nuclear Cyclin B (Holt et al., 2010). The model simulates both traditional CKIs dependent
and recently discovered Cdh1 dependent delay in the G2 phase. Cdh1 helps maintain certain
threshold levels of Cyclin B at G2, as suggested by (Holt et al., 2010), which are sufficient
enough to cause G2 arrest but not enough to suppress sudden pool of Cyclin B at G2/M tran-
sition. It would be very interesting to study the mechanisms that could possibly help maintain
such thresholds.
Irreversibility of mitosis in mammalian cells
Exit from mitosis is an irreversible event of the cell cycle. Regulated degradation of mitotic
cyclins is a major factor controlling the mitotic exit, but experimental studies have shown that
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it only provides directionality to the exit from mitosis (Potapova et al., 2006). There are other
mechanisms at the M-G1 that render exit from mitosis irreversible. In yeast cells this irre-
versibility is provided by the positive feedback cyclin-cdks and CKIs, which is active during
M/G1 transition (Tyson and Novak, 2008). Recently, it has been reported that the kinases (Wee1
and Myt1) and phosphatases (Cdc25) that control Cyclin B-Cdk1 activation during G2/M tran-
sition also control the low Cdk1 activity during G1. Thus the incidence of irreversibility might
be explained with the positive feedbacks induced by Wee1 activation and Cdc25 inactivation
in the G1 phase. The model, very clearly shows strong control of Cdc25 and Wee1 in Cyclin
B-Cdk1 inactivation in the early G1 phase. We intend to study this feedback system at the M-G1
interphase and understand if this irreversibility in the mitotic exit is caused by the Wee1/Cdc25
induced double positive feedback. To this end, a reduced model system for the mitotic exit was
generated. Wee1/Cdc25 mediated positive feedback loops on Cyclin B lead to a bistable switch
like activation of Cyclin B, resulting in abrupt G2/M transition.Further the goal is to study how
the Cyclin B concentrations evolve with respect to APCCdh1, the M-G1 degradator of Cyclin B.
The bifurcation analysis of this M-G1 system to study the possibility of irreversibility would be
an interesting extension of this thesis.
Heterogeneity of cell division in the liver
Although the liver tissue has a uniform histological appearance, it is heterogeneous at the level
of morphology and histochemistry. This heterogeneity is linked to the position of a cell within
the functional unit of the tissue, which in turn, is related to the blood supply: Cells located in
the upstream zone (periportal zone) differ from those in the downstream zone (pericentral zone)
with respect to subcellular structures, key enzymes, translocators, and receptors; and therefore,
have different metabolic capacities. Also, some hepatocytes divide only once during liver re-
generation, while others pass through two or more division cycles. Two models (which are not
mutually exclusive) may account for such hepatocyte heterogeneity: (a) individual hepatocytes
may significantly differ in their sensitivity towards cytokine concentrations due to random fluc-
tuations in protein expression (’stochastic model’); (b) a cytokine gradient may be formed during
liver regeneration, so that hepatocytes nearby injured sites or in the periportal zone of lobules
are subject to stronger stimulation, and thereby divide more often (’spatial model’).
Discoveries regarding the functional heterogeneity of the various liver cell types, including hep-
atocytes, hepatic stellate cells, sinusoidal, endothelial, and Kupffer cells, are providing new
insights into our understanding of the development, prevention and treatment of liver disease.
For example, functional differences along zonal patterns have been demonstrated for the hep-
atocytes and can explain the gradients and manifestations of disease observed within lobules.
Intralobular gradients of many metabolites like glucose uptake, glycogen depletion, xenobiotic
metabolism, have been demonstrated.
Extensive simulation studies with populations of proliferating hepatocytes will help generat-
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ing predictions that will allow experiments to distinguish stochastic and spatial heterogeneities.
Awareness of the complexities and heterogeneity of the liver will add to a greater understanding
of liver function and disease processes that lead to toxicity, cancer, and other diseases.
Circadian regulation of cell cycle
Cell division in many mammalian cells is associated with specific times of the day. There is
evidence that the cell division cycle is controlled by the intrinsic circadian clock of the cells.
Effect of circadian timing of treatment on regenerating liver cells in mice has been systematically
carried out by Matsuo et al. (Matsuo et al., 2003b). They investigate Wee1 as the gate-keeper
of circadian regulated cell cycle. Our model is able to reproduce their circadian mutants and we
reinforce role of Wee1 as a gatekeeper of circadian regulated cell cycle.
Interestingly, fatty liver, which is the most common liver disorder is also subjected to the cir-
cadian regulation. Wee1 deregulation is one of the causes of impaired mitosis in fatty liver
(Murata et al., 2007). The model simulates Wee1 dependent disrupted Cyclin B activity and
thus impaired mitosis in fatty liver. Pertaining to its important role in circadian control of cell
cycle and also in regulating circadian diseases, we suggest Wee1 mutant to be an important
model system to study circadian regulated tumors and xenobiotic metabolism.
It would be also very interesting to study dynamic simulations of circadian modulations of liver
regeneration through oscillating expression of Wee1.
FoxM1 and Cdh1 mutants for mammalian cells
FoxM1 is a typical mitotic transcription factor that is re-expressed in liver regenerative prolif-
eration following injury and is over-expressed in most of the human tumors. It is very widely
studied in age related and mitotic defects in regenerating mice livers. Also, recently it has been
implicated in G2 delay (Alvarez-Fernandez et al., 2010). We could successfully simulate Cyclin
A dependent control of FoxM1 at G2.
Although over-simplification of FoxM1 regulation in our model by lumping it with E2F, limits
us to further dissect into possible systems level controls. However, in the wake of upcoming
experimental evidences of FoxM1 and APCCdh1 related G2 delay, it would be very interesting to
dissect a reduced G2-M model at systems level to understand FoxM1 control of G2 transcription
and its interplay with APCCdh1 to control G2 delay. Thus, we suggest Cdh1 and FoxM1 to be
good model systems to study G2 delay in mammalian cells.
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Implications of liver regeneration to human disease
In humans, liver regeneration occurs most frequently after liver damage by ischaemia or hep-
atitis an inflammation of the liver that is caused by insults such as toxins, viral infection or
immune-mediated injury. Therefore, understanding liver regeneration in humans will help ex-
plain how the liver responds to toxic damage by alcohol and drug overdose, or infections like
viral hepatitis. Humans with certain hepatic conditions, including cirrhosis (fibrosis of the liver),
steatosis (fatty liver), and even those conditions that are due to old age, also have impaired liver
regeneration that results in increased morbidity and mortality in response to liver transplantation
or toxic chemicals. At present, there is little insight into how the molecular pathways that are
necessary for regeneration are altered in these disease states and pathophysiological conditions.
Greater insights will be required to develop improved pharmacological therapeutics and surgi-
cal approaches for the various medical conditions in which robust liver regeneration is needed.
Therefore, understanding the molecular bases regenerating liver cells will not only help to de-
fine the pathology in human conditions in which liver regeneration is impaired, it will ultimately
provide new treatment options for patients with liver damage.
Cell cycle and cancer
The core cyclin dependent regulatory machinery of the cell cycle is quite well understood in
yeast. Our model is an attempt in understanding mammalian cell cycle through a damage in-
duced model of regenerating liver cells in mice. The main challenge for the future is to further
understand core cell cycle machinery in mammalian cells and put this into larger contexts of cell
physiology, and to investigate, for example, how a cell copes with problems at checkpoints, how
it responds to environmental changes, why some cells leave the cell cycle and commit suicide,
etc.
The core cell cycle module is regulated by several incoming signals and it drives several down-
stream events. The duty of this central controller is to process the information it receives and
decide how to handle DNA replication and nuclear division. Current models use some parame-
ters as incoming signals and can tell how this input determines the timing of cell cycle events.
Some models already investigate how the circadian clock and checkpoint signals regulate cell
cycle. These models are very detailed either on the cell cycle machinery or on the signaling net-
work, but comprehensive models that incorporate both control systems in detail do not exist yet.
Several models are available for pathways that signal to the cell cycle machinery the presence
of nutrients, pheromones, stress inducing agents, etc. These could be merged with appropriate
cell cycle models to reveal if our current knowledge of the signaling pathway, cell cycle network
interactions is indeed complete. Similarly, many other biological pathways like NF-κB and p53
interact with the cell cycle. While computational models also exist for these processes, they still
need to be connected to the cell cycle models and to each other.
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Another perspective is to step up from the single cell level and simulate how cell-to-cell interac-
tions alter cell proliferation at the tissue level. This requires multi-scale parallel handling of the
cell cycle controls within individual cells while simulating their interactions through signaling at
the same time. For this problem we need, first of all, reliable cell cycle models for animal cells,
desirably specific models of specific cell types, and in addition we need experimental measure-
ments on the signaling between cells. Such detailed models are far in the future, but we already
can learn from some models that take steps in this direction.
These steps lead us to the major future goal: to understand how perturbations of the human cell
cycle machinery lead to tumor formation. Indeed mathematical modeling of cancer development
is another active research field. Predictive cell cycle models embedded into complex tissue
models can help us in the future to understand the dynamics of cancer formation.
After completion of the thesis and the manuscript, two papers have been published
which support the work done in this thesis. Gerard and Goldbeter (2009) presents
another mammalian cell cycle model based on the similar lines of sequential cyclin-
cdk activation. However, it is a growth factor induced model demonstrating repet-
itive cell cycling in the presence of suprathreshold amounts of GF. The main em-
phasis is on pRb-E2F network during G1 and Cyclin A dependent activation of
Cyclin B during mitotic entry. On the contrary, this model presents re-entry of nor-
mally quiescent liver cells in to cell cycle after being induced by injury and focuses
on Cdh1, FoxM1 and Wee1 dependent regulation of mitotic events. Kapuy et al.
(2009) discuss the systems-level positive feedbacks imposed by Cdc25/Wee1 to be
responsible for the irreversibility of mitotic exit in mammalian cells.
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Appendix
1 Model Equations
The model contains 24 variables and 75 parameters. The 24 variables are the concentrations of
the following proteins involved in the cell cycle control: Cyclins D, E, A, and B; the inhibitor
CKIs and its complexes with the active cyclin-cdk complexes; the active and inactive forms
phosphatase Cdc25 and of the kinase Wee1; the SCF proteasomal ligases involved in the degra-
dation of cyclin D, Cyclin E and CKIs; and the active and inactive forms of the proteins Cdh1
and Cdc20 involved in the degradation of cyclins A and B.
Vm represents mechaelis menten production parameters. V is the non-mechaelis menten produc-
tion parameters. P represents phosphorylation parameters. d represents degradation parameters.
kon is the stoichiometric complex association parameter and koff is stoichiometric complex dis-
sociation parameter. Subscripts are the corresponding product and superscripts are the inducers.
f is the positive feedback strength on HGF and ka1 is the positive feedback strength on active
Cyclin B.
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2 G1-S model
parameters
VmPIC = 1.54 KmPGEPIC = 0.9 Km
Dmg
PIC = 0.5
dPIC = 0.43 VPICPGE = 0.61 dPGE = 0.006
VmPICIEG = 4.6 Km
PIC
IEG = 0.7 dIEG = 6.15
VmPICPAI = 46.15 Km
PIC
PAI = 0.5 dPAI = 6.15
V IEGHGF = 5.06 Km
IEG
HGF = 0.12 Km
PAI
HGF = 0.18
dHGF = 0.06 VmHBEGF = 15 Km
Dmg
HBEGF = 0.9
KmIEGHBEGF = 0.005 Km
HGF
HBEGF = 1 dHBEGF = 0.05
VmPICCKI = 7.69 km
PIC
CKI = 0.001 dCKI = 7.69
VHGFCD = 3.12 Km
IEG
CD = 0.001 dCD = 0.031
VmHBEGFCE = 15 Km
HBEGF
CE = 30 Vm
CD
CE = 15
KmCDCE = 30 dCE = 0.02 kon
CD
CKI = 0.008
ko f fCDCKI = 0.0008 konCECKI = 2.23 ko f fCECKI = 6.15
VCESCF = 0.77 dSCF = 0.008
G1-S model equations
Input signal for the model is a decaying damage (Dmg) observed in regenerating hepatocytes
after PH. Damage signals induce priming via cytokine signaling which further induces growth
factor pathways leading to mitogenic stimulation of Cyclin D. Growth factor HB-EGF is also
directly induced by Dmg. Cyclin E is induced both by direct growth factor activation (via HB-
EGF) and cytokine mediated growth factor activation (via HGF and Cyclin D. Assumptions
and simplifications made for the model equations can be found in the supplementary data from
Chauhan et al. (2008).
[Dmg] = I0 · e−Idecay · t
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2 G1-S model
Priming: Cytokine induced
d [PIC]
dt
=
VmPIC
1+( PGE
KmPGEPIC
)2
· Dmg
KmDmgPIC +Dmg
−dPIC ·PIC
d [PGE]
dt
=VPICPGE ·PIC−dPGE ·PGE
d [IEG]
dt
=
VmPICIEG ·PIC3
KmPICIEG
3
+PIC3
−dIEG · IEG
d [PAI]
dt
=
VmPICPAI ·PIC3
(KmPICPAI
3
+PIC3
−dPAI ·PAI
G1 : Growth factor induced
d [HGF ]
dt
=
V IEGHGF · IEG
1+( PAIKmPAIHGF
)
4 ·
1+ f ·HGF
KmIEGHGF +HGF
−dHGF ·HGF
d [HBEGF ]
dt
=
VmHBEGF ·Dmg4
Dmg4+KmDmgHBEGF
4 ·
IEG
KmIEGHBEGF + IEG
· HGF
KmHGFHBEGF +HGF
−dHBEGF ·HBEGF
G1/S
Cyclin D
d [CycD]
dt
=
kHGFCycD ·HGF · IEG
KmIEGCycD+ IEG
−dCycD ·CycD ·SCF− d [CycD|CKI]dt
d [CycD|CKI]
dt
= kCycDCKI ·CycD ·CKI− ko f fCycD|CKI ·CycD|CKI
Cyclin E
d [CycE]
dt
=
VmHBEGFCycE ·HBEGF2
HBEGF2+KmHBEGFCycE
2 +
VmCycDCycE ·CycD4
KmCycDCycE
4
+CycD4
−dCycE ·CycE ·SCF− d [CycE|CKI]dt
d [CycE|CKI]
dt
= kCycECKI ·CycE ·CKI− ko f fCycE|CKI ·CycE|CKI
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3 G1/S model extension
The G1/S model was further extended and connected to mitosis via E2F and Cdh1. Sequential
activation of E2F by G1-S cyclins – Cyclin D and Cyclin E, leads to transcription of mitotic
cyclins – Cyclin A and Cyclin B. At the end of mitosis, Cyclin B degradation leads to Cdh1
binding to APC and activation of APCCdh1 which degrades G1 substrates – SCF and CKI and
also the mitotic substrates – Cyclin A, Cyclin B and Cdc20.
E2F–Rb system parameters
E2FT = 0.05 RbT = 1 p1 = 3
p−1 = 1 p2 = 4 p−2 = 1
k1 = 100 o f fRbE2F = 4 k2 = 1
o f fRbPE2F = 1 k3 = 1 o f fRbPPE2F = 10
E2F–Rb equations
The scheme depicts initiation of Rb phosphorylation by Cyclin D and release of some E2F,
which then increases Cyclin E transcription. Cyclin E further phosphorylates RbP to release
more E2F.
CycD CycE
↓ ↓
Rb
p1

p−1
Rbp
p2

p−2
Rbpp
Rb+E2F
k1

k−1
E2FRb
Rbp+E2F
k2

k−2
E2FRbp
Rbpp+E2F
k3

k−3
E2FRbpp
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3 G1/S model extension
Steady state Pool of E2F can be described by the temporal evolution of Cyclin D and Cyclin E,
if phosphorylation/dephsophorylation reactions of Rb and association/dissociation of its three
phosphorylated forms with E2F is in equilibrium is fast enough, as described in the kinetic
equations part of section 6.1.
[Rbp] =
p1
p−1
· [Rb] · [CycD]
[Rbpp] =
p1p2
p−1p−2
· [Rb] · [CycD] · [CycE]
[Rb ·E2F ] = k1
k−1
· [Rb] · [E2F ]
[Rbp ·E2F ] = p1k2p−1k−2 · [Rb] · [CycD] · [E2F ]
[Rbpp ·E2F ] = p1p2k3p−1p−2k−3 · [Rb] · [CycD] · [CycE] · [E2F ]
Total concentrations
[RbT ] = [Rb]+ [Rbp]+ [Rbpp]+ [Rb ·E2F ]+ [Rbp ·E2F ]+ [Rbpp ·E2F ]
[E2FT ] = [E2F ]+ [Rb ·E2F ]+ [Rbp ·E2F ]+ [Rbpp ·E2F ]
Substituting the steady state values of [Rb], [Rbp], [Rbpp], [Rb ·E2F ], [Rbp ·E2F ],
and [Rbpp ·E2F ] into the total concentrations of [RbT ] and [E2FT ], we solve the equation for
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E2F as,
nom= 1
+
p1
p−1
· [CycD]
+
p1 · p2
p−1 · p−2 · [CycD] · [CycE]
denom=
k1
k−1
+
k2
k−2
· p1
p−1
· [CycD]
+
k3
k−3
· p1 · p2
p−1 · p−2 · [CycD] · [CycE]
p= RbT −E2FT + nomdenom
q=− nom
denom
E2F =−p/2+
√
p · p/4−q
G1-S model extension parameters
dCdh1CKI = 7.69 k
Cdh1
SCF = 0.77
VE2FCA = 0.25 V
E2F
CB = 1
G1-S model extension equations
Following are the equations connecting CKI and SCF from G1-S model to mitosis via
APCCdh1. Transcriptional activation of mitotic cyclins – Cyclin A and Cyclin B by G1-S acti-
vated E2F is depicted in mitosis equations in section 4. Also Cdh1 binding and activation of
APCCdh1 is explained in mitosis section 4.
d [CKI]
dt
=VmPICCKI ·
PIC
kmPICCKI+PIC
−dCKI ·CKI−dCdh1CKI ·APCCdh1 ·CKI
− d [CycD|CKI]
dt
− d [CycE|CKI]
dt
− d [CycD|CKI]
dt
d [SCF ]
dt
=VCESCF ·CycE−dCdh1SCF ·SCF ·APCCdh1−dSCF ·SCF
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4 Mitosis model
Mitosis model parameters
APCT = 1 dCdh1CA = 0.5
dCA = 0.05 dCdh1CB = 2 d
Cdc20
CB = 4
dCB = 0.1 PWee1CB = 0.8 k1 = 5.4
k2 = 5 ka1 = 0.75 Wee1b = 0.1
PCBWee1 = 100 dWee1 = 0.25 dphosWee1 = 0.05
Cdc25b = 0.1 PCBCdc25 = 50 dCdc25 = 0.5
dphosCdc25 = 1 Cdh1b = 0.77 PCACdh1 = 0.38
PCBCdh1 = 0.77 kAPCCdh1 = 0.5 dCdh1 = 0.38
dphosCdh1 = 0.05 Cdc20b = 0.04 dCdc20 = 0.06
PCBCdc20 = 7.7 k
Cdc20p
APC = 1 dphosCdc20 = 0.03
dCdh1Cdc20 = 0.77 kon
CKI
CA = 0.01 ko f fCACKI = 0.1
Cyclin B derivations
Cyclin B exists in two forms in our model: CycB (active Cyclin B) and CycBp (inactive Cyclin
B). Inactive Cyclin B equation is adapted from (Pomerening et al., 2005) with the simplification
that the phosphorylation/dephosphorylation of the three inactive forms of Cyclin B viz tran-
scribed Cyclin B (CycB), Tyrosine phosphorylated (CycBY ), and Tyrosine and Threonine phos-
phorylated (CycBYT ) is fast enough to be always in equilibrium; so that equation forCycBYT can
be algebraically solved.
95
Appendix
CycB
Wee1

Cdc25p
CycBY
Wee1
 CycBYT
Cdc25p


Wee1
CycBT
CycB=CycBT (active)
CycBp =CycB+CycBY +CycBYT (inactive)
CycBY = k1
1
Wee1
·CycBYT
CycB= k2 ·Cdc25p
Wee1
·CycBY
Solving for CycBYT
CycBYT =
CycBp ·Wee12
Wee12+ k1 ·Wee1+ k1 · k2 ·Cdc25p
CycB= ka1 ·Cdc25p ·CycBYT
CycBp = PWee1CB ·Wee1 ·CycB
Mitosis model equations
Assumptions and simplifications made for rest of the model equations are explained in the kinetic
equations part of section 6.1. G1-S phase induced E2F activation is explained in previous section
3
Cyclin A
d [CycA]
dt
=VmE2FCycA ·E2F
− kCdh1CycA · [APC|Cdh1] · [CycA]−dCycA · [CycA]−
d [CycA|CKI]
dt
d [CycA|CKI]
dt
= konCycA|CKI · [CycA] · [CKI]− ko f fCycA|CKI · [CycA|CKI]
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Cyclin B
CyclinB(inactive) =CycB+CycBY +CycBYT
d [CycBp]
dt
=VmE2FCycB ·E2F
− ka1 ·Cdc25p · [CycBp] · [Wee1]
2
[Wee1]2+ k1 · [Wee1]+ k1 · k2 · [Cdc25p]
+ k · [Wee1] · [cycB]
− kCdh1CycB · [APC|Cdh1] · [CycBp]− kCdc20CycB · [APC|Cdc20p] · [CycBp]
−dCycB · [CycBp]
CyclinB(active) =CycBT
d [CycB]
dt
=−k · [Wee1] · [CycB]
+
ka1 · [Cdc25p] · [CycBp] · [Wee1]2
[Wee1]2+ k1 · [Wee1]+ k1 · k2 · [cdc25S]
− kCdh1CycB · [APC|Cdh1] · [CycB]− kCdc20CycB · [APC|Cdc20p] · [CycB]
−dCycB · [CycB]
Wee1
Wee1(active)
d [Wee1]
dt
=Wee1b−VCycBWee1 · [CycB] · [Wee1]+dphosWee1 · [Wee1p]
−dWee1 · [Wee1]
Wee1(inactive)
d [Wee1p]
dt
=VCycBWee1 · [CycB] · [Wee1]−dphosWee1 · [Wee1p]
−dWee1 · [Wee1p]
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Cdc25
Cdc25(inactive)
d [Cdc25]
dt
=Cdc25b−VCycBCdc25 · [CycB] · [Cdc25]+dphosCdc25 · [Cdc25p]
−dCdc25 · [Cdc25]
Cdc25(active)
d [Cdc25p]
dt
=VCycBCdc25 · [CycB] · [Cdc25]−dphosCdc25 · [Cdc25p]
−dCdc25 · [Cdc25p]
APC
APCT = APC+APCCdh1+APCCdc20p
APC =
APCT
1+ kCdh1APC · [Cdh1]+ kCdc20APC · [Cdc20p]
APCCdh1 = kCdh1APC · [Cdh1] · [APC]
APCCdc20p = kCdc20APC · [Cdc20p] · [APC]
Cdh1(active)
d [Cdh1]
dt
=Cdh1b−VCycACdh1 · [CycA] · [Cdh1]−VCycBCdh1 · [CycB] · [Cdh1]
+dphosCdh1 · [Cdh1p]−dCdh1 · [Cdh1]
Cdh1(inactive)
d [Cdh1p]
dt
=VCycACdh1 · [CycA] · [Cdh1]−VCycBCdh1 · [CycB] · [Cdh1]
−dphosCdh1 · [Cdh1p]−dCdh1 · [Cdh1p]
Cdc20(inactive)
d [Cdc20]
dt
=Cdc20b−VCycBCdc20 · [CycB] · [Cdc20]+dphosCdc20 · [Cdc20p]
−dCdh1Cdc20 · [APC|Cdh1] · [Cdc20]−dCdc20 · [Cdc20]
Cdc20(active)
d [Cdc20p]
dt
=VCycBCdc20 · [CycB] · [Cdc20]−dphosCdc20 · [Cdc20p]
−dCdh1Cdc20 · [APC|Cdh1] · [Cdc20p]−dCdc20 · [Cdc20p]
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5 Mutant parameters
Initial conditions
x0Wee1 = 0.4 x0Cdh1 = 1.7 x0others = 0.00001
Double peak parameters
Following are the parameters associated with increased feedback strengths of Cdc25, Wee1 and
APCCdc20 which lead to a secondary peak in mitosis as observed in regenerating hepatocytes.
ka1 = 20 kCdc20APC = 100
5 Mutant parameters
FoxM1 mutant
siRNA mutant of Cyclin A and Cyclin B affecting FoxM1 transcription.
VE2FCA = 1 V
E2F
CB = 0.1
Wee1 mutant
Wee1 mutant for
ka1 = 0.6 dWee1 = 0.025
HGF injection
hg f s= 0.4
dHGF =
V IEGHGF · IEG
1+( PAI
KmPAIHGF
4
)
· (1+ f ·HGF
KmIEGHGF +HGF
)
−dHGF ·HGF+hg f s · (t < 40) · (t > 36)
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6 Bistability
Cyclin BAPC-Cdh1
Wee1
Cdc25
APC-Cdc20Prod
Figure 1: reduced model of mitosis for bistabilty.
A reduced version of model which demonstrates bistability observed in the Cyclin B activation
during G2-M transition (Fig. 6.17). Total Cyclin B levels are dependent on its production and
degradation terms. Its activity is enhanced by positive feedbacks from Cdc25 and Wee1 and
its degradation is carried out by APCCdh1 in a positive feedback manner and by APCCdc20 in a
negative feedback manner (Fig 6.16).
Bistability parameters
k1 = 1 k2 = 10 k3 = 10
k4 = 1 dc = 10 db = 0.05
Cdh1T = 1 APCT = 1 Wee1T = 1
Cdc25T = 1 k7 = 1 k7i = 1
k8 = 1 Cdc20t = 1 k9 = 1
ds = 0.1 k5 = 1 k6 = 1
Initial conditions
BT = 0.01 APCCdc20s= 0.01 prod = 0.4
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Bistability equations
APCT = APC+APCCdh1+APCdc20p
Cdh1T =Cdh1+Cdh1p+APCCdh1
CycBT =CycB+CycBp
Wee1T =Wee1+Wee1p
Cdc25T =Cdc25+Cdc25p
k1 · [APC] · [Cdh1] = [APCCdh1]
k2 · [CycB] · [Cdh1] = [Cdh1p]
k3 · [Wee1] · [CycB] = [CycBp]
k4 · [CycB] · [Wee1] = [Wee1p]
k5 · [CycB] · [Cdc25] = [Cdc25p]
k6 · [Cdc25p] · [CycBp] = [CycB]
k7 · [APC] · [Cdc20p] = [AC20p]
k8 · [Cdc20] · [CycB] = [Cdc20p]
APCCdh1 = AC1
APCCdc20 = AC20
Solving for [CycBp],
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CycBT =CycB+ k3 · Wee1T1+ k4 · [CycB] · [CycB]+
1+ k5 · [CycB]
k5k6 · [Cdc25T ]
CycB=CB
CycBT = BT
CB=
−b1−b2 ·BT +
√
−4 ·b3 ·b4+(b1+b2 ·BT )2
2 ·b4
Cdc20p = k8 ·CB · (Cdc20t −AC20p)/(1+ k9 ·CB)
APC = APCT −AC1−AC20p
AC1 =
1
2 · k1 · (k2 ·CB+ c1− k1 ·AC20p
−
√
(−k2 ·CB− c1+ k1 ·AC20p)2−4 · k21 · (c3 ·AC20p))
d [bt]/dt = prod−dc ·AC1 · (BT −CB)−ds ·AC20p · (BT −CB)−db ·BT
d [AC20p]/dt = k7 ·APC ·Cdc20p− k7i ·AC20p
d [prod]/dt = 0
b1 =−k4− k5−Cdc25T · k5 · k6−Cdc25T · k3 · k5 · k6 ·Wee1T
b2 =Cdc25T · k4 · k5 · k6
b3 = 1−Cdc25T ·BT · k5 · k6
b4 = k4 · k5+Cdc25T · k4 · k5 · k6
c1 = k1 ·APCT + k1 ·Cdh1T +1
c2 = APCT ·Cdh1T
c3 = c2−Cdh1T
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